{"entity":"bristol-myers-squibb","name":"Bristol-Myers Squibb","kind":null,"summary":"Bristol-Myers Squibb's timeline holds 528 claims from 2006 to 2026: 3 people, 514 money & deals, 11 other. 11 are undated. The latest took effect on October 21, 2026.","counts":{"total":528,"by_kind":{"people":3,"money":514,"products":0,"models":0,"other":11}},"events":[{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb ticker: CELG-RI\", undated. Claim clm_1EFB3D1960DA, https://asof.is/claim/clm_1EFB3D1960DA, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000014272.","url":"https://asof.is/claim/clm_1EFB3D1960DA","accessed":"2026-11-09"},"kind":"other","predicate":"ticker","value":"CELG-RI","status":"valid","assertable":true,"id":"clm_1EFB3D1960DA","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb state of incorporation: DE\", undated. Claim clm_48211D1EBA75, https://asof.is/claim/clm_48211D1EBA75, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000014272.","url":"https://asof.is/claim/clm_48211D1EBA75","accessed":"2026-11-09"},"kind":"other","predicate":"state_of_incorporation","value":"DE","status":"valid","assertable":true,"id":"clm_48211D1EBA75","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cik: 0000014272\", undated. Claim clm_772C4FAC73F0, https://asof.is/claim/clm_772C4FAC73F0, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000014272.","url":"https://asof.is/claim/clm_772C4FAC73F0","accessed":"2026-11-09"},"kind":"other","predicate":"cik","value":"0000014272","status":"valid","assertable":true,"id":"clm_772C4FAC73F0","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":"2026-03-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cfo: David V. Elkins\", undated. Claim clm_7B0B3B31B401, https://asof.is/claim/clm_7B0B3B31B401, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000006/bmy-20260325.htm.","url":"https://asof.is/claim/clm_7B0B3B31B401","accessed":"2026-11-09"},"kind":"people","predicate":"cfo","value":"David V. Elkins","status":"valid","assertable":true,"id":"clm_7B0B3B31B401","evidence":{"by":"page-read","on":"2026-11-09","quote":"David V. Elkins EVP and Chief Financial Officer Cristian Massacesi, M.D. EVP and Chief Medical Officer, Head of Development","url":"https://www.sec.gov/Archives/edgar/data/14272/000001427226000006/bmy-20260325.htm"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb listed on: NYSE\", undated. Claim clm_7C0328B0E90C, https://asof.is/claim/clm_7C0328B0E90C, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000014272.","url":"https://asof.is/claim/clm_7C0328B0E90C","accessed":"2026-11-09"},"kind":"other","predicate":"listed_on","value":"NYSE","status":"valid","assertable":true,"id":"clm_7C0328B0E90C","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb registrant name: BRISTOL MYERS SQUIBB CO\", undated. Claim clm_B021E66EA136, https://asof.is/claim/clm_B021E66EA136, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000014272.","url":"https://asof.is/claim/clm_B021E66EA136","accessed":"2026-11-09"},"kind":"other","predicate":"registrant_name","value":"BRISTOL MYERS SQUIBB CO","status":"valid","assertable":true,"id":"clm_B021E66EA136","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb fiscal year end: 12-31\", undated. Claim clm_B055BC429569, https://asof.is/claim/clm_B055BC429569, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000014272.","url":"https://asof.is/claim/clm_B055BC429569","accessed":"2026-11-09"},"kind":"other","predicate":"fiscal_year_end","value":"12-31","status":"valid","assertable":true,"id":"clm_B055BC429569","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb headquarters: Princeton\", undated. Claim clm_C642296F0710, https://asof.is/claim/clm_C642296F0710, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000014272.","url":"https://asof.is/claim/clm_C642296F0710","accessed":"2026-11-09"},"kind":"other","predicate":"headquarters","value":"Princeton","status":"valid","assertable":true,"id":"clm_C642296F0710","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb sic industry: Pharmaceutical Preparations (2834)\", undated. Claim clm_DF7B0F2F37F6, https://asof.is/claim/clm_DF7B0F2F37F6, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000014272.","url":"https://asof.is/claim/clm_DF7B0F2F37F6","accessed":"2026-11-09"},"kind":"other","predicate":"sic_industry","value":"Pharmaceutical Preparations (2834)","status":"valid","assertable":true,"id":"clm_DF7B0F2F37F6","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb ticker: BMY\", undated. Claim clm_ED7EF0279BF9, https://asof.is/claim/clm_ED7EF0279BF9, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000014272.","url":"https://asof.is/claim/clm_ED7EF0279BF9","accessed":"2026-11-09"},"kind":"other","predicate":"ticker","value":"BMY","status":"valid","assertable":true,"id":"clm_ED7EF0279BF9","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb website: https://www.bms.com/\", undated. Claim clm_6C58446D45ED, https://asof.is/claim/clm_6C58446D45ED, accessed 2026-11-09. Source: https://www.wikidata.org/wiki/Q266423.","url":"https://asof.is/claim/clm_6C58446D45ED","accessed":"2026-11-09"},"kind":"other","predicate":"website","value":"https://www.bms.com/","status":"unverified","assertable":false,"why_not":"low_confidence","id":"clm_6C58446D45ED","evidence":{"by":"own-site","on":"2026-11-08","quote":"Bristol Myers Squibb - Global Biopharmaceutical Company.","url":"https://www.bms.com/"}},{"date":"2006-12-31","until":"2007-12-31","published":"2010-02-19","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 2,018,000,000 United States dollar\", as of 2006-12-31 (until 2007-12-31). Claim clm_140302496E1F, https://asof.is/claim/clm_140302496E1F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312510035167/0001193125-10-035167-index.htm.","url":"https://asof.is/claim/clm_140302496E1F","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"2,018,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_140302496E1F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2009, filed 2010-02-19"}},{"date":"2007-12-31","until":"2008-06-30","published":"2010-02-19","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 1,801,000,000 United States dollar\", as of 2007-12-31 (until 2008-06-30). Claim clm_0494564B2DA8, https://asof.is/claim/clm_0494564B2DA8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312510035167/0001193125-10-035167-index.htm.","url":"https://asof.is/claim/clm_0494564B2DA8","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,801,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0494564B2DA8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2009, filed 2010-02-19"}},{"date":"2007-12-31","until":"2008-12-31","published":"2010-02-19","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb research and development: 3,160,000,000 United States dollar\", as of 2007-12-31 (until 2008-12-31). Claim clm_3176728251F2, https://asof.is/claim/clm_3176728251F2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312510035167/0001193125-10-035167-index.htm.","url":"https://asof.is/claim/clm_3176728251F2","accessed":"2026-11-09"},"kind":"money","predicate":"research_and_development","value":"3,160,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3176728251F2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2009, filed 2010-02-19"}},{"date":"2007-12-31","until":"2008-12-31","published":"2010-02-19","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb net income: 2,165,000,000 United States dollar\", as of 2007-12-31 (until 2008-12-31). Claim clm_A576452DB99C, https://asof.is/claim/clm_A576452DB99C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312510035167/0001193125-10-035167-index.htm.","url":"https://asof.is/claim/clm_A576452DB99C","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"2,165,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A576452DB99C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2009, filed 2010-02-19"}},{"date":"2007-12-31","until":"2008-12-31","published":"2010-02-19","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb revenue: 15,617,000,000 United States dollar\", as of 2007-12-31 (until 2008-12-31). Claim clm_C385A7558EA1, https://asof.is/claim/clm_C385A7558EA1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312510035167/0001193125-10-035167-index.htm.","url":"https://asof.is/claim/clm_C385A7558EA1","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"15,617,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C385A7558EA1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-K FY2009, filed 2010-02-19"}},{"date":"2008-06-30","until":"2008-09-30","published":"2009-07-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 5,203,000,000 United States dollar\", as of 2008-06-30 (until 2008-09-30). Claim clm_BF6999DA6A38, https://asof.is/claim/clm_BF6999DA6A38, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312509153889/0001193125-09-153889-index.htm.","url":"https://asof.is/claim/clm_BF6999DA6A38","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"5,203,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BF6999DA6A38","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q2 FY2009, filed 2009-07-23"}},{"date":"2008-06-30","until":"2008-09-30","published":"2009-07-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 826,000,000 United States dollar\", as of 2008-06-30 (until 2008-09-30). Claim clm_D4A1B1B0AE97, https://asof.is/claim/clm_D4A1B1B0AE97, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312509153889/0001193125-09-153889-index.htm.","url":"https://asof.is/claim/clm_D4A1B1B0AE97","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"826,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D4A1B1B0AE97","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2009, filed 2009-07-23"}},{"date":"2008-06-30","until":"2008-09-30","published":"2009-07-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 4,047,000,000 United States dollar\", as of 2008-06-30 (until 2008-09-30). Claim clm_E1F5893FE2CE, https://asof.is/claim/clm_E1F5893FE2CE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312509153889/0001193125-09-153889-index.htm.","url":"https://asof.is/claim/clm_E1F5893FE2CE","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"4,047,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E1F5893FE2CE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2009, filed 2009-07-23"}},{"date":"2008-06-30","until":"2008-09-30","published":"2009-07-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 764,000,000 United States dollar\", as of 2008-06-30 (until 2008-09-30). Claim clm_E71C501C8306, https://asof.is/claim/clm_E71C501C8306, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312509153889/0001193125-09-153889-index.htm.","url":"https://asof.is/claim/clm_E71C501C8306","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"764,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E71C501C8306","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2009, filed 2009-07-23"}},{"date":"2008-09-30","until":"2008-12-31","published":"2009-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 7,173,000,000 United States dollar\", as of 2008-09-30 (until 2008-12-31). Claim clm_130C987CF3F0, https://asof.is/claim/clm_130C987CF3F0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312509211734/0001193125-09-211734-index.htm.","url":"https://asof.is/claim/clm_130C987CF3F0","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"7,173,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_130C987CF3F0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2009, filed 2009-10-22"}},{"date":"2008-09-30","until":"2009-03-31","published":"2009-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 834,000,000 United States dollar\", as of 2008-09-30 (until 2009-03-31). Claim clm_474970165AA1, https://asof.is/claim/clm_474970165AA1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312509211734/0001193125-09-211734-index.htm.","url":"https://asof.is/claim/clm_474970165AA1","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"834,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_474970165AA1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2009, filed 2009-10-22"}},{"date":"2008-09-30","until":"2009-03-31","published":"2009-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 2,578,000,000 United States dollar\", as of 2008-09-30 (until 2009-03-31). Claim clm_F064DBE19873, https://asof.is/claim/clm_F064DBE19873, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312509211734/0001193125-09-211734-index.htm.","url":"https://asof.is/claim/clm_F064DBE19873","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"2,578,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F064DBE19873","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2009, filed 2009-10-22"}},{"date":"2008-09-30","until":"2009-03-31","published":"2009-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 5,254,000,000 United States dollar\", as of 2008-09-30 (until 2009-03-31). Claim clm_F7EF5D23F54F, https://asof.is/claim/clm_F7EF5D23F54F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312509211734/0001193125-09-211734-index.htm.","url":"https://asof.is/claim/clm_F7EF5D23F54F","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"5,254,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F7EF5D23F54F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q3 FY2009, filed 2009-10-22"}},{"date":"2008-12-31","until":"2009-03-31","published":"2010-02-19","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 7,976,000,000 United States dollar\", as of 2008-12-31 (until 2009-03-31). Claim clm_3190F41977D5, https://asof.is/claim/clm_3190F41977D5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312510035167/0001193125-10-035167-index.htm.","url":"https://asof.is/claim/clm_3190F41977D5","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"7,976,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3190F41977D5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2009, filed 2010-02-19"}},{"date":"2008-12-31","until":"2009-06-30","published":"2010-02-19","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 12,241,000,000 United States dollar\", as of 2008-12-31 (until 2009-06-30). Claim clm_375333654B18, https://asof.is/claim/clm_375333654B18, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312510035167/0001193125-10-035167-index.htm.","url":"https://asof.is/claim/clm_375333654B18","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"12,241,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_375333654B18","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2009, filed 2010-02-19"}},{"date":"2008-12-31","until":"2009-12-31","published":"2010-02-19","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb net income: 5,247,000,000 United States dollar\", as of 2008-12-31 (until 2009-12-31). Claim clm_7A0B346282B2, https://asof.is/claim/clm_7A0B346282B2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312510035167/0001193125-10-035167-index.htm.","url":"https://asof.is/claim/clm_7A0B346282B2","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"5,247,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7A0B346282B2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2009, filed 2010-02-19"}},{"date":"2008-12-31","until":"2009-12-31","published":"2010-02-19","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb research and development: 3,512,000,000 United States dollar\", as of 2008-12-31 (until 2009-12-31). Claim clm_9CF416D4E085, https://asof.is/claim/clm_9CF416D4E085, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312510035167/0001193125-10-035167-index.htm.","url":"https://asof.is/claim/clm_9CF416D4E085","accessed":"2026-11-09"},"kind":"money","predicate":"research_and_development","value":"3,512,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9CF416D4E085","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2009, filed 2010-02-19"}},{"date":"2008-12-31","until":"2009-12-31","published":"2010-02-19","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb revenue: 17,715,000,000 United States dollar\", as of 2008-12-31 (until 2009-12-31). Claim clm_A34D5877A520, https://asof.is/claim/clm_A34D5877A520, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312510035167/0001193125-10-035167-index.htm.","url":"https://asof.is/claim/clm_A34D5877A520","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"17,715,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A34D5877A520","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-K FY2009, filed 2010-02-19"}},{"date":"2008-12-31","until":"2009-06-30","published":"2010-02-19","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 29,486,000,000 United States dollar\", as of 2008-12-31 (until 2009-06-30). Claim clm_D3A5975B919A, https://asof.is/claim/clm_D3A5975B919A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312510035167/0001193125-10-035167-index.htm.","url":"https://asof.is/claim/clm_D3A5975B919A","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"29,486,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D3A5975B919A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2009, filed 2010-02-19"}},{"date":"2009-03-31","until":"2009-06-30","published":"2011-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 7,832,000,000 United States dollar\", as of 2009-03-31 (until 2009-06-30). Claim clm_49121E860939, https://asof.is/claim/clm_49121E860939, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312511040120/0001193125-11-040120-index.htm.","url":"https://asof.is/claim/clm_49121E860939","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"7,832,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_49121E860939","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2010, filed 2011-02-18"}},{"date":"2009-03-31","until":"2009-06-30","published":"2010-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 4,322,000,000 United States dollar\", as of 2009-03-31 (until 2009-06-30). Claim clm_C2AB7EFEF874, https://asof.is/claim/clm_C2AB7EFEF874, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312510098285/0001193125-10-098285-index.htm.","url":"https://asof.is/claim/clm_C2AB7EFEF874","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"4,322,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C2AB7EFEF874","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q1 FY2010, filed 2010-04-29"}},{"date":"2009-03-31","until":"2009-06-30","published":"2010-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 638,000,000 United States dollar\", as of 2009-03-31 (until 2009-06-30). Claim clm_C4DE364B4900, https://asof.is/claim/clm_C4DE364B4900, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312510098285/0001193125-10-098285-index.htm.","url":"https://asof.is/claim/clm_C4DE364B4900","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"638,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C4DE364B4900","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2010, filed 2010-04-29"}},{"date":"2009-03-31","until":"2009-06-30","published":"2010-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 908,000,000 United States dollar\", as of 2009-03-31 (until 2009-06-30). Claim clm_E1D89EF594F5, https://asof.is/claim/clm_E1D89EF594F5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312510098285/0001193125-10-098285-index.htm.","url":"https://asof.is/claim/clm_E1D89EF594F5","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"908,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E1D89EF594F5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2010, filed 2010-04-29"}},{"date":"2009-04-21","until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb x username: bmsnews\", as of 2009-04-21. Claim clm_7954DAE3098C, https://asof.is/claim/clm_7954DAE3098C, accessed 2026-11-09. Source: https://www.wikidata.org/wiki/Q266423.","url":"https://asof.is/claim/clm_7954DAE3098C","accessed":"2026-11-09"},"kind":"other","predicate":"x_username","value":"bmsnews","status":"unverified","assertable":false,"why_not":"unverified","id":"clm_7954DAE3098C","evidence":{"by":"own-site","on":"2026-11-08","quote":"https://twitter.com/BMSNEWS","url":"https://www.bms.com/"}},{"date":"2009-06-30","until":"2009-09-30","published":"2009-07-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 14,096,000,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_19E3172F2603, https://asof.is/claim/clm_19E3172F2603, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312509153889/0001193125-09-153889-index.htm.","url":"https://asof.is/claim/clm_19E3172F2603","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"14,096,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_19E3172F2603","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2009, filed 2009-07-23"}},{"date":"2009-06-30","until":"2009-09-30","published":"2009-07-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 5,384,000,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_23AB41FFB556, https://asof.is/claim/clm_23AB41FFB556, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312509153889/0001193125-09-153889-index.htm.","url":"https://asof.is/claim/clm_23AB41FFB556","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"5,384,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_23AB41FFB556","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q2 FY2009, filed 2009-07-23"}},{"date":"2009-06-30","until":"2009-09-30","published":"2011-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 7,507,000,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_4924AC9C6DD6, https://asof.is/claim/clm_4924AC9C6DD6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312511040120/0001193125-11-040120-index.htm.","url":"https://asof.is/claim/clm_4924AC9C6DD6","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"7,507,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4924AC9C6DD6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2010, filed 2011-02-18"}},{"date":"2009-06-30","until":"2009-09-30","published":"2009-07-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 983,000,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_519A562D2C58, https://asof.is/claim/clm_519A562D2C58, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312509153889/0001193125-09-153889-index.htm.","url":"https://asof.is/claim/clm_519A562D2C58","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"983,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_519A562D2C58","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2009, filed 2009-07-23"}},{"date":"2009-06-30","until":"2009-09-30","published":"2009-07-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 829,000,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_7C98CAE61978, https://asof.is/claim/clm_7C98CAE61978, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312509153889/0001193125-09-153889-index.htm.","url":"https://asof.is/claim/clm_7C98CAE61978","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"829,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7C98CAE61978","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2009, filed 2009-07-23"}},{"date":"2009-06-30","until":"2009-09-30","published":"2009-07-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 29,809,000,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_8D8A51B2F4B9, https://asof.is/claim/clm_8D8A51B2F4B9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312509153889/0001193125-09-153889-index.htm.","url":"https://asof.is/claim/clm_8D8A51B2F4B9","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"29,809,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8D8A51B2F4B9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2009, filed 2009-07-23"}},{"date":"2009-06-30","until":"2009-09-30","published":"2009-07-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 1,980,924,717 shares\", as of 2009-06-30 (until 2009-09-30). Claim clm_EB69B4618AB6, https://asof.is/claim/clm_EB69B4618AB6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312509153889/0001193125-09-153889-index.htm.","url":"https://asof.is/claim/clm_EB69B4618AB6","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,980,924,717 shares","status":"superseded","assertable":true,"id":"clm_EB69B4618AB6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2009, filed 2009-07-23"}},{"date":"2009-09-30","until":"2010-03-31","published":"2009-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 966,000,000 United States dollar\", as of 2009-09-30 (until 2010-03-31). Claim clm_19F93EC97E86, https://asof.is/claim/clm_19F93EC97E86, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312509211734/0001193125-09-211734-index.htm.","url":"https://asof.is/claim/clm_19F93EC97E86","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"966,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_19F93EC97E86","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2009, filed 2009-10-22"}},{"date":"2009-09-30","until":"2010-03-31","published":"2009-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 5,487,000,000 United States dollar\", as of 2009-09-30 (until 2010-03-31). Claim clm_80EE21A24A79, https://asof.is/claim/clm_80EE21A24A79, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312509211734/0001193125-09-211734-index.htm.","url":"https://asof.is/claim/clm_80EE21A24A79","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"5,487,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_80EE21A24A79","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q3 FY2009, filed 2009-10-22"}},{"date":"2009-09-30","until":"2010-03-31","published":"2009-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 838,000,000 United States dollar\", as of 2009-09-30 (until 2010-03-31). Claim clm_9539553B388C, https://asof.is/claim/clm_9539553B388C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312509211734/0001193125-09-211734-index.htm.","url":"https://asof.is/claim/clm_9539553B388C","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"838,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9539553B388C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2009, filed 2009-10-22"}},{"date":"2009-09-30","until":"2009-12-31","published":"2009-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 30,951,000,000 United States dollar\", as of 2009-09-30 (until 2009-12-31). Claim clm_9F6D3418BE8B, https://asof.is/claim/clm_9F6D3418BE8B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312509211734/0001193125-09-211734-index.htm.","url":"https://asof.is/claim/clm_9F6D3418BE8B","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"30,951,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9F6D3418BE8B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2009, filed 2009-10-22"}},{"date":"2009-09-30","until":"2010-02-01","published":"2009-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 1,980,980,141 shares\", as of 2009-09-30 (until 2010-02-01). Claim clm_A22CE6E75963, https://asof.is/claim/clm_A22CE6E75963, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312509211734/0001193125-09-211734-index.htm.","url":"https://asof.is/claim/clm_A22CE6E75963","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,980,980,141 shares","status":"superseded","assertable":true,"id":"clm_A22CE6E75963","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2009, filed 2009-10-22"}},{"date":"2009-09-30","until":"2009-12-31","published":"2011-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 6,367,000,000 United States dollar\", as of 2009-09-30 (until 2009-12-31). Claim clm_CEBD9898E6DD, https://asof.is/claim/clm_CEBD9898E6DD, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312511040120/0001193125-11-040120-index.htm.","url":"https://asof.is/claim/clm_CEBD9898E6DD","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"6,367,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CEBD9898E6DD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2010, filed 2011-02-18"}},{"date":"2009-09-30","until":"2009-12-31","published":"2009-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 14,518,000,000 United States dollar\", as of 2009-09-30 (until 2009-12-31). Claim clm_F1E095F901DB, https://asof.is/claim/clm_F1E095F901DB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312509211734/0001193125-09-211734-index.htm.","url":"https://asof.is/claim/clm_F1E095F901DB","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"14,518,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F1E095F901DB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2009, filed 2009-10-22"}},{"date":"2009-12-31","until":"2010-03-31","published":"2010-02-19","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 31,008,000,000 United States dollar\", as of 2009-12-31 (until 2010-03-31). Claim clm_1A542B42096D, https://asof.is/claim/clm_1A542B42096D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312510035167/0001193125-10-035167-index.htm.","url":"https://asof.is/claim/clm_1A542B42096D","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"31,008,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1A542B42096D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2009, filed 2010-02-19"}},{"date":"2009-12-31","until":"2010-03-31","published":"2010-02-19","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 7,683,000,000 United States dollar\", as of 2009-12-31 (until 2010-03-31). Claim clm_4EFB031CC777, https://asof.is/claim/clm_4EFB031CC777, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312510035167/0001193125-10-035167-index.htm.","url":"https://asof.is/claim/clm_4EFB031CC777","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"7,683,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4EFB031CC777","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2009, filed 2010-02-19"}},{"date":"2009-12-31","until":"2010-12-31","published":"2010-02-19","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb revenue: 18,808,000,000 United States dollar\", as of 2009-12-31 (until 2010-12-31). Claim clm_5E03D7303B2C, https://asof.is/claim/clm_5E03D7303B2C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312510035167/0001193125-10-035167-index.htm.","url":"https://asof.is/claim/clm_5E03D7303B2C","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"18,808,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5E03D7303B2C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-K FY2009, filed 2010-02-19"}},{"date":"2009-12-31","until":"2010-03-31","published":"2010-02-19","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 14,843,000,000 United States dollar\", as of 2009-12-31 (until 2010-03-31). Claim clm_B283AB8C502B, https://asof.is/claim/clm_B283AB8C502B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312510035167/0001193125-10-035167-index.htm.","url":"https://asof.is/claim/clm_B283AB8C502B","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"14,843,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B283AB8C502B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2009, filed 2010-02-19"}},{"date":"2009-12-31","until":"2010-12-31","published":"2010-02-19","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb net income: 10,612,000,000 United States dollar\", as of 2009-12-31 (until 2010-12-31). Claim clm_BA69B9ABC777, https://asof.is/claim/clm_BA69B9ABC777, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312510035167/0001193125-10-035167-index.htm.","url":"https://asof.is/claim/clm_BA69B9ABC777","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"10,612,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BA69B9ABC777","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2009, filed 2010-02-19"}},{"date":"2009-12-31","until":"2010-12-31","published":"2010-02-19","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb research and development: 3,647,000,000 United States dollar\", as of 2009-12-31 (until 2010-12-31). Claim clm_DAABE58B1D2F, https://asof.is/claim/clm_DAABE58B1D2F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312510035167/0001193125-10-035167-index.htm.","url":"https://asof.is/claim/clm_DAABE58B1D2F","accessed":"2026-11-09"},"kind":"money","predicate":"research_and_development","value":"3,647,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DAABE58B1D2F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2009, filed 2010-02-19"}},{"date":"2010-02-01","until":"2010-03-31","published":"2010-02-19","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 1,714,140,539 shares\", as of 2010-02-01 (until 2010-03-31). Claim clm_7BE350E8CA7A, https://asof.is/claim/clm_7BE350E8CA7A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312510035167/0001193125-10-035167-index.htm.","url":"https://asof.is/claim/clm_7BE350E8CA7A","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,714,140,539 shares","status":"superseded","assertable":true,"id":"clm_7BE350E8CA7A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2009, filed 2010-02-19"}},{"date":"2010-03-31","until":"2010-06-30","published":"2010-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 743,000,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_1106AB9EACF1, https://asof.is/claim/clm_1106AB9EACF1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312510098285/0001193125-10-098285-index.htm.","url":"https://asof.is/claim/clm_1106AB9EACF1","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"743,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1106AB9EACF1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2010, filed 2010-04-29"}},{"date":"2010-03-31","until":"2010-06-30","published":"2010-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 30,753,000,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_19E988AD4CF7, https://asof.is/claim/clm_19E988AD4CF7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312510098285/0001193125-10-098285-index.htm.","url":"https://asof.is/claim/clm_19E988AD4CF7","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"30,753,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_19E988AD4CF7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2010, filed 2010-04-29"}},{"date":"2010-03-31","until":"2010-06-30","published":"2010-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 1,719,674,383 shares\", as of 2010-03-31 (until 2010-06-30). Claim clm_A2051A49A962, https://asof.is/claim/clm_A2051A49A962, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312510098285/0001193125-10-098285-index.htm.","url":"https://asof.is/claim/clm_A2051A49A962","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,719,674,383 shares","status":"superseded","assertable":true,"id":"clm_A2051A49A962","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2010, filed 2010-04-29"}},{"date":"2010-03-31","until":"2010-06-30","published":"2011-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 5,135,000,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_AE4EED1D907A, https://asof.is/claim/clm_AE4EED1D907A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312511040120/0001193125-11-040120-index.htm.","url":"https://asof.is/claim/clm_AE4EED1D907A","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"5,135,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AE4EED1D907A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2010, filed 2011-02-18"}},{"date":"2010-03-31","until":"2010-06-30","published":"2010-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 910,000,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_BF436A5728D0, https://asof.is/claim/clm_BF436A5728D0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312510098285/0001193125-10-098285-index.htm.","url":"https://asof.is/claim/clm_BF436A5728D0","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"910,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BF436A5728D0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2010, filed 2010-04-29"}},{"date":"2010-03-31","until":"2010-06-30","published":"2010-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 15,249,000,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_F593E486E4B0, https://asof.is/claim/clm_F593E486E4B0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312510098285/0001193125-10-098285-index.htm.","url":"https://asof.is/claim/clm_F593E486E4B0","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"15,249,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F593E486E4B0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2010, filed 2010-04-29"}},{"date":"2010-03-31","until":"2010-06-30","published":"2010-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 4,807,000,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_F86EF4975AB0, https://asof.is/claim/clm_F86EF4975AB0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312510098285/0001193125-10-098285-index.htm.","url":"https://asof.is/claim/clm_F86EF4975AB0","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"4,807,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F86EF4975AB0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q1 FY2010, filed 2010-04-29"}},{"date":"2010-06-30","until":"2010-09-30","published":"2010-07-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 822,000,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_23291C065B20, https://asof.is/claim/clm_23291C065B20, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312510163487/0001193125-10-163487-index.htm.","url":"https://asof.is/claim/clm_23291C065B20","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"822,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_23291C065B20","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2010, filed 2010-07-22"}},{"date":"2010-06-30","until":"2010-09-30","published":"2010-07-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 1,714,842,193 shares\", as of 2010-06-30 (until 2010-09-30). Claim clm_26DAB597B294, https://asof.is/claim/clm_26DAB597B294, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312510163487/0001193125-10-163487-index.htm.","url":"https://asof.is/claim/clm_26DAB597B294","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,714,842,193 shares","status":"superseded","assertable":true,"id":"clm_26DAB597B294","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2010, filed 2010-07-22"}},{"date":"2010-06-30","until":"2010-09-30","published":"2010-07-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 31,051,000,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_590012138198, https://asof.is/claim/clm_590012138198, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312510163487/0001193125-10-163487-index.htm.","url":"https://asof.is/claim/clm_590012138198","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"31,051,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_590012138198","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2010, filed 2010-07-22"}},{"date":"2010-06-30","until":"2010-09-30","published":"2010-07-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 4,768,000,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_7E9207656793, https://asof.is/claim/clm_7E9207656793, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312510163487/0001193125-10-163487-index.htm.","url":"https://asof.is/claim/clm_7E9207656793","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"4,768,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7E9207656793","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q2 FY2010, filed 2010-07-22"}},{"date":"2010-06-30","until":"2010-09-30","published":"2010-07-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 927,000,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_83C2F51E059C, https://asof.is/claim/clm_83C2F51E059C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312510163487/0001193125-10-163487-index.htm.","url":"https://asof.is/claim/clm_83C2F51E059C","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"927,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_83C2F51E059C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2010, filed 2010-07-22"}},{"date":"2010-06-30","until":"2010-09-30","published":"2010-07-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 15,668,000,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_9A6F8C68D6D2, https://asof.is/claim/clm_9A6F8C68D6D2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312510163487/0001193125-10-163487-index.htm.","url":"https://asof.is/claim/clm_9A6F8C68D6D2","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"15,668,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9A6F8C68D6D2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2010, filed 2010-07-22"}},{"date":"2010-06-30","until":"2010-09-30","published":"2011-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 5,918,000,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_D13C1060B3B6, https://asof.is/claim/clm_D13C1060B3B6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312511040120/0001193125-11-040120-index.htm.","url":"https://asof.is/claim/clm_D13C1060B3B6","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"5,918,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D13C1060B3B6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2010, filed 2011-02-18"}},{"date":"2010-09-30","until":"2010-12-31","published":"2010-10-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 15,970,000,000 United States dollar\", as of 2010-09-30 (until 2010-12-31). Claim clm_5333ECE10209, https://asof.is/claim/clm_5333ECE10209, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312510236328/0001193125-10-236328-index.htm.","url":"https://asof.is/claim/clm_5333ECE10209","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"15,970,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5333ECE10209","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2010, filed 2010-10-26"}},{"date":"2010-09-30","until":"2011-03-31","published":"2010-10-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 824,000,000 United States dollar\", as of 2010-09-30 (until 2011-03-31). Claim clm_695BB0FA11F0, https://asof.is/claim/clm_695BB0FA11F0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312510236328/0001193125-10-236328-index.htm.","url":"https://asof.is/claim/clm_695BB0FA11F0","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"824,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_695BB0FA11F0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2010, filed 2010-10-26"}},{"date":"2010-09-30","until":"2010-12-31","published":"2010-10-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 31,885,000,000 United States dollar\", as of 2010-09-30 (until 2010-12-31). Claim clm_6F0AA4DE7420, https://asof.is/claim/clm_6F0AA4DE7420, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312510236328/0001193125-10-236328-index.htm.","url":"https://asof.is/claim/clm_6F0AA4DE7420","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"31,885,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6F0AA4DE7420","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2010, filed 2010-10-26"}},{"date":"2010-09-30","until":"2011-03-31","published":"2010-10-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 949,000,000 United States dollar\", as of 2010-09-30 (until 2011-03-31). Claim clm_951D8222BE42, https://asof.is/claim/clm_951D8222BE42, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312510236328/0001193125-10-236328-index.htm.","url":"https://asof.is/claim/clm_951D8222BE42","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"949,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_951D8222BE42","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2010, filed 2010-10-26"}},{"date":"2010-09-30","until":"2011-03-31","published":"2010-10-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 4,798,000,000 United States dollar\", as of 2010-09-30 (until 2011-03-31). Claim clm_953918B58D21, https://asof.is/claim/clm_953918B58D21, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312510236328/0001193125-10-236328-index.htm.","url":"https://asof.is/claim/clm_953918B58D21","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"4,798,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_953918B58D21","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q3 FY2010, filed 2010-10-26"}},{"date":"2010-09-30","until":"2010-12-31","published":"2011-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 7,581,000,000 United States dollar\", as of 2010-09-30 (until 2010-12-31). Claim clm_A2A893CB84D0, https://asof.is/claim/clm_A2A893CB84D0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312511040120/0001193125-11-040120-index.htm.","url":"https://asof.is/claim/clm_A2A893CB84D0","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"7,581,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A2A893CB84D0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2010, filed 2011-02-18"}},{"date":"2010-09-30","until":"2011-02-01","published":"2010-10-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 1,711,685,361 shares\", as of 2010-09-30 (until 2011-02-01). Claim clm_E792F08DCA9E, https://asof.is/claim/clm_E792F08DCA9E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312510236328/0001193125-10-236328-index.htm.","url":"https://asof.is/claim/clm_E792F08DCA9E","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,711,685,361 shares","status":"superseded","assertable":true,"id":"clm_E792F08DCA9E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2010, filed 2010-10-26"}},{"date":"2010-12-31","until":"2011-12-31","published":"2011-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb revenue: 19,484,000,000 United States dollar\", as of 2010-12-31 (until 2011-12-31). Claim clm_09D474D26D0F, https://asof.is/claim/clm_09D474D26D0F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312511040120/0001193125-11-040120-index.htm.","url":"https://asof.is/claim/clm_09D474D26D0F","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"19,484,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_09D474D26D0F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-K FY2010, filed 2011-02-18"}},{"date":"2010-12-31","until":"2011-03-31","published":"2011-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 5,033,000,000 United States dollar\", as of 2010-12-31 (until 2011-03-31). Claim clm_2B15511DC840, https://asof.is/claim/clm_2B15511DC840, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312511040120/0001193125-11-040120-index.htm.","url":"https://asof.is/claim/clm_2B15511DC840","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"5,033,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2B15511DC840","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2010, filed 2011-02-18"}},{"date":"2010-12-31","until":"2011-03-31","published":"2011-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 31,076,000,000 United States dollar\", as of 2010-12-31 (until 2011-03-31). Claim clm_2B3414D511E2, https://asof.is/claim/clm_2B3414D511E2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312511040120/0001193125-11-040120-index.htm.","url":"https://asof.is/claim/clm_2B3414D511E2","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"31,076,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2B3414D511E2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2010, filed 2011-02-18"}},{"date":"2010-12-31","until":"2011-03-31","published":"2011-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 15,713,000,000 United States dollar\", as of 2010-12-31 (until 2011-03-31). Claim clm_65A0EE5A7F89, https://asof.is/claim/clm_65A0EE5A7F89, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312511040120/0001193125-11-040120-index.htm.","url":"https://asof.is/claim/clm_65A0EE5A7F89","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"15,713,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_65A0EE5A7F89","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2010, filed 2011-02-18"}},{"date":"2010-12-31","until":"2011-12-31","published":"2011-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb research and development: 3,566,000,000 United States dollar\", as of 2010-12-31 (until 2011-12-31). Claim clm_6B24FDF6B4D7, https://asof.is/claim/clm_6B24FDF6B4D7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312511040120/0001193125-11-040120-index.htm.","url":"https://asof.is/claim/clm_6B24FDF6B4D7","accessed":"2026-11-09"},"kind":"money","predicate":"research_and_development","value":"3,566,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6B24FDF6B4D7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2010, filed 2011-02-18"}},{"date":"2010-12-31","until":"2011-12-31","published":"2011-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb net income: 3,102,000,000 United States dollar\", as of 2010-12-31 (until 2011-12-31). Claim clm_ED3F0DB21357, https://asof.is/claim/clm_ED3F0DB21357, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312511040120/0001193125-11-040120-index.htm.","url":"https://asof.is/claim/clm_ED3F0DB21357","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"3,102,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_ED3F0DB21357","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2010, filed 2011-02-18"}},{"date":"2011-02-01","until":"2011-03-31","published":"2011-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 1,702,427,438 shares\", as of 2011-02-01 (until 2011-03-31). Claim clm_9FDA4D1635BA, https://asof.is/claim/clm_9FDA4D1635BA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312511040120/0001193125-11-040120-index.htm.","url":"https://asof.is/claim/clm_9FDA4D1635BA","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,702,427,438 shares","status":"superseded","assertable":true,"id":"clm_9FDA4D1635BA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2010, filed 2011-02-18"}},{"date":"2011-03-31","until":"2011-06-30","published":"2011-04-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 986,000,000 United States dollar\", as of 2011-03-31 (until 2011-06-30). Claim clm_1923C9EC0F5F, https://asof.is/claim/clm_1923C9EC0F5F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312511113907/0001193125-11-113907-index.htm.","url":"https://asof.is/claim/clm_1923C9EC0F5F","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"986,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1923C9EC0F5F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2011, filed 2011-04-28"}},{"date":"2011-03-31","until":"2011-06-30","published":"2013-02-15","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 30,851,000,000 United States dollar\", as of 2011-03-31 (until 2011-06-30). Claim clm_1D31481A724A, https://asof.is/claim/clm_1D31481A724A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm.","url":"https://asof.is/claim/clm_1D31481A724A","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"30,851,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1D31481A724A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2012, filed 2013-02-15"}},{"date":"2011-03-31","until":"2011-06-30","published":"2012-02-17","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 3,405,000,000 United States dollar\", as of 2011-03-31 (until 2011-06-30). Claim clm_53D8339DBD3E, https://asof.is/claim/clm_53D8339DBD3E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312512066416/0001193125-12-066416-index.htm.","url":"https://asof.is/claim/clm_53D8339DBD3E","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"3,405,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_53D8339DBD3E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2011, filed 2012-02-17"}},{"date":"2011-03-31","until":"2011-06-30","published":"2011-04-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 5,011,000,000 United States dollar\", as of 2011-03-31 (until 2011-06-30). Claim clm_73076406AD2F, https://asof.is/claim/clm_73076406AD2F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312511113907/0001193125-11-113907-index.htm.","url":"https://asof.is/claim/clm_73076406AD2F","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"5,011,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_73076406AD2F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q1 FY2011, filed 2011-04-28"}},{"date":"2011-03-31","until":"2012-03-31","published":"2012-04-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly operating income: 1,288,000,000 United States dollar\", as of 2011-03-31 (until 2012-03-31). Claim clm_81753CE151BB, https://asof.is/claim/clm_81753CE151BB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312512184689/0001193125-12-184689-index.htm.","url":"https://asof.is/claim/clm_81753CE151BB","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,288,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_81753CE151BB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2012, filed 2012-04-26"}},{"date":"2011-03-31","until":"2011-06-30","published":"2011-04-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 1,705,988,458 shares\", as of 2011-03-31 (until 2011-06-30). Claim clm_93DA371874DF, https://asof.is/claim/clm_93DA371874DF, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312511113907/0001193125-11-113907-index.htm.","url":"https://asof.is/claim/clm_93DA371874DF","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,705,988,458 shares","status":"superseded","assertable":true,"id":"clm_93DA371874DF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2011, filed 2011-04-28"}},{"date":"2011-03-31","until":"2011-06-30","published":"2011-04-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 935,000,000 United States dollar\", as of 2011-03-31 (until 2011-06-30). Claim clm_A119CE234655, https://asof.is/claim/clm_A119CE234655, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312511113907/0001193125-11-113907-index.htm.","url":"https://asof.is/claim/clm_A119CE234655","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"935,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A119CE234655","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2011, filed 2011-04-28"}},{"date":"2011-03-31","until":"2011-06-30","published":"2013-02-15","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 15,901,000,000 United States dollar\", as of 2011-03-31 (until 2011-06-30). Claim clm_DED765641022, https://asof.is/claim/clm_DED765641022, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm.","url":"https://asof.is/claim/clm_DED765641022","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"15,901,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DED765641022","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2012, filed 2013-02-15"}},{"date":"2011-06-30","until":"2011-09-30","published":"2013-02-15","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 16,145,000,000 United States dollar\", as of 2011-06-30 (until 2011-09-30). Claim clm_2E2E0A543705, https://asof.is/claim/clm_2E2E0A543705, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm.","url":"https://asof.is/claim/clm_2E2E0A543705","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"16,145,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2E2E0A543705","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2012, filed 2013-02-15"}},{"date":"2011-06-30","until":"2011-09-30","published":"2011-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 902,000,000 United States dollar\", as of 2011-06-30 (until 2011-09-30). Claim clm_39908922AB57, https://asof.is/claim/clm_39908922AB57, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312511200164/0001193125-11-200164-index.htm.","url":"https://asof.is/claim/clm_39908922AB57","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"902,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_39908922AB57","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2011, filed 2011-07-28"}},{"date":"2011-06-30","until":"2011-09-30","published":"2011-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 923,000,000 United States dollar\", as of 2011-06-30 (until 2011-09-30). Claim clm_57CE22C1D3E7, https://asof.is/claim/clm_57CE22C1D3E7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312511200164/0001193125-11-200164-index.htm.","url":"https://asof.is/claim/clm_57CE22C1D3E7","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"923,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_57CE22C1D3E7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2011, filed 2011-07-28"}},{"date":"2011-06-30","until":"2011-09-30","published":"2013-02-15","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 31,833,000,000 United States dollar\", as of 2011-06-30 (until 2011-09-30). Claim clm_99C2CB91CAD8, https://asof.is/claim/clm_99C2CB91CAD8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm.","url":"https://asof.is/claim/clm_99C2CB91CAD8","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"31,833,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_99C2CB91CAD8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2012, filed 2013-02-15"}},{"date":"2011-06-30","until":"2011-09-30","published":"2012-02-17","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 3,665,000,000 United States dollar\", as of 2011-06-30 (until 2011-09-30). Claim clm_A562DF98ED52, https://asof.is/claim/clm_A562DF98ED52, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312512066416/0001193125-12-066416-index.htm.","url":"https://asof.is/claim/clm_A562DF98ED52","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"3,665,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A562DF98ED52","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2011, filed 2012-02-17"}},{"date":"2011-06-30","until":"2011-09-30","published":"2011-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 5,434,000,000 United States dollar\", as of 2011-06-30 (until 2011-09-30). Claim clm_E02B6AA5ECE7, https://asof.is/claim/clm_E02B6AA5ECE7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312511200164/0001193125-11-200164-index.htm.","url":"https://asof.is/claim/clm_E02B6AA5ECE7","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"5,434,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E02B6AA5ECE7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q2 FY2011, filed 2011-07-28"}},{"date":"2011-06-30","until":"2011-09-30","published":"2011-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 1,705,666,684 shares\", as of 2011-06-30 (until 2011-09-30). Claim clm_EA443BD9D9F9, https://asof.is/claim/clm_EA443BD9D9F9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312511200164/0001193125-11-200164-index.htm.","url":"https://asof.is/claim/clm_EA443BD9D9F9","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,705,666,684 shares","status":"superseded","assertable":true,"id":"clm_EA443BD9D9F9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2011, filed 2011-07-28"}},{"date":"2011-09-30","until":"2011-12-31","published":"2013-02-15","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 32,014,000,000 United States dollar\", as of 2011-09-30 (until 2011-12-31). Claim clm_2694BD596845, https://asof.is/claim/clm_2694BD596845, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm.","url":"https://asof.is/claim/clm_2694BD596845","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"32,014,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2694BD596845","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2012, filed 2013-02-15"}},{"date":"2011-09-30","until":"2012-03-31","published":"2011-10-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 969,000,000 United States dollar\", as of 2011-09-30 (until 2012-03-31). Claim clm_47B6838E35BE, https://asof.is/claim/clm_47B6838E35BE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312511283608/0001193125-11-283608-index.htm.","url":"https://asof.is/claim/clm_47B6838E35BE","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"969,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_47B6838E35BE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2011, filed 2011-10-27"}},{"date":"2011-09-30","until":"2012-03-31","published":"2011-10-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 973,000,000 United States dollar\", as of 2011-09-30 (until 2012-03-31). Claim clm_52390711AFA3, https://asof.is/claim/clm_52390711AFA3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312511283608/0001193125-11-283608-index.htm.","url":"https://asof.is/claim/clm_52390711AFA3","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"973,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_52390711AFA3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2011, filed 2011-10-27"}},{"date":"2011-09-30","until":"2012-03-31","published":"2011-10-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 5,345,000,000 United States dollar\", as of 2011-09-30 (until 2012-03-31). Claim clm_814D2D7EDE03, https://asof.is/claim/clm_814D2D7EDE03, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312511283608/0001193125-11-283608-index.htm.","url":"https://asof.is/claim/clm_814D2D7EDE03","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"5,345,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_814D2D7EDE03","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q3 FY2011, filed 2011-10-27"}},{"date":"2011-09-30","until":"2011-12-31","published":"2013-02-15","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 16,436,000,000 United States dollar\", as of 2011-09-30 (until 2011-12-31). Claim clm_AE4D8667202B, https://asof.is/claim/clm_AE4D8667202B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm.","url":"https://asof.is/claim/clm_AE4D8667202B","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"16,436,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AE4D8667202B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2012, filed 2013-02-15"}},{"date":"2011-09-30","until":"2012-02-01","published":"2011-10-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 1,694,531,520 shares\", as of 2011-09-30 (until 2012-02-01). Claim clm_D5297B7922AC, https://asof.is/claim/clm_D5297B7922AC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312511283608/0001193125-11-283608-index.htm.","url":"https://asof.is/claim/clm_D5297B7922AC","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,694,531,520 shares","status":"superseded","assertable":true,"id":"clm_D5297B7922AC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2011, filed 2011-10-27"}},{"date":"2011-09-30","until":"2011-12-31","published":"2012-02-17","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 4,471,000,000 United States dollar\", as of 2011-09-30 (until 2011-12-31). Claim clm_FA3C67F400B6, https://asof.is/claim/clm_FA3C67F400B6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312512066416/0001193125-12-066416-index.htm.","url":"https://asof.is/claim/clm_FA3C67F400B6","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"4,471,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FA3C67F400B6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2011, filed 2012-02-17"}},{"date":"2011-12-31","until":"2012-03-31","published":"2012-02-17","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 32,970,000,000 United States dollar\", as of 2011-12-31 (until 2012-03-31). Claim clm_13C65F81B665, https://asof.is/claim/clm_13C65F81B665, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312512066416/0001193125-12-066416-index.htm.","url":"https://asof.is/claim/clm_13C65F81B665","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"32,970,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_13C65F81B665","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2011, filed 2012-02-17"}},{"date":"2011-12-31","until":"2012-12-31","published":"2012-02-17","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb net income: 3,709,000,000 United States dollar\", as of 2011-12-31 (until 2012-12-31). Claim clm_18995E577EB1, https://asof.is/claim/clm_18995E577EB1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312512066416/0001193125-12-066416-index.htm.","url":"https://asof.is/claim/clm_18995E577EB1","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"3,709,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_18995E577EB1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2011, filed 2012-02-17"}},{"date":"2011-12-31","until":"2012-12-31","published":"2012-02-17","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb revenue: 21,244,000,000 United States dollar\", as of 2011-12-31 (until 2012-12-31). Claim clm_63A21B1FADCA, https://asof.is/claim/clm_63A21B1FADCA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312512066416/0001193125-12-066416-index.htm.","url":"https://asof.is/claim/clm_63A21B1FADCA","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"21,244,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_63A21B1FADCA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-K FY2011, filed 2012-02-17"}},{"date":"2011-12-31","until":"2012-03-31","published":"2012-02-17","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 5,776,000,000 United States dollar\", as of 2011-12-31 (until 2012-03-31). Claim clm_724CC60F8B98, https://asof.is/claim/clm_724CC60F8B98, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312512066416/0001193125-12-066416-index.htm.","url":"https://asof.is/claim/clm_724CC60F8B98","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"5,776,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_724CC60F8B98","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2011, filed 2012-02-17"}},{"date":"2011-12-31","until":"2012-03-31","published":"2012-02-17","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 15,956,000,000 United States dollar\", as of 2011-12-31 (until 2012-03-31). Claim clm_936DFDC00DD3, https://asof.is/claim/clm_936DFDC00DD3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312512066416/0001193125-12-066416-index.htm.","url":"https://asof.is/claim/clm_936DFDC00DD3","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"15,956,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_936DFDC00DD3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2011, filed 2012-02-17"}},{"date":"2011-12-31","until":"2012-12-31","published":"2012-02-17","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb research and development: 3,839,000,000 United States dollar\", as of 2011-12-31 (until 2012-12-31). Claim clm_E409DEC1EB09, https://asof.is/claim/clm_E409DEC1EB09, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312512066416/0001193125-12-066416-index.htm.","url":"https://asof.is/claim/clm_E409DEC1EB09","accessed":"2026-11-09"},"kind":"money","predicate":"research_and_development","value":"3,839,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E409DEC1EB09","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2011, filed 2012-02-17"}},{"date":"2012-02-01","until":"2012-03-31","published":"2012-02-17","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 1,688,107,071 shares\", as of 2012-02-01 (until 2012-03-31). Claim clm_82A20B1B8801, https://asof.is/claim/clm_82A20B1B8801, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312512066416/0001193125-12-066416-index.htm.","url":"https://asof.is/claim/clm_82A20B1B8801","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,688,107,071 shares","status":"superseded","assertable":true,"id":"clm_82A20B1B8801","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2011, filed 2012-02-17"}},{"date":"2012-03-31","until":"2012-06-30","published":"2012-04-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 909,000,000 United States dollar\", as of 2012-03-31 (until 2012-06-30). Claim clm_654F010BC1A6, https://asof.is/claim/clm_654F010BC1A6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312512184689/0001193125-12-184689-index.htm.","url":"https://asof.is/claim/clm_654F010BC1A6","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"909,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_654F010BC1A6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2012, filed 2012-04-26"}},{"date":"2012-03-31","until":"2012-06-30","published":"2013-02-15","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 2,307,000,000 United States dollar\", as of 2012-03-31 (until 2012-06-30). Claim clm_69D36896A414, https://asof.is/claim/clm_69D36896A414, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm.","url":"https://asof.is/claim/clm_69D36896A414","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"2,307,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_69D36896A414","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2012, filed 2013-02-15"}},{"date":"2012-03-31","until":"2012-06-30","published":"2013-02-15","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 32,408,000,000 United States dollar\", as of 2012-03-31 (until 2012-06-30). Claim clm_A3954CF64C23, https://asof.is/claim/clm_A3954CF64C23, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm.","url":"https://asof.is/claim/clm_A3954CF64C23","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"32,408,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A3954CF64C23","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2012, filed 2013-02-15"}},{"date":"2012-03-31","until":null,"published":"2012-04-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly operating income: 1,402,000,000 United States dollar\", as of 2012-03-31. Claim clm_B92B3F0BD51E, https://asof.is/claim/clm_B92B3F0BD51E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312512184689/0001193125-12-184689-index.htm.","url":"https://asof.is/claim/clm_B92B3F0BD51E","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,402,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_B92B3F0BD51E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2012, filed 2012-04-26"}},{"date":"2012-03-31","until":"2012-06-30","published":"2012-04-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 1,101,000,000 United States dollar\", as of 2012-03-31 (until 2012-06-30). Claim clm_BCEA508603AD, https://asof.is/claim/clm_BCEA508603AD, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312512184689/0001193125-12-184689-index.htm.","url":"https://asof.is/claim/clm_BCEA508603AD","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,101,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BCEA508603AD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2012, filed 2012-04-26"}},{"date":"2012-03-31","until":"2012-06-30","published":"2012-04-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 1,689,084,439 shares\", as of 2012-03-31 (until 2012-06-30). Claim clm_C6683CEE0217, https://asof.is/claim/clm_C6683CEE0217, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312512184689/0001193125-12-184689-index.htm.","url":"https://asof.is/claim/clm_C6683CEE0217","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,689,084,439 shares","status":"superseded","assertable":true,"id":"clm_C6683CEE0217","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2012, filed 2012-04-26"}},{"date":"2012-03-31","until":"2012-06-30","published":"2012-04-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 5,251,000,000 United States dollar\", as of 2012-03-31 (until 2012-06-30). Claim clm_D79B75C428AC, https://asof.is/claim/clm_D79B75C428AC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312512184689/0001193125-12-184689-index.htm.","url":"https://asof.is/claim/clm_D79B75C428AC","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"5,251,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D79B75C428AC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q1 FY2012, filed 2012-04-26"}},{"date":"2012-03-31","until":"2012-06-30","published":"2013-02-15","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 16,246,000,000 United States dollar\", as of 2012-03-31 (until 2012-06-30). Claim clm_E1F91BE97869, https://asof.is/claim/clm_E1F91BE97869, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm.","url":"https://asof.is/claim/clm_E1F91BE97869","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"16,246,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E1F91BE97869","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2012, filed 2013-02-15"}},{"date":"2012-06-30","until":"2012-09-30","published":"2013-02-15","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 2,801,000,000 United States dollar\", as of 2012-06-30 (until 2012-09-30). Claim clm_32ACB5993B93, https://asof.is/claim/clm_32ACB5993B93, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm.","url":"https://asof.is/claim/clm_32ACB5993B93","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"2,801,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_32ACB5993B93","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2012, filed 2013-02-15"}},{"date":"2012-06-30","until":"2012-09-30","published":"2012-07-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 645,000,000 United States dollar\", as of 2012-06-30 (until 2012-09-30). Claim clm_400E6A76F107, https://asof.is/claim/clm_400E6A76F107, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312512313811/0001193125-12-313811-index.htm.","url":"https://asof.is/claim/clm_400E6A76F107","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"645,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_400E6A76F107","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2012, filed 2012-07-25"}},{"date":"2012-06-30","until":"2012-09-30","published":"2013-02-15","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 31,667,000,000 United States dollar\", as of 2012-06-30 (until 2012-09-30). Claim clm_4EE281D526FD, https://asof.is/claim/clm_4EE281D526FD, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm.","url":"https://asof.is/claim/clm_4EE281D526FD","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"31,667,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4EE281D526FD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2012, filed 2013-02-15"}},{"date":"2012-06-30","until":"2012-09-30","published":"2012-07-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 4,443,000,000 United States dollar\", as of 2012-06-30 (until 2012-09-30). Claim clm_962B22363E26, https://asof.is/claim/clm_962B22363E26, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312512313811/0001193125-12-313811-index.htm.","url":"https://asof.is/claim/clm_962B22363E26","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"4,443,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_962B22363E26","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q2 FY2012, filed 2012-07-25"}},{"date":"2012-06-30","until":"2012-09-30","published":"2012-07-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 962,000,000 United States dollar\", as of 2012-06-30 (until 2012-09-30). Claim clm_CB25B0A2ED5C, https://asof.is/claim/clm_CB25B0A2ED5C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312512313811/0001193125-12-313811-index.htm.","url":"https://asof.is/claim/clm_CB25B0A2ED5C","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"962,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CB25B0A2ED5C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2012, filed 2012-07-25"}},{"date":"2012-06-30","until":"2012-09-30","published":"2013-02-15","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 15,812,000,000 United States dollar\", as of 2012-06-30 (until 2012-09-30). Claim clm_D90C800D5F23, https://asof.is/claim/clm_D90C800D5F23, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm.","url":"https://asof.is/claim/clm_D90C800D5F23","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"15,812,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D90C800D5F23","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2012, filed 2013-02-15"}},{"date":"2012-06-30","until":"2012-09-30","published":"2012-07-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 1,679,022,076 shares\", as of 2012-06-30 (until 2012-09-30). Claim clm_E4AD7E9FAFC7, https://asof.is/claim/clm_E4AD7E9FAFC7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312512313811/0001193125-12-313811-index.htm.","url":"https://asof.is/claim/clm_E4AD7E9FAFC7","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,679,022,076 shares","status":"superseded","assertable":true,"id":"clm_E4AD7E9FAFC7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2012, filed 2012-07-25"}},{"date":"2012-09-30","until":"2012-12-31","published":"2013-02-15","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 1,503,000,000 United States dollar\", as of 2012-09-30 (until 2012-12-31). Claim clm_0A3FD4469F2B, https://asof.is/claim/clm_0A3FD4469F2B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm.","url":"https://asof.is/claim/clm_0A3FD4469F2B","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,503,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0A3FD4469F2B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2012, filed 2013-02-15"}},{"date":"2012-09-30","until":"2012-12-31","published":"2013-02-15","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 13,900,000,000 United States dollar\", as of 2012-09-30 (until 2012-12-31). Claim clm_30E51F0761D7, https://asof.is/claim/clm_30E51F0761D7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm.","url":"https://asof.is/claim/clm_30E51F0761D7","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"13,900,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_30E51F0761D7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2012, filed 2013-02-15"}},{"date":"2012-09-30","until":"2013-03-31","published":"2012-10-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 951,000,000 United States dollar\", as of 2012-09-30 (until 2013-03-31). Claim clm_3A1E9B6A06D0, https://asof.is/claim/clm_3A1E9B6A06D0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312512432664/0001193125-12-432664-index.htm.","url":"https://asof.is/claim/clm_3A1E9B6A06D0","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"951,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3A1E9B6A06D0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2012, filed 2012-10-24"}},{"date":"2012-09-30","until":"2013-03-31","published":"2012-10-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 3,736,000,000 United States dollar\", as of 2012-09-30 (until 2013-03-31). Claim clm_5F4D49DAD603, https://asof.is/claim/clm_5F4D49DAD603, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312512432664/0001193125-12-432664-index.htm.","url":"https://asof.is/claim/clm_5F4D49DAD603","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"3,736,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5F4D49DAD603","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q3 FY2012, filed 2012-10-24"}},{"date":"2012-09-30","until":"2012-12-31","published":"2013-02-15","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 36,044,000,000 United States dollar\", as of 2012-09-30 (until 2012-12-31). Claim clm_85051BD0A395, https://asof.is/claim/clm_85051BD0A395, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm.","url":"https://asof.is/claim/clm_85051BD0A395","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"36,044,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_85051BD0A395","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2012, filed 2013-02-15"}},{"date":"2012-09-30","until":"2013-03-31","published":"2012-10-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: -711,000,000 United States dollar\", as of 2012-09-30 (until 2013-03-31). Claim clm_D544780A3D80, https://asof.is/claim/clm_D544780A3D80, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312512432664/0001193125-12-432664-index.htm.","url":"https://asof.is/claim/clm_D544780A3D80","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"-711,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D544780A3D80","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2012, filed 2012-10-24"}},{"date":"2012-09-30","until":"2013-03-31","published":"2012-10-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 1,650,688,859 shares\", as of 2012-09-30 (until 2013-03-31). Claim clm_E7B997AAC550, https://asof.is/claim/clm_E7B997AAC550, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312512432664/0001193125-12-432664-index.htm.","url":"https://asof.is/claim/clm_E7B997AAC550","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,650,688,859 shares","status":"superseded","assertable":true,"id":"clm_E7B997AAC550","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2012, filed 2012-10-24"}},{"date":"2012-12-31","until":"2013-12-31","published":"2013-02-15","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb net income: 1,960,000,000 United States dollar\", as of 2012-12-31 (until 2013-12-31). Claim clm_13B8A096CB86, https://asof.is/claim/clm_13B8A096CB86, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm.","url":"https://asof.is/claim/clm_13B8A096CB86","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"1,960,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_13B8A096CB86","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2012, filed 2013-02-15"}},{"date":"2012-12-31","until":"2013-12-31","published":"2013-02-15","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb revenue: 17,621,000,000 United States dollar\", as of 2012-12-31 (until 2013-12-31). Claim clm_184933260070, https://asof.is/claim/clm_184933260070, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm.","url":"https://asof.is/claim/clm_184933260070","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"17,621,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_184933260070","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-K FY2012, filed 2013-02-15"}},{"date":"2012-12-31","until":"2013-03-31","published":"2013-02-15","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 1,656,000,000 United States dollar\", as of 2012-12-31 (until 2013-03-31). Claim clm_2673EE4231F4, https://asof.is/claim/clm_2673EE4231F4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm.","url":"https://asof.is/claim/clm_2673EE4231F4","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,656,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2673EE4231F4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2012, filed 2013-02-15"}},{"date":"2012-12-31","until":"2013-12-31","published":"2013-02-15","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb research and development: 3,904,000,000 United States dollar\", as of 2012-12-31 (until 2013-12-31). Claim clm_28B48A890504, https://asof.is/claim/clm_28B48A890504, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm.","url":"https://asof.is/claim/clm_28B48A890504","accessed":"2026-11-09"},"kind":"money","predicate":"research_and_development","value":"3,904,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_28B48A890504","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2012, filed 2013-02-15"}},{"date":"2012-12-31","until":"2013-03-31","published":"2013-02-15","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 35,897,000,000 United States dollar\", as of 2012-12-31 (until 2013-03-31). Claim clm_8335B31C7803, https://asof.is/claim/clm_8335B31C7803, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm.","url":"https://asof.is/claim/clm_8335B31C7803","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"35,897,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8335B31C7803","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2012, filed 2013-02-15"}},{"date":"2012-12-31","until":"2013-03-31","published":"2013-02-15","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 13,623,000,000 United States dollar\", as of 2012-12-31 (until 2013-03-31). Claim clm_B2D5089F7D8F, https://asof.is/claim/clm_B2D5089F7D8F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312513061678/0001193125-13-061678-index.htm.","url":"https://asof.is/claim/clm_B2D5089F7D8F","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"13,623,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B2D5089F7D8F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2012, filed 2013-02-15"}},{"date":"2013-03-31","until":"2013-06-30","published":"2013-04-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 1,642,551,939 shares\", as of 2013-03-31 (until 2013-06-30). Claim clm_1D91FA8CD9C4, https://asof.is/claim/clm_1D91FA8CD9C4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312513172698/0001193125-13-172698-index.htm.","url":"https://asof.is/claim/clm_1D91FA8CD9C4","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,642,551,939 shares","status":"superseded","assertable":true,"id":"clm_1D91FA8CD9C4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2013, filed 2013-04-25"}},{"date":"2013-03-31","until":"2013-06-30","published":"2014-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 1,355,000,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_22BCB38F2FC7, https://asof.is/claim/clm_22BCB38F2FC7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427214000054/0000014272-14-000054-index.htm.","url":"https://asof.is/claim/clm_22BCB38F2FC7","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,355,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_22BCB38F2FC7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2013, filed 2014-02-14"}},{"date":"2013-03-31","until":"2013-06-30","published":"2014-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 13,699,000,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_3CD12612970A, https://asof.is/claim/clm_3CD12612970A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427214000054/0000014272-14-000054-index.htm.","url":"https://asof.is/claim/clm_3CD12612970A","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"13,699,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3CD12612970A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2013, filed 2014-02-14"}},{"date":"2013-03-31","until":"2013-06-30","published":"2013-04-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 609,000,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_5A43CA71F161, https://asof.is/claim/clm_5A43CA71F161, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312513172698/0001193125-13-172698-index.htm.","url":"https://asof.is/claim/clm_5A43CA71F161","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"609,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5A43CA71F161","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2013, filed 2013-04-25"}},{"date":"2013-03-31","until":"2013-06-30","published":"2013-04-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 3,831,000,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_7AD34DF2085B, https://asof.is/claim/clm_7AD34DF2085B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312513172698/0001193125-13-172698-index.htm.","url":"https://asof.is/claim/clm_7AD34DF2085B","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"3,831,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7AD34DF2085B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q1 FY2013, filed 2013-04-25"}},{"date":"2013-03-31","until":"2013-06-30","published":"2013-04-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 930,000,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_87AEB86D7C6E, https://asof.is/claim/clm_87AEB86D7C6E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000119312513172698/0001193125-13-172698-index.htm.","url":"https://asof.is/claim/clm_87AEB86D7C6E","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"930,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_87AEB86D7C6E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2013, filed 2013-04-25"}},{"date":"2013-03-31","until":"2013-06-30","published":"2014-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 35,958,000,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_F99C1BE84142, https://asof.is/claim/clm_F99C1BE84142, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427214000054/0000014272-14-000054-index.htm.","url":"https://asof.is/claim/clm_F99C1BE84142","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"35,958,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F99C1BE84142","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2013, filed 2014-02-14"}},{"date":"2013-06-30","until":"2013-09-30","published":"2013-07-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 536,000,000 United States dollar\", as of 2013-06-30 (until 2013-09-30). Claim clm_0CBE35C30190, https://asof.is/claim/clm_0CBE35C30190, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427213000005/0000014272-13-000005-index.htm.","url":"https://asof.is/claim/clm_0CBE35C30190","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"536,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0CBE35C30190","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2013, filed 2013-07-25"}},{"date":"2013-06-30","until":"2013-09-30","published":"2014-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 1,821,000,000 United States dollar\", as of 2013-06-30 (until 2013-09-30). Claim clm_3B17D68F5937, https://asof.is/claim/clm_3B17D68F5937, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427214000054/0000014272-14-000054-index.htm.","url":"https://asof.is/claim/clm_3B17D68F5937","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,821,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3B17D68F5937","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2013, filed 2014-02-14"}},{"date":"2013-06-30","until":"2013-09-30","published":"2014-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 14,373,000,000 United States dollar\", as of 2013-06-30 (until 2013-09-30). Claim clm_4AC64166F770, https://asof.is/claim/clm_4AC64166F770, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427214000054/0000014272-14-000054-index.htm.","url":"https://asof.is/claim/clm_4AC64166F770","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"14,373,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4AC64166F770","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2013, filed 2014-02-14"}},{"date":"2013-06-30","until":"2013-09-30","published":"2013-07-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 4,048,000,000 United States dollar\", as of 2013-06-30 (until 2013-09-30). Claim clm_5071BA073AB1, https://asof.is/claim/clm_5071BA073AB1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427213000005/0000014272-13-000005-index.htm.","url":"https://asof.is/claim/clm_5071BA073AB1","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"4,048,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5071BA073AB1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q2 FY2013, filed 2013-07-25"}},{"date":"2013-06-30","until":"2013-09-30","published":"2013-07-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 951,000,000 United States dollar\", as of 2013-06-30 (until 2013-09-30). Claim clm_8A08DB5FE15E, https://asof.is/claim/clm_8A08DB5FE15E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427213000005/0000014272-13-000005-index.htm.","url":"https://asof.is/claim/clm_8A08DB5FE15E","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"951,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8A08DB5FE15E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2013, filed 2013-07-25"}},{"date":"2013-06-30","until":"2013-09-30","published":"2014-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 36,252,000,000 United States dollar\", as of 2013-06-30 (until 2013-09-30). Claim clm_8A51A9748631, https://asof.is/claim/clm_8A51A9748631, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427214000054/0000014272-14-000054-index.htm.","url":"https://asof.is/claim/clm_8A51A9748631","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"36,252,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8A51A9748631","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2013, filed 2014-02-14"}},{"date":"2013-06-30","until":"2013-09-30","published":"2013-07-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 1,646,323,647 shares\", as of 2013-06-30 (until 2013-09-30). Claim clm_F86E304869FA, https://asof.is/claim/clm_F86E304869FA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427213000005/0000014272-13-000005-index.htm.","url":"https://asof.is/claim/clm_F86E304869FA","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,646,323,647 shares","status":"superseded","assertable":true,"id":"clm_F86E304869FA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2013, filed 2013-07-25"}},{"date":"2013-09-30","until":"2014-03-31","published":"2013-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 893,000,000 United States dollar\", as of 2013-09-30 (until 2014-03-31). Claim clm_27A7E1F022F1, https://asof.is/claim/clm_27A7E1F022F1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427213000029/0000014272-13-000029-index.htm.","url":"https://asof.is/claim/clm_27A7E1F022F1","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"893,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_27A7E1F022F1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2013, filed 2013-10-23"}},{"date":"2013-09-30","until":"2013-12-31","published":"2014-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 1,771,000,000 United States dollar\", as of 2013-09-30 (until 2013-12-31). Claim clm_363905365AEB, https://asof.is/claim/clm_363905365AEB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427214000054/0000014272-14-000054-index.htm.","url":"https://asof.is/claim/clm_363905365AEB","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,771,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_363905365AEB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2013, filed 2014-02-14"}},{"date":"2013-09-30","until":"2014-03-31","published":"2013-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 692,000,000 United States dollar\", as of 2013-09-30 (until 2014-03-31). Claim clm_5D173FA6435E, https://asof.is/claim/clm_5D173FA6435E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427213000029/0000014272-13-000029-index.htm.","url":"https://asof.is/claim/clm_5D173FA6435E","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"692,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5D173FA6435E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2013, filed 2013-10-23"}},{"date":"2013-09-30","until":"2013-12-31","published":"2014-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 14,714,000,000 United States dollar\", as of 2013-09-30 (until 2013-12-31). Claim clm_B1D91187EE1D, https://asof.is/claim/clm_B1D91187EE1D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427214000054/0000014272-14-000054-index.htm.","url":"https://asof.is/claim/clm_B1D91187EE1D","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"14,714,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B1D91187EE1D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2013, filed 2014-02-14"}},{"date":"2013-09-30","until":"2014-03-31","published":"2013-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 4,065,000,000 United States dollar\", as of 2013-09-30 (until 2014-03-31). Claim clm_B320413C225B, https://asof.is/claim/clm_B320413C225B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427213000029/0000014272-13-000029-index.htm.","url":"https://asof.is/claim/clm_B320413C225B","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"4,065,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B320413C225B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q3 FY2013, filed 2013-10-23"}},{"date":"2013-09-30","until":"2013-12-31","published":"2014-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 36,804,000,000 United States dollar\", as of 2013-09-30 (until 2013-12-31). Claim clm_C99CF666DA8F, https://asof.is/claim/clm_C99CF666DA8F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427214000054/0000014272-14-000054-index.htm.","url":"https://asof.is/claim/clm_C99CF666DA8F","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"36,804,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C99CF666DA8F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2013, filed 2014-02-14"}},{"date":"2013-09-30","until":"2014-01-31","published":"2013-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 1,646,542,902 shares\", as of 2013-09-30 (until 2014-01-31). Claim clm_D362098E13A0, https://asof.is/claim/clm_D362098E13A0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427213000029/0000014272-13-000029-index.htm.","url":"https://asof.is/claim/clm_D362098E13A0","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,646,542,902 shares","status":"superseded","assertable":true,"id":"clm_D362098E13A0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2013, filed 2013-10-23"}},{"date":"2013-12-31","until":"2014-12-31","published":"2014-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb research and development: 3,731,000,000 United States dollar\", as of 2013-12-31 (until 2014-12-31). Claim clm_7AA4E6476ED6, https://asof.is/claim/clm_7AA4E6476ED6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427214000054/0000014272-14-000054-index.htm.","url":"https://asof.is/claim/clm_7AA4E6476ED6","accessed":"2026-11-09"},"kind":"money","predicate":"research_and_development","value":"3,731,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7AA4E6476ED6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2013, filed 2014-02-14"}},{"date":"2013-12-31","until":"2014-03-31","published":"2014-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 3,586,000,000 United States dollar\", as of 2013-12-31 (until 2014-03-31). Claim clm_9739D1EF5F99, https://asof.is/claim/clm_9739D1EF5F99, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427214000054/0000014272-14-000054-index.htm.","url":"https://asof.is/claim/clm_9739D1EF5F99","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"3,586,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9739D1EF5F99","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2013, filed 2014-02-14"}},{"date":"2013-12-31","until":"2014-12-31","published":"2014-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb revenue: 16,385,000,000 United States dollar\", as of 2013-12-31 (until 2014-12-31). Claim clm_E61BAA33F6AB, https://asof.is/claim/clm_E61BAA33F6AB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427214000054/0000014272-14-000054-index.htm.","url":"https://asof.is/claim/clm_E61BAA33F6AB","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"16,385,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E61BAA33F6AB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-K FY2013, filed 2014-02-14"}},{"date":"2013-12-31","until":"2014-03-31","published":"2014-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 38,592,000,000 United States dollar\", as of 2013-12-31 (until 2014-03-31). Claim clm_EC7E8D5CA72D, https://asof.is/claim/clm_EC7E8D5CA72D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427214000054/0000014272-14-000054-index.htm.","url":"https://asof.is/claim/clm_EC7E8D5CA72D","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"38,592,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EC7E8D5CA72D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2013, filed 2014-02-14"}},{"date":"2013-12-31","until":"2014-03-31","published":"2014-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 15,154,000,000 United States dollar\", as of 2013-12-31 (until 2014-03-31). Claim clm_F7A44B0C37D3, https://asof.is/claim/clm_F7A44B0C37D3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427214000054/0000014272-14-000054-index.htm.","url":"https://asof.is/claim/clm_F7A44B0C37D3","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"15,154,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F7A44B0C37D3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2013, filed 2014-02-14"}},{"date":"2013-12-31","until":"2014-12-31","published":"2014-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb net income: 2,563,000,000 United States dollar\", as of 2013-12-31 (until 2014-12-31). Claim clm_FED892DDF9CE, https://asof.is/claim/clm_FED892DDF9CE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427214000054/0000014272-14-000054-index.htm.","url":"https://asof.is/claim/clm_FED892DDF9CE","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"2,563,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FED892DDF9CE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2013, filed 2014-02-14"}},{"date":"2014-01-31","until":"2014-03-31","published":"2014-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 1,650,232,566 shares\", as of 2014-01-31 (until 2014-03-31). Claim clm_8BCCB5038439, https://asof.is/claim/clm_8BCCB5038439, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427214000054/0000014272-14-000054-index.htm.","url":"https://asof.is/claim/clm_8BCCB5038439","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,650,232,566 shares","status":"superseded","assertable":true,"id":"clm_8BCCB5038439","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2013, filed 2014-02-14"}},{"date":"2014-03-31","until":"2014-06-30","published":"2015-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 33,424,000,000 United States dollar\", as of 2014-03-31 (until 2014-06-30). Claim clm_165903BD583C, https://asof.is/claim/clm_165903BD583C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427215000055/0000014272-15-000055-index.htm.","url":"https://asof.is/claim/clm_165903BD583C","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"33,424,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_165903BD583C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2014, filed 2015-02-13"}},{"date":"2014-03-31","until":"2014-06-30","published":"2015-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 5,225,000,000 United States dollar\", as of 2014-03-31 (until 2014-06-30). Claim clm_2667BF40F6D4, https://asof.is/claim/clm_2667BF40F6D4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427215000055/0000014272-15-000055-index.htm.","url":"https://asof.is/claim/clm_2667BF40F6D4","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"5,225,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2667BF40F6D4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2014, filed 2015-02-13"}},{"date":"2014-03-31","until":"2014-06-30","published":"2015-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 15,531,000,000 United States dollar\", as of 2014-03-31 (until 2014-06-30). Claim clm_4166B33E0FF5, https://asof.is/claim/clm_4166B33E0FF5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427215000055/0000014272-15-000055-index.htm.","url":"https://asof.is/claim/clm_4166B33E0FF5","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"15,531,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4166B33E0FF5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2014, filed 2015-02-13"}},{"date":"2014-03-31","until":"2014-06-30","published":"2014-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 937,000,000 United States dollar\", as of 2014-03-31 (until 2014-06-30). Claim clm_C49A2C3D8244, https://asof.is/claim/clm_C49A2C3D8244, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427214000175/0000014272-14-000175-index.htm.","url":"https://asof.is/claim/clm_C49A2C3D8244","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"937,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C49A2C3D8244","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2014, filed 2014-04-29"}},{"date":"2014-03-31","until":"2014-06-30","published":"2014-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 946,000,000 United States dollar\", as of 2014-03-31 (until 2014-06-30). Claim clm_C5B379B462EE, https://asof.is/claim/clm_C5B379B462EE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427214000175/0000014272-14-000175-index.htm.","url":"https://asof.is/claim/clm_C5B379B462EE","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"946,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C5B379B462EE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2014, filed 2014-04-29"}},{"date":"2014-03-31","until":"2014-06-30","published":"2014-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 1,657,176,162 shares\", as of 2014-03-31 (until 2014-06-30). Claim clm_DA71505ABBC2, https://asof.is/claim/clm_DA71505ABBC2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427214000175/0000014272-14-000175-index.htm.","url":"https://asof.is/claim/clm_DA71505ABBC2","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,657,176,162 shares","status":"superseded","assertable":true,"id":"clm_DA71505ABBC2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2014, filed 2014-04-29"}},{"date":"2014-03-31","until":"2014-06-30","published":"2014-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 3,811,000,000 United States dollar\", as of 2014-03-31 (until 2014-06-30). Claim clm_FBA07B943AA7, https://asof.is/claim/clm_FBA07B943AA7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427214000175/0000014272-14-000175-index.htm.","url":"https://asof.is/claim/clm_FBA07B943AA7","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"3,811,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FBA07B943AA7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q1 FY2014, filed 2014-04-29"}},{"date":"2014-06-30","until":"2014-09-30","published":"2014-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 1,657,904,666 shares\", as of 2014-06-30 (until 2014-09-30). Claim clm_099A5E3E5A27, https://asof.is/claim/clm_099A5E3E5A27, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427214000214/0000014272-14-000214-index.htm.","url":"https://asof.is/claim/clm_099A5E3E5A27","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,657,904,666 shares","status":"superseded","assertable":true,"id":"clm_099A5E3E5A27","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2014, filed 2014-07-24"}},{"date":"2014-06-30","until":"2014-09-30","published":"2015-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 4,282,000,000 United States dollar\", as of 2014-06-30 (until 2014-09-30). Claim clm_7ABFC31A8BB3, https://asof.is/claim/clm_7ABFC31A8BB3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427215000055/0000014272-15-000055-index.htm.","url":"https://asof.is/claim/clm_7ABFC31A8BB3","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"4,282,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7ABFC31A8BB3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2014, filed 2015-02-13"}},{"date":"2014-06-30","until":"2014-09-30","published":"2015-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 33,503,000,000 United States dollar\", as of 2014-06-30 (until 2014-09-30). Claim clm_95358B86E7F7, https://asof.is/claim/clm_95358B86E7F7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427215000055/0000014272-15-000055-index.htm.","url":"https://asof.is/claim/clm_95358B86E7F7","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"33,503,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_95358B86E7F7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2014, filed 2015-02-13"}},{"date":"2014-06-30","until":"2014-09-30","published":"2014-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 333,000,000 United States dollar\", as of 2014-06-30 (until 2014-09-30). Claim clm_AC6E23B2F9C9, https://asof.is/claim/clm_AC6E23B2F9C9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427214000214/0000014272-14-000214-index.htm.","url":"https://asof.is/claim/clm_AC6E23B2F9C9","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"333,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AC6E23B2F9C9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2014, filed 2014-07-24"}},{"date":"2014-06-30","until":"2014-09-30","published":"2014-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 1,416,000,000 United States dollar\", as of 2014-06-30 (until 2014-09-30). Claim clm_B68B536C52EB, https://asof.is/claim/clm_B68B536C52EB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427214000214/0000014272-14-000214-index.htm.","url":"https://asof.is/claim/clm_B68B536C52EB","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"1,416,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B68B536C52EB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2014, filed 2014-07-24"}},{"date":"2014-06-30","until":"2014-09-30","published":"2014-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 3,889,000,000 United States dollar\", as of 2014-06-30 (until 2014-09-30). Claim clm_C0146E275324, https://asof.is/claim/clm_C0146E275324, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427214000214/0000014272-14-000214-index.htm.","url":"https://asof.is/claim/clm_C0146E275324","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"3,889,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C0146E275324","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q2 FY2014, filed 2014-07-24"}},{"date":"2014-06-30","until":"2014-09-30","published":"2015-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 15,379,000,000 United States dollar\", as of 2014-06-30 (until 2014-09-30). Claim clm_F524606EDD03, https://asof.is/claim/clm_F524606EDD03, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427215000055/0000014272-15-000055-index.htm.","url":"https://asof.is/claim/clm_F524606EDD03","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"15,379,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F524606EDD03","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2014, filed 2015-02-13"}},{"date":"2014-09-30","until":"2015-03-31","published":"2014-10-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 721,000,000 United States dollar\", as of 2014-09-30 (until 2015-03-31). Claim clm_046118EE4074, https://asof.is/claim/clm_046118EE4074, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427214000257/0000014272-14-000257-index.htm.","url":"https://asof.is/claim/clm_046118EE4074","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"721,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_046118EE4074","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2014, filed 2014-10-24"}},{"date":"2014-09-30","until":"2015-02-02","published":"2014-10-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 1,658,776,491 shares\", as of 2014-09-30 (until 2015-02-02). Claim clm_0B78835A0141, https://asof.is/claim/clm_0B78835A0141, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427214000257/0000014272-14-000257-index.htm.","url":"https://asof.is/claim/clm_0B78835A0141","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,658,776,491 shares","status":"superseded","assertable":true,"id":"clm_0B78835A0141","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2014, filed 2014-10-24"}},{"date":"2014-09-30","until":"2014-12-31","published":"2015-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 4,851,000,000 United States dollar\", as of 2014-09-30 (until 2014-12-31). Claim clm_11320D01EF6B, https://asof.is/claim/clm_11320D01EF6B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427215000055/0000014272-15-000055-index.htm.","url":"https://asof.is/claim/clm_11320D01EF6B","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"4,851,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_11320D01EF6B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2014, filed 2015-02-13"}},{"date":"2014-09-30","until":"2015-03-31","published":"2014-10-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 3,921,000,000 United States dollar\", as of 2014-09-30 (until 2015-03-31). Claim clm_B93057222A64, https://asof.is/claim/clm_B93057222A64, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427214000257/0000014272-14-000257-index.htm.","url":"https://asof.is/claim/clm_B93057222A64","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"3,921,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B93057222A64","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q3 FY2014, filed 2014-10-24"}},{"date":"2014-09-30","until":"2015-03-31","published":"2014-10-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 983,000,000 United States dollar\", as of 2014-09-30 (until 2015-03-31). Claim clm_C74D8497C168, https://asof.is/claim/clm_C74D8497C168, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427214000257/0000014272-14-000257-index.htm.","url":"https://asof.is/claim/clm_C74D8497C168","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"983,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C74D8497C168","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2014, filed 2014-10-24"}},{"date":"2014-09-30","until":"2014-12-31","published":"2015-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 15,201,000,000 United States dollar\", as of 2014-09-30 (until 2014-12-31). Claim clm_D7BAD79013E2, https://asof.is/claim/clm_D7BAD79013E2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427215000055/0000014272-15-000055-index.htm.","url":"https://asof.is/claim/clm_D7BAD79013E2","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"15,201,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D7BAD79013E2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2014, filed 2015-02-13"}},{"date":"2014-09-30","until":"2014-12-31","published":"2015-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 33,450,000,000 United States dollar\", as of 2014-09-30 (until 2014-12-31). Claim clm_DA44714068D4, https://asof.is/claim/clm_DA44714068D4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427215000055/0000014272-15-000055-index.htm.","url":"https://asof.is/claim/clm_DA44714068D4","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"33,450,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DA44714068D4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2014, filed 2015-02-13"}},{"date":"2014-12-31","until":"2015-12-31","published":"2015-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb net income: 2,004,000,000 United States dollar\", as of 2014-12-31 (until 2015-12-31). Claim clm_849DE9DA8A78, https://asof.is/claim/clm_849DE9DA8A78, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427215000055/0000014272-15-000055-index.htm.","url":"https://asof.is/claim/clm_849DE9DA8A78","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"2,004,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_849DE9DA8A78","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2014, filed 2015-02-13"}},{"date":"2014-12-31","until":"2015-03-31","published":"2015-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 33,749,000,000 United States dollar\", as of 2014-12-31 (until 2015-03-31). Claim clm_86A59CABE1F2, https://asof.is/claim/clm_86A59CABE1F2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427215000055/0000014272-15-000055-index.htm.","url":"https://asof.is/claim/clm_86A59CABE1F2","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"33,749,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_86A59CABE1F2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2014, filed 2015-02-13"}},{"date":"2014-12-31","until":"2015-12-31","published":"2015-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb research and development: 4,534,000,000 United States dollar\", as of 2014-12-31 (until 2015-12-31). Claim clm_B78350FCAC19, https://asof.is/claim/clm_B78350FCAC19, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427215000055/0000014272-15-000055-index.htm.","url":"https://asof.is/claim/clm_B78350FCAC19","accessed":"2026-11-09"},"kind":"money","predicate":"research_and_development","value":"4,534,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B78350FCAC19","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2014, filed 2015-02-13"}},{"date":"2014-12-31","until":"2015-03-31","published":"2015-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 5,571,000,000 United States dollar\", as of 2014-12-31 (until 2015-03-31). Claim clm_D2BA081EDED0, https://asof.is/claim/clm_D2BA081EDED0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427215000055/0000014272-15-000055-index.htm.","url":"https://asof.is/claim/clm_D2BA081EDED0","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"5,571,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D2BA081EDED0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2014, filed 2015-02-13"}},{"date":"2014-12-31","until":"2015-12-31","published":"2015-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb revenue: 15,879,000,000 United States dollar\", as of 2014-12-31 (until 2015-12-31). Claim clm_E35D5B28759F, https://asof.is/claim/clm_E35D5B28759F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427215000055/0000014272-15-000055-index.htm.","url":"https://asof.is/claim/clm_E35D5B28759F","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"15,879,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E35D5B28759F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-K FY2014, filed 2015-02-13"}},{"date":"2014-12-31","until":"2015-03-31","published":"2015-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 14,852,000,000 United States dollar\", as of 2014-12-31 (until 2015-03-31). Claim clm_F27D0B683974, https://asof.is/claim/clm_F27D0B683974, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427215000055/0000014272-15-000055-index.htm.","url":"https://asof.is/claim/clm_F27D0B683974","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"14,852,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F27D0B683974","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2014, filed 2015-02-13"}},{"date":"2015-02-02","until":"2015-03-31","published":"2015-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 1,662,118,446 shares\", as of 2015-02-02 (until 2015-03-31). Claim clm_47A9EEF643F4, https://asof.is/claim/clm_47A9EEF643F4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427215000055/0000014272-15-000055-index.htm.","url":"https://asof.is/claim/clm_47A9EEF643F4","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,662,118,446 shares","status":"superseded","assertable":true,"id":"clm_47A9EEF643F4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2014, filed 2015-02-13"}},{"date":"2015-03-31","until":"2015-06-30","published":"2016-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 15,689,000,000 United States dollar\", as of 2015-03-31 (until 2015-06-30). Claim clm_0192022AE328, https://asof.is/claim/clm_0192022AE328, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427216000288/0000014272-16-000288-index.htm.","url":"https://asof.is/claim/clm_0192022AE328","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"15,689,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0192022AE328","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2015, filed 2016-02-12"}},{"date":"2015-03-31","until":"2015-06-30","published":"2015-04-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 4,041,000,000 United States dollar\", as of 2015-03-31 (until 2015-06-30). Claim clm_1DAC03642CAB, https://asof.is/claim/clm_1DAC03642CAB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427215000178/0000014272-15-000178-index.htm.","url":"https://asof.is/claim/clm_1DAC03642CAB","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"4,041,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1DAC03642CAB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q1 FY2015, filed 2015-04-28"}},{"date":"2015-03-31","until":"2015-06-30","published":"2016-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 6,294,000,000 United States dollar\", as of 2015-03-31 (until 2015-06-30). Claim clm_2D49EA7CA617, https://asof.is/claim/clm_2D49EA7CA617, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427216000288/0000014272-16-000288-index.htm.","url":"https://asof.is/claim/clm_2D49EA7CA617","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"6,294,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2D49EA7CA617","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2015, filed 2016-02-12"}},{"date":"2015-03-31","until":"2015-06-30","published":"2015-04-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 1,016,000,000 United States dollar\", as of 2015-03-31 (until 2015-06-30). Claim clm_4FBA1EFF7D90, https://asof.is/claim/clm_4FBA1EFF7D90, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427215000178/0000014272-15-000178-index.htm.","url":"https://asof.is/claim/clm_4FBA1EFF7D90","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"1,016,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4FBA1EFF7D90","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2015, filed 2015-04-28"}},{"date":"2015-03-31","until":"2015-06-30","published":"2015-04-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 1,666,974,545 shares\", as of 2015-03-31 (until 2015-06-30). Claim clm_7ECB754D94B8, https://asof.is/claim/clm_7ECB754D94B8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427215000178/0000014272-15-000178-index.htm.","url":"https://asof.is/claim/clm_7ECB754D94B8","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,666,974,545 shares","status":"superseded","assertable":true,"id":"clm_7ECB754D94B8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2015, filed 2015-04-28"}},{"date":"2015-03-31","until":"2015-06-30","published":"2016-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 33,579,000,000 United States dollar\", as of 2015-03-31 (until 2015-06-30). Claim clm_9763696C10AA, https://asof.is/claim/clm_9763696C10AA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427216000288/0000014272-16-000288-index.htm.","url":"https://asof.is/claim/clm_9763696C10AA","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"33,579,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9763696C10AA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2015, filed 2016-02-12"}},{"date":"2015-03-31","until":"2015-06-30","published":"2015-04-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 1,186,000,000 United States dollar\", as of 2015-03-31 (until 2015-06-30). Claim clm_EB00F078653A, https://asof.is/claim/clm_EB00F078653A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427215000178/0000014272-15-000178-index.htm.","url":"https://asof.is/claim/clm_EB00F078653A","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,186,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EB00F078653A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2015, filed 2015-04-28"}},{"date":"2015-06-30","until":"2015-09-30","published":"2015-07-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 1,667,502,766 shares\", as of 2015-06-30 (until 2015-09-30). Claim clm_0DDECD3BC6A2, https://asof.is/claim/clm_0DDECD3BC6A2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427215000212/0000014272-15-000212-index.htm.","url":"https://asof.is/claim/clm_0DDECD3BC6A2","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,667,502,766 shares","status":"superseded","assertable":true,"id":"clm_0DDECD3BC6A2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2015, filed 2015-07-23"}},{"date":"2015-06-30","until":"2015-09-30","published":"2016-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 31,954,000,000 United States dollar\", as of 2015-06-30 (until 2015-09-30). Claim clm_64FCE5F5CC75, https://asof.is/claim/clm_64FCE5F5CC75, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427216000288/0000014272-16-000288-index.htm.","url":"https://asof.is/claim/clm_64FCE5F5CC75","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"31,954,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_64FCE5F5CC75","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2015, filed 2016-02-12"}},{"date":"2015-06-30","until":"2015-09-30","published":"2015-07-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 1,856,000,000 United States dollar\", as of 2015-06-30 (until 2015-09-30). Claim clm_6771195A5964, https://asof.is/claim/clm_6771195A5964, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427215000212/0000014272-15-000212-index.htm.","url":"https://asof.is/claim/clm_6771195A5964","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"1,856,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6771195A5964","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2015, filed 2015-07-23"}},{"date":"2015-06-30","until":"2015-09-30","published":"2015-07-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: -130,000,000 United States dollar\", as of 2015-06-30 (until 2015-09-30). Claim clm_96165F529E51, https://asof.is/claim/clm_96165F529E51, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427215000212/0000014272-15-000212-index.htm.","url":"https://asof.is/claim/clm_96165F529E51","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"-130,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_96165F529E51","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2015, filed 2015-07-23"}},{"date":"2015-06-30","until":"2015-09-30","published":"2016-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 15,291,000,000 United States dollar\", as of 2015-06-30 (until 2015-09-30). Claim clm_AAF5F66DD904, https://asof.is/claim/clm_AAF5F66DD904, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427216000288/0000014272-16-000288-index.htm.","url":"https://asof.is/claim/clm_AAF5F66DD904","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"15,291,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AAF5F66DD904","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2015, filed 2016-02-12"}},{"date":"2015-06-30","until":"2015-09-30","published":"2015-07-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 4,163,000,000 United States dollar\", as of 2015-06-30 (until 2015-09-30). Claim clm_AB1D876445CB, https://asof.is/claim/clm_AB1D876445CB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427215000212/0000014272-15-000212-index.htm.","url":"https://asof.is/claim/clm_AB1D876445CB","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"4,163,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AB1D876445CB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q2 FY2015, filed 2015-07-23"}},{"date":"2015-06-30","until":"2015-09-30","published":"2016-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 4,199,000,000 United States dollar\", as of 2015-06-30 (until 2015-09-30). Claim clm_CCE8F02B208C, https://asof.is/claim/clm_CCE8F02B208C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427216000288/0000014272-16-000288-index.htm.","url":"https://asof.is/claim/clm_CCE8F02B208C","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"4,199,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CCE8F02B208C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2015, filed 2016-02-12"}},{"date":"2015-09-30","until":"2015-12-31","published":"2016-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 31,779,000,000 United States dollar\", as of 2015-09-30 (until 2015-12-31). Claim clm_3D268281546C, https://asof.is/claim/clm_3D268281546C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427216000288/0000014272-16-000288-index.htm.","url":"https://asof.is/claim/clm_3D268281546C","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"31,779,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3D268281546C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2015, filed 2016-02-12"}},{"date":"2015-09-30","until":"2016-02-01","published":"2015-10-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 1,668,286,317 shares\", as of 2015-09-30 (until 2016-02-01). Claim clm_8EB882510175, https://asof.is/claim/clm_8EB882510175, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427215000235/0000014272-15-000235-index.htm.","url":"https://asof.is/claim/clm_8EB882510175","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,668,286,317 shares","status":"superseded","assertable":true,"id":"clm_8EB882510175","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2015, filed 2015-10-27"}},{"date":"2015-09-30","until":"2015-12-31","published":"2016-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 15,273,000,000 United States dollar\", as of 2015-09-30 (until 2015-12-31). Claim clm_9B6FCBCD9BB0, https://asof.is/claim/clm_9B6FCBCD9BB0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427216000288/0000014272-16-000288-index.htm.","url":"https://asof.is/claim/clm_9B6FCBCD9BB0","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"15,273,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9B6FCBCD9BB0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2015, filed 2016-02-12"}},{"date":"2015-09-30","until":"2015-12-31","published":"2016-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 3,975,000,000 United States dollar\", as of 2015-09-30 (until 2015-12-31). Claim clm_B0117C04AB60, https://asof.is/claim/clm_B0117C04AB60, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427216000288/0000014272-16-000288-index.htm.","url":"https://asof.is/claim/clm_B0117C04AB60","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"3,975,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B0117C04AB60","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2015, filed 2016-02-12"}},{"date":"2015-09-30","until":"2016-03-31","published":"2015-10-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 706,000,000 United States dollar\", as of 2015-09-30 (until 2016-03-31). Claim clm_C819205D6190, https://asof.is/claim/clm_C819205D6190, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427215000235/0000014272-15-000235-index.htm.","url":"https://asof.is/claim/clm_C819205D6190","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"706,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C819205D6190","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2015, filed 2015-10-27"}},{"date":"2015-09-30","until":"2016-03-31","published":"2015-10-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 4,069,000,000 United States dollar\", as of 2015-09-30 (until 2016-03-31). Claim clm_F94A6EEA38D3, https://asof.is/claim/clm_F94A6EEA38D3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427215000235/0000014272-15-000235-index.htm.","url":"https://asof.is/claim/clm_F94A6EEA38D3","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"4,069,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F94A6EEA38D3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q3 FY2015, filed 2015-10-27"}},{"date":"2015-09-30","until":"2016-03-31","published":"2015-10-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 1,132,000,000 United States dollar\", as of 2015-09-30 (until 2016-03-31). Claim clm_FD8FE6AED540, https://asof.is/claim/clm_FD8FE6AED540, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427215000235/0000014272-15-000235-index.htm.","url":"https://asof.is/claim/clm_FD8FE6AED540","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"1,132,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FD8FE6AED540","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2015, filed 2015-10-27"}},{"date":"2015-12-31","until":"2016-12-31","published":"2016-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb research and development: 5,920,000,000 United States dollar\", as of 2015-12-31 (until 2016-12-31). Claim clm_0EB21ED2CFE3, https://asof.is/claim/clm_0EB21ED2CFE3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427216000288/0000014272-16-000288-index.htm.","url":"https://asof.is/claim/clm_0EB21ED2CFE3","accessed":"2026-11-09"},"kind":"money","predicate":"research_and_development","value":"5,920,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0EB21ED2CFE3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2015, filed 2016-02-12"}},{"date":"2015-12-31","until":"2016-03-31","published":"2016-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 14,266,000,000 United States dollar\", as of 2015-12-31 (until 2016-03-31). Claim clm_76099FA48BDF, https://asof.is/claim/clm_76099FA48BDF, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427216000288/0000014272-16-000288-index.htm.","url":"https://asof.is/claim/clm_76099FA48BDF","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"14,266,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_76099FA48BDF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2015, filed 2016-02-12"}},{"date":"2015-12-31","until":"2016-12-31","published":"2016-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb revenue: 16,560,000,000 United States dollar\", as of 2015-12-31 (until 2016-12-31). Claim clm_B192EABF21B6, https://asof.is/claim/clm_B192EABF21B6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427216000288/0000014272-16-000288-index.htm.","url":"https://asof.is/claim/clm_B192EABF21B6","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"16,560,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B192EABF21B6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-K FY2015, filed 2016-02-12"}},{"date":"2015-12-31","until":"2016-03-31","published":"2016-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 2,385,000,000 United States dollar\", as of 2015-12-31 (until 2016-03-31). Claim clm_D4314A88ED11, https://asof.is/claim/clm_D4314A88ED11, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427216000288/0000014272-16-000288-index.htm.","url":"https://asof.is/claim/clm_D4314A88ED11","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"2,385,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D4314A88ED11","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2015, filed 2016-02-12"}},{"date":"2015-12-31","until":"2016-03-31","published":"2016-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 31,748,000,000 United States dollar\", as of 2015-12-31 (until 2016-03-31). Claim clm_DF29D46189B8, https://asof.is/claim/clm_DF29D46189B8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427216000288/0000014272-16-000288-index.htm.","url":"https://asof.is/claim/clm_DF29D46189B8","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"31,748,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DF29D46189B8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2015, filed 2016-02-12"}},{"date":"2015-12-31","until":"2016-12-31","published":"2016-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb net income: 1,565,000,000 United States dollar\", as of 2015-12-31 (until 2016-12-31). Claim clm_EE77C19D23BB, https://asof.is/claim/clm_EE77C19D23BB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427216000288/0000014272-16-000288-index.htm.","url":"https://asof.is/claim/clm_EE77C19D23BB","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"1,565,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EE77C19D23BB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2015, filed 2016-02-12"}},{"date":"2016-02-01","until":"2016-03-31","published":"2016-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 1,669,459,090 shares\", as of 2016-02-01 (until 2016-03-31). Claim clm_92668B1A6C2E, https://asof.is/claim/clm_92668B1A6C2E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427216000288/0000014272-16-000288-index.htm.","url":"https://asof.is/claim/clm_92668B1A6C2E","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,669,459,090 shares","status":"superseded","assertable":true,"id":"clm_92668B1A6C2E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2015, filed 2016-02-12"}},{"date":"2016-03-31","until":"2016-06-30","published":"2017-02-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 14,551,000,000 United States dollar\", as of 2016-03-31 (until 2016-06-30). Claim clm_0B00A3BD5E84, https://asof.is/claim/clm_0B00A3BD5E84, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427217000047/0000014272-17-000047-index.htm.","url":"https://asof.is/claim/clm_0B00A3BD5E84","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"14,551,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0B00A3BD5E84","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2016, filed 2017-02-21"}},{"date":"2016-03-31","until":"2016-06-30","published":"2016-04-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 1,195,000,000 United States dollar\", as of 2016-03-31 (until 2016-06-30). Claim clm_70E0D16FEF0D, https://asof.is/claim/clm_70E0D16FEF0D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427216000399/0000014272-16-000399-index.htm.","url":"https://asof.is/claim/clm_70E0D16FEF0D","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,195,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_70E0D16FEF0D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2016, filed 2016-04-28"}},{"date":"2016-03-31","until":"2016-06-30","published":"2016-04-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 4,391,000,000 United States dollar\", as of 2016-03-31 (until 2016-06-30). Claim clm_76DE4FA9E643, https://asof.is/claim/clm_76DE4FA9E643, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427216000399/0000014272-16-000399-index.htm.","url":"https://asof.is/claim/clm_76DE4FA9E643","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"4,391,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_76DE4FA9E643","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q1 FY2016, filed 2016-04-28"}},{"date":"2016-03-31","until":"2016-06-30","published":"2016-04-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 1,669,307,273 shares\", as of 2016-03-31 (until 2016-06-30). Claim clm_8EE01557A4E6, https://asof.is/claim/clm_8EE01557A4E6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427216000399/0000014272-16-000399-index.htm.","url":"https://asof.is/claim/clm_8EE01557A4E6","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,669,307,273 shares","status":"superseded","assertable":true,"id":"clm_8EE01557A4E6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2016, filed 2016-04-28"}},{"date":"2016-03-31","until":"2016-06-30","published":"2017-02-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 2,644,000,000 United States dollar\", as of 2016-03-31 (until 2016-06-30). Claim clm_B8B01A4BE920, https://asof.is/claim/clm_B8B01A4BE920, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427217000047/0000014272-17-000047-index.htm.","url":"https://asof.is/claim/clm_B8B01A4BE920","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"2,644,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B8B01A4BE920","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2016, filed 2017-02-21"}},{"date":"2016-03-31","until":"2016-06-30","published":"2016-04-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 1,136,000,000 United States dollar\", as of 2016-03-31 (until 2016-06-30). Claim clm_F353300DD7DB, https://asof.is/claim/clm_F353300DD7DB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427216000399/0000014272-16-000399-index.htm.","url":"https://asof.is/claim/clm_F353300DD7DB","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"1,136,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F353300DD7DB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2016, filed 2016-04-28"}},{"date":"2016-03-31","until":"2016-06-30","published":"2017-02-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 31,892,000,000 United States dollar\", as of 2016-03-31 (until 2016-06-30). Claim clm_F3C80A297662, https://asof.is/claim/clm_F3C80A297662, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427217000047/0000014272-17-000047-index.htm.","url":"https://asof.is/claim/clm_F3C80A297662","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"31,892,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F3C80A297662","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2016, filed 2017-02-21"}},{"date":"2016-06-30","until":"2016-09-30","published":"2016-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 1,166,000,000 United States dollar\", as of 2016-06-30 (until 2016-09-30). Claim clm_15CE83DC11F7, https://asof.is/claim/clm_15CE83DC11F7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427216000461/0000014272-16-000461-index.htm.","url":"https://asof.is/claim/clm_15CE83DC11F7","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,166,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_15CE83DC11F7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2016, filed 2016-07-28"}},{"date":"2016-06-30","until":"2016-09-30","published":"2016-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 4,871,000,000 United States dollar\", as of 2016-06-30 (until 2016-09-30). Claim clm_1DD87B004226, https://asof.is/claim/clm_1DD87B004226, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427216000461/0000014272-16-000461-index.htm.","url":"https://asof.is/claim/clm_1DD87B004226","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"4,871,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1DD87B004226","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q2 FY2016, filed 2016-07-28"}},{"date":"2016-06-30","until":"2016-09-30","published":"2017-02-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 15,078,000,000 United States dollar\", as of 2016-06-30 (until 2016-09-30). Claim clm_30F9393ADCF1, https://asof.is/claim/clm_30F9393ADCF1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427217000047/0000014272-17-000047-index.htm.","url":"https://asof.is/claim/clm_30F9393ADCF1","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"15,078,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_30F9393ADCF1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2016, filed 2017-02-21"}},{"date":"2016-06-30","until":"2016-09-30","published":"2017-02-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 32,831,000,000 United States dollar\", as of 2016-06-30 (until 2016-09-30). Claim clm_5CC6CD0DCABD, https://asof.is/claim/clm_5CC6CD0DCABD, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427217000047/0000014272-17-000047-index.htm.","url":"https://asof.is/claim/clm_5CC6CD0DCABD","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"32,831,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5CC6CD0DCABD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2016, filed 2017-02-21"}},{"date":"2016-06-30","until":"2016-09-30","published":"2017-02-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 2,934,000,000 United States dollar\", as of 2016-06-30 (until 2016-09-30). Claim clm_957363951295, https://asof.is/claim/clm_957363951295, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427217000047/0000014272-17-000047-index.htm.","url":"https://asof.is/claim/clm_957363951295","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"2,934,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_957363951295","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2016, filed 2017-02-21"}},{"date":"2016-06-30","until":"2016-09-30","published":"2016-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 1,266,000,000 United States dollar\", as of 2016-06-30 (until 2016-09-30). Claim clm_978C16624868, https://asof.is/claim/clm_978C16624868, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427216000461/0000014272-16-000461-index.htm.","url":"https://asof.is/claim/clm_978C16624868","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"1,266,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_978C16624868","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2016, filed 2016-07-28"}},{"date":"2016-06-30","until":"2016-09-30","published":"2016-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 1,670,858,535 shares\", as of 2016-06-30 (until 2016-09-30). Claim clm_B8969CB68765, https://asof.is/claim/clm_B8969CB68765, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427216000461/0000014272-16-000461-index.htm.","url":"https://asof.is/claim/clm_B8969CB68765","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,670,858,535 shares","status":"superseded","assertable":true,"id":"clm_B8969CB68765","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2016, filed 2016-07-28"}},{"date":"2016-09-30","until":"2017-03-31","published":"2016-10-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 4,922,000,000 United States dollar\", as of 2016-09-30 (until 2017-03-31). Claim clm_18781A133073, https://asof.is/claim/clm_18781A133073, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427216000491/0000014272-16-000491-index.htm.","url":"https://asof.is/claim/clm_18781A133073","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"4,922,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_18781A133073","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q3 FY2016, filed 2016-10-27"}},{"date":"2016-09-30","until":"2016-12-31","published":"2017-02-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 3,432,000,000 United States dollar\", as of 2016-09-30 (until 2016-12-31). Claim clm_32AAF035F0A8, https://asof.is/claim/clm_32AAF035F0A8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427217000047/0000014272-17-000047-index.htm.","url":"https://asof.is/claim/clm_32AAF035F0A8","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"3,432,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_32AAF035F0A8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2016, filed 2017-02-21"}},{"date":"2016-09-30","until":"2017-02-01","published":"2016-10-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 1,671,229,946 shares\", as of 2016-09-30 (until 2017-02-01). Claim clm_8063757EF4E7, https://asof.is/claim/clm_8063757EF4E7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427216000491/0000014272-16-000491-index.htm.","url":"https://asof.is/claim/clm_8063757EF4E7","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,671,229,946 shares","status":"superseded","assertable":true,"id":"clm_8063757EF4E7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2016, filed 2016-10-27"}},{"date":"2016-09-30","until":"2017-03-31","published":"2016-10-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 1,202,000,000 United States dollar\", as of 2016-09-30 (until 2017-03-31). Claim clm_986BCF3AD62C, https://asof.is/claim/clm_986BCF3AD62C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427216000491/0000014272-16-000491-index.htm.","url":"https://asof.is/claim/clm_986BCF3AD62C","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,202,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_986BCF3AD62C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2016, filed 2016-10-27"}},{"date":"2016-09-30","until":"2017-03-31","published":"2016-10-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 1,138,000,000 United States dollar\", as of 2016-09-30 (until 2017-03-31). Claim clm_98768D817D6F, https://asof.is/claim/clm_98768D817D6F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427216000491/0000014272-16-000491-index.htm.","url":"https://asof.is/claim/clm_98768D817D6F","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"1,138,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_98768D817D6F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2016, filed 2016-10-27"}},{"date":"2016-09-30","until":"2016-12-31","published":"2017-02-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 33,727,000,000 United States dollar\", as of 2016-09-30 (until 2016-12-31). Claim clm_9BDC1541B164, https://asof.is/claim/clm_9BDC1541B164, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427217000047/0000014272-17-000047-index.htm.","url":"https://asof.is/claim/clm_9BDC1541B164","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"33,727,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9BDC1541B164","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2016, filed 2017-02-21"}},{"date":"2016-09-30","until":"2016-12-31","published":"2017-02-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 15,781,000,000 United States dollar\", as of 2016-09-30 (until 2016-12-31). Claim clm_ECD179DF015D, https://asof.is/claim/clm_ECD179DF015D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427217000047/0000014272-17-000047-index.htm.","url":"https://asof.is/claim/clm_ECD179DF015D","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"15,781,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_ECD179DF015D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2016, filed 2017-02-21"}},{"date":"2016-12-31","until":"2017-03-31","published":"2017-02-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 4,237,000,000 United States dollar\", as of 2016-12-31 (until 2017-03-31). Claim clm_1035AAAB0ABB, https://asof.is/claim/clm_1035AAAB0ABB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427217000047/0000014272-17-000047-index.htm.","url":"https://asof.is/claim/clm_1035AAAB0ABB","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"4,237,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1035AAAB0ABB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2016, filed 2017-02-21"}},{"date":"2016-12-31","until":"2017-12-31","published":"2017-02-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb net income: 4,457,000,000 United States dollar\", as of 2016-12-31 (until 2017-12-31). Claim clm_4981ADA710E1, https://asof.is/claim/clm_4981ADA710E1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427217000047/0000014272-17-000047-index.htm.","url":"https://asof.is/claim/clm_4981ADA710E1","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"4,457,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4981ADA710E1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2016, filed 2017-02-21"}},{"date":"2016-12-31","until":"2017-03-31","published":"2017-02-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 33,707,000,000 United States dollar\", as of 2016-12-31 (until 2017-03-31). Claim clm_4F679F70F3C0, https://asof.is/claim/clm_4F679F70F3C0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427217000047/0000014272-17-000047-index.htm.","url":"https://asof.is/claim/clm_4F679F70F3C0","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"33,707,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4F679F70F3C0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2016, filed 2017-02-21"}},{"date":"2016-12-31","until":"2017-12-31","published":"2019-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb revenue: 19,427,000,000 United States dollar\", as of 2016-12-31 (until 2017-12-31). Claim clm_57A579F455C8, https://asof.is/claim/clm_57A579F455C8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427219000047/0000014272-19-000047-index.htm.","url":"https://asof.is/claim/clm_57A579F455C8","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"19,427,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_57A579F455C8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2018, filed 2019-02-25"}},{"date":"2016-12-31","until":"2017-12-31","published":"2017-02-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb research and development: 4,940,000,000 United States dollar\", as of 2016-12-31 (until 2017-12-31). Claim clm_6393A7B2A9CB, https://asof.is/claim/clm_6393A7B2A9CB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427217000047/0000014272-17-000047-index.htm.","url":"https://asof.is/claim/clm_6393A7B2A9CB","accessed":"2026-11-09"},"kind":"money","predicate":"research_and_development","value":"4,940,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6393A7B2A9CB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2016, filed 2017-02-21"}},{"date":"2016-12-31","until":"2017-03-31","published":"2017-02-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 16,177,000,000 United States dollar\", as of 2016-12-31 (until 2017-03-31). Claim clm_7A0A9FB10012, https://asof.is/claim/clm_7A0A9FB10012, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427217000047/0000014272-17-000047-index.htm.","url":"https://asof.is/claim/clm_7A0A9FB10012","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"16,177,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7A0A9FB10012","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2016, filed 2017-02-21"}},{"date":"2017-02-01","until":"2017-03-31","published":"2017-02-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 1,672,715,340 shares\", as of 2017-02-01 (until 2017-03-31). Claim clm_EE65A79883E4, https://asof.is/claim/clm_EE65A79883E4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427217000047/0000014272-17-000047-index.htm.","url":"https://asof.is/claim/clm_EE65A79883E4","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,672,715,340 shares","status":"superseded","assertable":true,"id":"clm_EE65A79883E4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2016, filed 2017-02-21"}},{"date":"2017-03-31","until":"2017-06-30","published":"2017-04-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 1,288,000,000 United States dollar\", as of 2017-03-31 (until 2017-06-30). Claim clm_1CFFBAD49F89, https://asof.is/claim/clm_1CFFBAD49F89, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427217000132/0000014272-17-000132-index.htm.","url":"https://asof.is/claim/clm_1CFFBAD49F89","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"1,288,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1CFFBAD49F89","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2017, filed 2017-04-27"}},{"date":"2017-03-31","until":"2017-06-30","published":"2018-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 3,910,000,000 United States dollar\", as of 2017-03-31 (until 2017-06-30). Claim clm_347D00E298E7, https://asof.is/claim/clm_347D00E298E7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427218000055/0000014272-18-000055-index.htm.","url":"https://asof.is/claim/clm_347D00E298E7","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"3,910,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_347D00E298E7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2017, filed 2018-02-13"}},{"date":"2017-03-31","until":"2017-06-30","published":"2018-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 32,937,000,000 United States dollar\", as of 2017-03-31 (until 2017-06-30). Claim clm_3C926135F3AA, https://asof.is/claim/clm_3C926135F3AA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427218000055/0000014272-18-000055-index.htm.","url":"https://asof.is/claim/clm_3C926135F3AA","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"32,937,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3C926135F3AA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2017, filed 2018-02-13"}},{"date":"2017-03-31","until":"2017-06-30","published":"2017-04-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 4,929,000,000 United States dollar\", as of 2017-03-31 (until 2017-06-30). Claim clm_5F8F7439821E, https://asof.is/claim/clm_5F8F7439821E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427217000132/0000014272-17-000132-index.htm.","url":"https://asof.is/claim/clm_5F8F7439821E","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"4,929,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5F8F7439821E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q1 FY2017, filed 2017-04-27"}},{"date":"2017-03-31","until":"2017-06-30","published":"2018-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 14,535,000,000 United States dollar\", as of 2017-03-31 (until 2017-06-30). Claim clm_7515238AD7A3, https://asof.is/claim/clm_7515238AD7A3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427218000055/0000014272-18-000055-index.htm.","url":"https://asof.is/claim/clm_7515238AD7A3","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"14,535,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7515238AD7A3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2017, filed 2018-02-13"}},{"date":"2017-03-31","until":"2017-06-30","published":"2017-04-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 1,574,000,000 United States dollar\", as of 2017-03-31 (until 2017-06-30). Claim clm_851C1B81A4D2, https://asof.is/claim/clm_851C1B81A4D2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427217000132/0000014272-17-000132-index.htm.","url":"https://asof.is/claim/clm_851C1B81A4D2","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,574,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_851C1B81A4D2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2017, filed 2017-04-27"}},{"date":"2017-03-31","until":"2017-06-30","published":"2017-04-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 1,647,434,458 shares\", as of 2017-03-31 (until 2017-06-30). Claim clm_8ACD59EA48B0, https://asof.is/claim/clm_8ACD59EA48B0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427217000132/0000014272-17-000132-index.htm.","url":"https://asof.is/claim/clm_8ACD59EA48B0","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,647,434,458 shares","status":"superseded","assertable":true,"id":"clm_8ACD59EA48B0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2017, filed 2017-04-27"}},{"date":"2017-06-30","until":"2017-09-30","published":"2017-07-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 5,144,000,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_13C469851C8D, https://asof.is/claim/clm_13C469851C8D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427217000165/0000014272-17-000165-index.htm.","url":"https://asof.is/claim/clm_13C469851C8D","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"5,144,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_13C469851C8D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q2 FY2017, filed 2017-07-27"}},{"date":"2017-06-30","until":"2017-09-30","published":"2018-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 14,821,000,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_1592847EAB0A, https://asof.is/claim/clm_1592847EAB0A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427218000055/0000014272-18-000055-index.htm.","url":"https://asof.is/claim/clm_1592847EAB0A","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"14,821,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1592847EAB0A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2017, filed 2018-02-13"}},{"date":"2017-06-30","until":"2017-09-30","published":"2017-07-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 1,639,926,446 shares\", as of 2017-06-30 (until 2017-09-30). Claim clm_1EF6874F3B9E, https://asof.is/claim/clm_1EF6874F3B9E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427217000165/0000014272-17-000165-index.htm.","url":"https://asof.is/claim/clm_1EF6874F3B9E","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,639,926,446 shares","status":"superseded","assertable":true,"id":"clm_1EF6874F3B9E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2017, filed 2017-07-27"}},{"date":"2017-06-30","until":"2017-09-30","published":"2017-07-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 916,000,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_7A1E5B3278B9, https://asof.is/claim/clm_7A1E5B3278B9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427217000165/0000014272-17-000165-index.htm.","url":"https://asof.is/claim/clm_7A1E5B3278B9","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"916,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7A1E5B3278B9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2017, filed 2017-07-27"}},{"date":"2017-06-30","until":"2017-09-30","published":"2018-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 3,470,000,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_7BA54E495432, https://asof.is/claim/clm_7BA54E495432, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427218000055/0000014272-18-000055-index.htm.","url":"https://asof.is/claim/clm_7BA54E495432","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"3,470,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7BA54E495432","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2017, filed 2018-02-13"}},{"date":"2017-06-30","until":"2017-09-30","published":"2017-07-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 1,659,000,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_7C9FD51E8911, https://asof.is/claim/clm_7C9FD51E8911, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427217000165/0000014272-17-000165-index.htm.","url":"https://asof.is/claim/clm_7C9FD51E8911","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"1,659,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7C9FD51E8911","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2017, filed 2017-07-27"}},{"date":"2017-06-30","until":"2017-09-30","published":"2018-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 33,409,000,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_DCD3B33FD8BF, https://asof.is/claim/clm_DCD3B33FD8BF, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427218000055/0000014272-18-000055-index.htm.","url":"https://asof.is/claim/clm_DCD3B33FD8BF","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"33,409,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DCD3B33FD8BF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2017, filed 2018-02-13"}},{"date":"2017-09-30","until":"2017-12-31","published":"2018-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 33,977,000,000 United States dollar\", as of 2017-09-30 (until 2017-12-31). Claim clm_0138C65261E5, https://asof.is/claim/clm_0138C65261E5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427218000055/0000014272-18-000055-index.htm.","url":"https://asof.is/claim/clm_0138C65261E5","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"33,977,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0138C65261E5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2017, filed 2018-02-13"}},{"date":"2017-09-30","until":"2018-02-01","published":"2017-10-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 1,636,699,696 shares\", as of 2017-09-30 (until 2018-02-01). Claim clm_36A1F4B8C3C8, https://asof.is/claim/clm_36A1F4B8C3C8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427217000195/0000014272-17-000195-index.htm.","url":"https://asof.is/claim/clm_36A1F4B8C3C8","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,636,699,696 shares","status":"superseded","assertable":true,"id":"clm_36A1F4B8C3C8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2017, filed 2017-10-26"}},{"date":"2017-09-30","until":"2018-03-31","published":"2017-10-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 5,254,000,000 United States dollar\", as of 2017-09-30 (until 2018-03-31). Claim clm_3FA32606AD67, https://asof.is/claim/clm_3FA32606AD67, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427217000195/0000014272-17-000195-index.htm.","url":"https://asof.is/claim/clm_3FA32606AD67","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"5,254,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3FA32606AD67","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q3 FY2017, filed 2017-10-26"}},{"date":"2017-09-30","until":"2018-03-31","published":"2017-10-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 1,543,000,000 United States dollar\", as of 2017-09-30 (until 2018-03-31). Claim clm_7CA800414703, https://asof.is/claim/clm_7CA800414703, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427217000195/0000014272-17-000195-index.htm.","url":"https://asof.is/claim/clm_7CA800414703","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"1,543,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7CA800414703","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2017, filed 2017-10-26"}},{"date":"2017-09-30","until":"2018-03-31","published":"2017-10-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 845,000,000 United States dollar\", as of 2017-09-30 (until 2018-03-31). Claim clm_ADE2F00E4DDB, https://asof.is/claim/clm_ADE2F00E4DDB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427217000195/0000014272-17-000195-index.htm.","url":"https://asof.is/claim/clm_ADE2F00E4DDB","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"845,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_ADE2F00E4DDB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2017, filed 2017-10-26"}},{"date":"2017-09-30","until":"2017-12-31","published":"2018-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 4,644,000,000 United States dollar\", as of 2017-09-30 (until 2017-12-31). Claim clm_BAA6A9BFA238, https://asof.is/claim/clm_BAA6A9BFA238, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427218000055/0000014272-18-000055-index.htm.","url":"https://asof.is/claim/clm_BAA6A9BFA238","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"4,644,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BAA6A9BFA238","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2017, filed 2018-02-13"}},{"date":"2017-09-30","until":"2017-12-31","published":"2018-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 14,914,000,000 United States dollar\", as of 2017-09-30 (until 2017-12-31). Claim clm_DDD45770BE4E, https://asof.is/claim/clm_DDD45770BE4E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427218000055/0000014272-18-000055-index.htm.","url":"https://asof.is/claim/clm_DDD45770BE4E","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"14,914,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DDD45770BE4E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2017, filed 2018-02-13"}},{"date":"2017-12-31","until":"2018-03-31","published":"2018-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 33,551,000,000 United States dollar\", as of 2017-12-31 (until 2018-03-31). Claim clm_23E53864B4D3, https://asof.is/claim/clm_23E53864B4D3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427218000055/0000014272-18-000055-index.htm.","url":"https://asof.is/claim/clm_23E53864B4D3","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"33,551,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_23E53864B4D3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2017, filed 2018-02-13"}},{"date":"2017-12-31","until":"2018-12-31","published":"2018-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb research and development: 6,411,000,000 United States dollar\", as of 2017-12-31 (until 2018-12-31). Claim clm_49AB8FAB8853, https://asof.is/claim/clm_49AB8FAB8853, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427218000055/0000014272-18-000055-index.htm.","url":"https://asof.is/claim/clm_49AB8FAB8853","accessed":"2026-11-09"},"kind":"money","predicate":"research_and_development","value":"6,411,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_49AB8FAB8853","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2017, filed 2018-02-13"}},{"date":"2017-12-31","until":"2018-03-31","published":"2018-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 5,421,000,000 United States dollar\", as of 2017-12-31 (until 2018-03-31). Claim clm_4B9607419F92, https://asof.is/claim/clm_4B9607419F92, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427218000055/0000014272-18-000055-index.htm.","url":"https://asof.is/claim/clm_4B9607419F92","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"5,421,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4B9607419F92","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2017, filed 2018-02-13"}},{"date":"2017-12-31","until":"2018-12-31","published":"2018-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb net income: 1,007,000,000 United States dollar\", as of 2017-12-31 (until 2018-12-31). Claim clm_73D0FA4C51CF, https://asof.is/claim/clm_73D0FA4C51CF, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427218000055/0000014272-18-000055-index.htm.","url":"https://asof.is/claim/clm_73D0FA4C51CF","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"1,007,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_73D0FA4C51CF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2017, filed 2018-02-13"}},{"date":"2017-12-31","until":"2018-03-31","published":"2018-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 11,741,000,000 United States dollar\", as of 2017-12-31 (until 2018-03-31). Claim clm_DA2627C3AE6A, https://asof.is/claim/clm_DA2627C3AE6A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427218000055/0000014272-18-000055-index.htm.","url":"https://asof.is/claim/clm_DA2627C3AE6A","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"11,741,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DA2627C3AE6A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2017, filed 2018-02-13"}},{"date":"2017-12-31","until":"2018-12-31","published":"2019-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb revenue: 20,776,000,000 United States dollar\", as of 2017-12-31 (until 2018-12-31). Claim clm_F2061DAE77B3, https://asof.is/claim/clm_F2061DAE77B3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427219000047/0000014272-19-000047-index.htm.","url":"https://asof.is/claim/clm_F2061DAE77B3","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"20,776,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F2061DAE77B3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2018, filed 2019-02-25"}},{"date":"2018-02-01","until":"2018-03-31","published":"2018-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 1,632,582,502 shares\", as of 2018-02-01 (until 2018-03-31). Claim clm_18C230DCFBC6, https://asof.is/claim/clm_18C230DCFBC6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427218000055/0000014272-18-000055-index.htm.","url":"https://asof.is/claim/clm_18C230DCFBC6","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,632,582,502 shares","status":"superseded","assertable":true,"id":"clm_18C230DCFBC6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2017, filed 2018-02-13"}},{"date":"2018-03-31","until":"2018-06-30","published":"2018-04-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 1,634,538,458 shares\", as of 2018-03-31 (until 2018-06-30). Claim clm_0E4D8DE1C7EA, https://asof.is/claim/clm_0E4D8DE1C7EA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427218000117/0000014272-18-000117-index.htm.","url":"https://asof.is/claim/clm_0E4D8DE1C7EA","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,634,538,458 shares","status":"superseded","assertable":true,"id":"clm_0E4D8DE1C7EA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2018, filed 2018-04-26"}},{"date":"2018-03-31","until":"2018-06-30","published":"2019-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 5,342,000,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_2573A3BBCBF5, https://asof.is/claim/clm_2573A3BBCBF5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427219000047/0000014272-19-000047-index.htm.","url":"https://asof.is/claim/clm_2573A3BBCBF5","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"5,342,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2573A3BBCBF5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2018, filed 2019-02-25"}},{"date":"2018-03-31","until":"2018-06-30","published":"2018-04-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 1,486,000,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_99C117669E0D, https://asof.is/claim/clm_99C117669E0D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427218000117/0000014272-18-000117-index.htm.","url":"https://asof.is/claim/clm_99C117669E0D","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,486,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_99C117669E0D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2018, filed 2018-04-26"}},{"date":"2018-03-31","until":"2018-06-30","published":"2019-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 12,906,000,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_AD378F8920A1, https://asof.is/claim/clm_AD378F8920A1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427219000047/0000014272-19-000047-index.htm.","url":"https://asof.is/claim/clm_AD378F8920A1","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"12,906,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AD378F8920A1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2018, filed 2019-02-25"}},{"date":"2018-03-31","until":"2018-06-30","published":"2018-04-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 1,250,000,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_CE50CA7EBC72, https://asof.is/claim/clm_CE50CA7EBC72, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427218000117/0000014272-18-000117-index.htm.","url":"https://asof.is/claim/clm_CE50CA7EBC72","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"1,250,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CE50CA7EBC72","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2018, filed 2018-04-26"}},{"date":"2018-03-31","until":"2018-06-30","published":"2019-04-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 5,193,000,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_EA4AEE2CC782, https://asof.is/claim/clm_EA4AEE2CC782, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427219000107/0000014272-19-000107-index.htm.","url":"https://asof.is/claim/clm_EA4AEE2CC782","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"5,193,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EA4AEE2CC782","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2019, filed 2019-04-25"}},{"date":"2018-03-31","until":"2018-06-30","published":"2019-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 33,083,000,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_FE1738896D5E, https://asof.is/claim/clm_FE1738896D5E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427219000047/0000014272-19-000047-index.htm.","url":"https://asof.is/claim/clm_FE1738896D5E","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"33,083,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FE1738896D5E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2018, filed 2019-02-25"}},{"date":"2018-06-30","until":"2018-09-30","published":"2018-07-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 1,631,876,909 shares\", as of 2018-06-30 (until 2018-09-30). Claim clm_0192CB6E8E4B, https://asof.is/claim/clm_0192CB6E8E4B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427218000160/0000014272-18-000160-index.htm.","url":"https://asof.is/claim/clm_0192CB6E8E4B","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,631,876,909 shares","status":"superseded","assertable":true,"id":"clm_0192CB6E8E4B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2018, filed 2018-07-26"}},{"date":"2018-06-30","until":"2018-09-30","published":"2019-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 12,418,000,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_056F9B84FFD1, https://asof.is/claim/clm_056F9B84FFD1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427219000047/0000014272-19-000047-index.htm.","url":"https://asof.is/claim/clm_056F9B84FFD1","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"12,418,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_056F9B84FFD1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2018, filed 2019-02-25"}},{"date":"2018-06-30","until":"2018-09-30","published":"2019-07-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 5,704,000,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_1C9B88505F80, https://asof.is/claim/clm_1C9B88505F80, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427219000160/0000014272-19-000160-index.htm.","url":"https://asof.is/claim/clm_1C9B88505F80","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"5,704,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1C9B88505F80","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2019, filed 2019-07-25"}},{"date":"2018-06-30","until":"2018-09-30","published":"2019-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 32,641,000,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_43FB16AECDDD, https://asof.is/claim/clm_43FB16AECDDD, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427219000047/0000014272-19-000047-index.htm.","url":"https://asof.is/claim/clm_43FB16AECDDD","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"32,641,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_43FB16AECDDD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2018, filed 2019-02-25"}},{"date":"2018-06-30","until":"2018-09-30","published":"2018-07-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 2,435,000,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_711CD08A7AE6, https://asof.is/claim/clm_711CD08A7AE6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427218000160/0000014272-18-000160-index.htm.","url":"https://asof.is/claim/clm_711CD08A7AE6","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"2,435,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_711CD08A7AE6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2018, filed 2018-07-26"}},{"date":"2018-06-30","until":"2018-09-30","published":"2018-07-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 373,000,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_865C2D20072F, https://asof.is/claim/clm_865C2D20072F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427218000160/0000014272-18-000160-index.htm.","url":"https://asof.is/claim/clm_865C2D20072F","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"373,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_865C2D20072F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2018, filed 2018-07-26"}},{"date":"2018-06-30","until":"2018-09-30","published":"2019-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 4,999,000,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_CC7BB12DEC8A, https://asof.is/claim/clm_CC7BB12DEC8A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427219000047/0000014272-19-000047-index.htm.","url":"https://asof.is/claim/clm_CC7BB12DEC8A","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"4,999,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CC7BB12DEC8A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2018, filed 2019-02-25"}},{"date":"2018-09-30","until":"2019-03-31","published":"2018-10-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 1,901,000,000 United States dollar\", as of 2018-09-30 (until 2019-03-31). Claim clm_01F359D6771D, https://asof.is/claim/clm_01F359D6771D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427218000197/0000014272-18-000197-index.htm.","url":"https://asof.is/claim/clm_01F359D6771D","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,901,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_01F359D6771D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2018, filed 2018-10-25"}},{"date":"2018-09-30","until":"2018-12-31","published":"2019-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 33,734,000,000 United States dollar\", as of 2018-09-30 (until 2018-12-31). Claim clm_0283BB48D5DC, https://asof.is/claim/clm_0283BB48D5DC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427219000047/0000014272-19-000047-index.htm.","url":"https://asof.is/claim/clm_0283BB48D5DC","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"33,734,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0283BB48D5DC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2018, filed 2019-02-25"}},{"date":"2018-09-30","until":"2018-12-31","published":"2019-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 13,750,000,000 United States dollar\", as of 2018-09-30 (until 2018-12-31). Claim clm_16267AA5D734, https://asof.is/claim/clm_16267AA5D734, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427219000047/0000014272-19-000047-index.htm.","url":"https://asof.is/claim/clm_16267AA5D734","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"13,750,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_16267AA5D734","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2018, filed 2019-02-25"}},{"date":"2018-09-30","until":"2019-03-31","published":"2018-10-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 1,280,000,000 United States dollar\", as of 2018-09-30 (until 2019-03-31). Claim clm_45DDDCF11BF8, https://asof.is/claim/clm_45DDDCF11BF8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427218000197/0000014272-18-000197-index.htm.","url":"https://asof.is/claim/clm_45DDDCF11BF8","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"1,280,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_45DDDCF11BF8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2018, filed 2018-10-25"}},{"date":"2018-09-30","until":"2019-02-01","published":"2018-10-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 1,632,198,774 shares\", as of 2018-09-30 (until 2019-02-01). Claim clm_644B8C483B86, https://asof.is/claim/clm_644B8C483B86, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427218000197/0000014272-18-000197-index.htm.","url":"https://asof.is/claim/clm_644B8C483B86","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,632,198,774 shares","status":"superseded","assertable":true,"id":"clm_644B8C483B86","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2018, filed 2018-10-25"}},{"date":"2018-09-30","until":"2019-03-31","published":"2019-10-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 5,691,000,000 United States dollar\", as of 2018-09-30 (until 2019-03-31). Claim clm_94497E05D84C, https://asof.is/claim/clm_94497E05D84C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427219000194/0000014272-19-000194-index.htm.","url":"https://asof.is/claim/clm_94497E05D84C","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"5,691,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_94497E05D84C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2019, filed 2019-10-31"}},{"date":"2018-09-30","until":"2018-12-31","published":"2019-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 5,408,000,000 United States dollar\", as of 2018-09-30 (until 2018-12-31). Claim clm_9CC0E50BC241, https://asof.is/claim/clm_9CC0E50BC241, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427219000047/0000014272-19-000047-index.htm.","url":"https://asof.is/claim/clm_9CC0E50BC241","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"5,408,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9CC0E50BC241","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2018, filed 2019-02-25"}},{"date":"2018-12-31","until":"2019-03-31","published":"2019-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 34,986,000,000 United States dollar\", as of 2018-12-31 (until 2019-03-31). Claim clm_0F8FF0DB46E7, https://asof.is/claim/clm_0F8FF0DB46E7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427219000047/0000014272-19-000047-index.htm.","url":"https://asof.is/claim/clm_0F8FF0DB46E7","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"34,986,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0F8FF0DB46E7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2018, filed 2019-02-25"}},{"date":"2018-12-31","until":"2019-03-31","published":"2019-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 6,911,000,000 United States dollar\", as of 2018-12-31 (until 2019-03-31). Claim clm_30A3E0BC16D5, https://asof.is/claim/clm_30A3E0BC16D5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427219000047/0000014272-19-000047-index.htm.","url":"https://asof.is/claim/clm_30A3E0BC16D5","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"6,911,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_30A3E0BC16D5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2018, filed 2019-02-25"}},{"date":"2018-12-31","until":"2019-12-31","published":"2019-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb net income: 4,920,000,000 United States dollar\", as of 2018-12-31 (until 2019-12-31). Claim clm_64236E065BCB, https://asof.is/claim/clm_64236E065BCB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427219000047/0000014272-19-000047-index.htm.","url":"https://asof.is/claim/clm_64236E065BCB","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"4,920,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_64236E065BCB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2018, filed 2019-02-25"}},{"date":"2018-12-31","until":"2019-03-31","published":"2019-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 14,031,000,000 United States dollar\", as of 2018-12-31 (until 2019-03-31). Claim clm_6998F49CC4C9, https://asof.is/claim/clm_6998F49CC4C9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427219000047/0000014272-19-000047-index.htm.","url":"https://asof.is/claim/clm_6998F49CC4C9","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"14,031,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6998F49CC4C9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2018, filed 2019-02-25"}},{"date":"2018-12-31","until":"2019-12-31","published":"2019-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb research and development: 6,345,000,000 United States dollar\", as of 2018-12-31 (until 2019-12-31). Claim clm_7E477650E516, https://asof.is/claim/clm_7E477650E516, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427219000047/0000014272-19-000047-index.htm.","url":"https://asof.is/claim/clm_7E477650E516","accessed":"2026-11-09"},"kind":"money","predicate":"research_and_development","value":"6,345,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7E477650E516","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2018, filed 2019-02-25"}},{"date":"2018-12-31","until":"2019-12-31","published":"2019-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb revenue: 22,561,000,000 United States dollar\", as of 2018-12-31 (until 2019-12-31). Claim clm_ADD516471339, https://asof.is/claim/clm_ADD516471339, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427219000047/0000014272-19-000047-index.htm.","url":"https://asof.is/claim/clm_ADD516471339","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"22,561,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_ADD516471339","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2018, filed 2019-02-25"}},{"date":"2019-02-01","until":"2019-03-31","published":"2019-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 1,632,675,877 shares\", as of 2019-02-01 (until 2019-03-31). Claim clm_BCA073817AB3, https://asof.is/claim/clm_BCA073817AB3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427219000047/0000014272-19-000047-index.htm.","url":"https://asof.is/claim/clm_BCA073817AB3","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,632,675,877 shares","status":"superseded","assertable":true,"id":"clm_BCA073817AB3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2018, filed 2019-02-25"}},{"date":"2019-03-31","until":"2019-06-30","published":"2020-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 15,317,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_4C3A6CBEE24D, https://asof.is/claim/clm_4C3A6CBEE24D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427220000082/0000014272-20-000082-index.htm.","url":"https://asof.is/claim/clm_4C3A6CBEE24D","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"15,317,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4C3A6CBEE24D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2019, filed 2020-02-24"}},{"date":"2019-03-31","until":"2019-06-30","published":"2019-04-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 1,710,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_719B72CC321F, https://asof.is/claim/clm_719B72CC321F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427219000107/0000014272-19-000107-index.htm.","url":"https://asof.is/claim/clm_719B72CC321F","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,710,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_719B72CC321F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2019, filed 2019-04-25"}},{"date":"2019-03-31","until":"2019-06-30","published":"2019-04-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 5,920,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_72FA5EB78BF3, https://asof.is/claim/clm_72FA5EB78BF3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427219000107/0000014272-19-000107-index.htm.","url":"https://asof.is/claim/clm_72FA5EB78BF3","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"5,920,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_72FA5EB78BF3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2019, filed 2019-04-25"}},{"date":"2019-03-31","until":"2019-06-30","published":"2019-04-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 1,351,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_8F9CDE701651, https://asof.is/claim/clm_8F9CDE701651, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427219000107/0000014272-19-000107-index.htm.","url":"https://asof.is/claim/clm_8F9CDE701651","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"1,351,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8F9CDE701651","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2019, filed 2019-04-25"}},{"date":"2019-03-31","until":"2019-06-30","published":"2020-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 34,834,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_99721B72EBF7, https://asof.is/claim/clm_99721B72EBF7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427220000082/0000014272-20-000082-index.htm.","url":"https://asof.is/claim/clm_99721B72EBF7","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"34,834,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_99721B72EBF7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2019, filed 2020-02-24"}},{"date":"2019-03-31","until":"2019-06-30","published":"2019-04-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 1,635,705,782 shares\", as of 2019-03-31 (until 2019-06-30). Claim clm_B296621709ED, https://asof.is/claim/clm_B296621709ED, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427219000107/0000014272-19-000107-index.htm.","url":"https://asof.is/claim/clm_B296621709ED","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,635,705,782 shares","status":"superseded","assertable":true,"id":"clm_B296621709ED","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2019, filed 2019-04-25"}},{"date":"2019-03-31","until":"2019-06-30","published":"2020-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 7,335,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_CE2CD25F73DE, https://asof.is/claim/clm_CE2CD25F73DE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427220000082/0000014272-20-000082-index.htm.","url":"https://asof.is/claim/clm_CE2CD25F73DE","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"7,335,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CE2CD25F73DE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2019, filed 2020-02-24"}},{"date":"2019-06-30","until":"2019-09-30","published":"2019-07-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 1,328,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_194E6D7B5322, https://asof.is/claim/clm_194E6D7B5322, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427219000160/0000014272-19-000160-index.htm.","url":"https://asof.is/claim/clm_194E6D7B5322","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"1,328,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_194E6D7B5322","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2019, filed 2019-07-25"}},{"date":"2019-06-30","until":"2019-09-30","published":"2019-07-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 1,432,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_3E7F99B36E7F, https://asof.is/claim/clm_3E7F99B36E7F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427219000160/0000014272-19-000160-index.htm.","url":"https://asof.is/claim/clm_3E7F99B36E7F","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,432,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3E7F99B36E7F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2019, filed 2019-07-25"}},{"date":"2019-06-30","until":"2019-09-30","published":"2020-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 16,151,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_4614511A1408, https://asof.is/claim/clm_4614511A1408, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427220000082/0000014272-20-000082-index.htm.","url":"https://asof.is/claim/clm_4614511A1408","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"16,151,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4614511A1408","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2019, filed 2020-02-24"}},{"date":"2019-06-30","until":"2019-09-30","published":"2019-07-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 1,635,766,530 shares\", as of 2019-06-30 (until 2019-09-30). Claim clm_6E714A180173, https://asof.is/claim/clm_6E714A180173, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427219000160/0000014272-19-000160-index.htm.","url":"https://asof.is/claim/clm_6E714A180173","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,635,766,530 shares","status":"superseded","assertable":true,"id":"clm_6E714A180173","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2019, filed 2019-07-25"}},{"date":"2019-06-30","until":"2019-09-30","published":"2020-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 55,163,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_8B3E326E2E0A, https://asof.is/claim/clm_8B3E326E2E0A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427220000082/0000014272-20-000082-index.htm.","url":"https://asof.is/claim/clm_8B3E326E2E0A","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"55,163,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8B3E326E2E0A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2019, filed 2020-02-24"}},{"date":"2019-06-30","until":"2019-09-30","published":"2019-07-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 6,273,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_A94D041424B3, https://asof.is/claim/clm_A94D041424B3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427219000160/0000014272-19-000160-index.htm.","url":"https://asof.is/claim/clm_A94D041424B3","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"6,273,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A94D041424B3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2019, filed 2019-07-25"}},{"date":"2019-06-30","until":"2019-09-30","published":"2020-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 28,404,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_D1B939B07F88, https://asof.is/claim/clm_D1B939B07F88, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427220000082/0000014272-20-000082-index.htm.","url":"https://asof.is/claim/clm_D1B939B07F88","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"28,404,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D1B939B07F88","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2019, filed 2020-02-24"}},{"date":"2019-09-30","until":"2020-03-31","published":"2019-10-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 1,382,000,000 United States dollar\", as of 2019-09-30 (until 2020-03-31). Claim clm_223CF07E8DCB, https://asof.is/claim/clm_223CF07E8DCB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427219000194/0000014272-19-000194-index.htm.","url":"https://asof.is/claim/clm_223CF07E8DCB","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"1,382,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_223CF07E8DCB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2019, filed 2019-10-31"}},{"date":"2019-09-30","until":"2019-12-31","published":"2020-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 57,433,000,000 United States dollar\", as of 2019-09-30 (until 2019-12-31). Claim clm_269A6A024BB7, https://asof.is/claim/clm_269A6A024BB7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427220000082/0000014272-20-000082-index.htm.","url":"https://asof.is/claim/clm_269A6A024BB7","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"57,433,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_269A6A024BB7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2019, filed 2020-02-24"}},{"date":"2019-09-30","until":"2020-02-03","published":"2019-10-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 1,629,284,798 shares\", as of 2019-09-30 (until 2020-02-03). Claim clm_6DD303AFB74A, https://asof.is/claim/clm_6DD303AFB74A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427219000194/0000014272-19-000194-index.htm.","url":"https://asof.is/claim/clm_6DD303AFB74A","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,629,284,798 shares","status":"superseded","assertable":true,"id":"clm_6DD303AFB74A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2019, filed 2019-10-31"}},{"date":"2019-09-30","until":"2019-12-31","published":"2020-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 17,754,000,000 United States dollar\", as of 2019-09-30 (until 2019-12-31). Claim clm_8D917D55CCA8, https://asof.is/claim/clm_8D917D55CCA8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427220000082/0000014272-20-000082-index.htm.","url":"https://asof.is/claim/clm_8D917D55CCA8","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"17,754,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8D917D55CCA8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2019, filed 2020-02-24"}},{"date":"2019-09-30","until":"2020-03-31","published":"2019-10-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 1,353,000,000 United States dollar\", as of 2019-09-30 (until 2020-03-31). Claim clm_9782F540E4D7, https://asof.is/claim/clm_9782F540E4D7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427219000194/0000014272-19-000194-index.htm.","url":"https://asof.is/claim/clm_9782F540E4D7","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,353,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9782F540E4D7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2019, filed 2019-10-31"}},{"date":"2019-09-30","until":"2019-12-31","published":"2020-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 30,489,000,000 United States dollar\", as of 2019-09-30 (until 2019-12-31). Claim clm_F33683F3C5F0, https://asof.is/claim/clm_F33683F3C5F0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427220000082/0000014272-20-000082-index.htm.","url":"https://asof.is/claim/clm_F33683F3C5F0","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"30,489,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F33683F3C5F0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2019, filed 2020-02-24"}},{"date":"2019-09-30","until":"2020-03-31","published":"2019-10-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 6,007,000,000 United States dollar\", as of 2019-09-30 (until 2020-03-31). Claim clm_F9A04C9D9D15, https://asof.is/claim/clm_F9A04C9D9D15, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427219000194/0000014272-19-000194-index.htm.","url":"https://asof.is/claim/clm_F9A04C9D9D15","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"6,007,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F9A04C9D9D15","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2019, filed 2019-10-31"}},{"date":"2019-12-31","until":"2020-03-31","published":"2020-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 51,598,000,000 United States dollar\", as of 2019-12-31 (until 2020-03-31). Claim clm_397E1F968A33, https://asof.is/claim/clm_397E1F968A33, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427220000082/0000014272-20-000082-index.htm.","url":"https://asof.is/claim/clm_397E1F968A33","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"51,598,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_397E1F968A33","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2019, filed 2020-02-24"}},{"date":"2019-12-31","until":"2020-03-31","published":"2020-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 12,346,000,000 United States dollar\", as of 2019-12-31 (until 2020-03-31). Claim clm_44F09489928F, https://asof.is/claim/clm_44F09489928F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427220000082/0000014272-20-000082-index.htm.","url":"https://asof.is/claim/clm_44F09489928F","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"12,346,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_44F09489928F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2019, filed 2020-02-24"}},{"date":"2019-12-31","until":"2020-12-31","published":"2020-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb revenue: 26,145,000,000 United States dollar\", as of 2019-12-31 (until 2020-12-31). Claim clm_8CDC7F496B1F, https://asof.is/claim/clm_8CDC7F496B1F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427220000082/0000014272-20-000082-index.htm.","url":"https://asof.is/claim/clm_8CDC7F496B1F","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"26,145,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8CDC7F496B1F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2019, filed 2020-02-24"}},{"date":"2019-12-31","until":"2020-12-31","published":"2020-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb research and development: 6,148,000,000 United States dollar\", as of 2019-12-31 (until 2020-12-31). Claim clm_9F214679BDA4, https://asof.is/claim/clm_9F214679BDA4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427220000082/0000014272-20-000082-index.htm.","url":"https://asof.is/claim/clm_9F214679BDA4","accessed":"2026-11-09"},"kind":"money","predicate":"research_and_development","value":"6,148,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9F214679BDA4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2019, filed 2020-02-24"}},{"date":"2019-12-31","until":"2020-03-31","published":"2020-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 129,944,000,000 United States dollar\", as of 2019-12-31 (until 2020-03-31). Claim clm_C1D1EC448AA2, https://asof.is/claim/clm_C1D1EC448AA2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427220000082/0000014272-20-000082-index.htm.","url":"https://asof.is/claim/clm_C1D1EC448AA2","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"129,944,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C1D1EC448AA2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2019, filed 2020-02-24"}},{"date":"2019-12-31","until":"2020-12-31","published":"2020-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb net income: 3,439,000,000 United States dollar\", as of 2019-12-31 (until 2020-12-31). Claim clm_C8A05222B289, https://asof.is/claim/clm_C8A05222B289, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427220000082/0000014272-20-000082-index.htm.","url":"https://asof.is/claim/clm_C8A05222B289","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"3,439,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C8A05222B289","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2019, filed 2020-02-24"}},{"date":"2020-02-03","until":"2020-03-31","published":"2020-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 2,257,510,796 shares\", as of 2020-02-03 (until 2020-03-31). Claim clm_09C7002CC551, https://asof.is/claim/clm_09C7002CC551, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427220000082/0000014272-20-000082-index.htm.","url":"https://asof.is/claim/clm_09C7002CC551","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"2,257,510,796 shares","status":"superseded","assertable":true,"id":"clm_09C7002CC551","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2019, filed 2020-02-24"}},{"date":"2020-03-31","until":"2020-06-30","published":"2021-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 49,977,000,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_11D9A4FE1C1E, https://asof.is/claim/clm_11D9A4FE1C1E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427221000066/0000014272-21-000066-index.htm.","url":"https://asof.is/claim/clm_11D9A4FE1C1E","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"49,977,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_11D9A4FE1C1E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2020, filed 2021-02-10"}},{"date":"2020-03-31","until":"2020-06-30","published":"2020-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 2,372,000,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_2EA411A55113, https://asof.is/claim/clm_2EA411A55113, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427220000168/0000014272-20-000168-index.htm.","url":"https://asof.is/claim/clm_2EA411A55113","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"2,372,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2EA411A55113","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2020, filed 2020-05-07"}},{"date":"2020-03-31","until":"2020-06-30","published":"2021-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 15,817,000,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_3C9C32E3F722, https://asof.is/claim/clm_3C9C32E3F722, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427221000066/0000014272-21-000066-index.htm.","url":"https://asof.is/claim/clm_3C9C32E3F722","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"15,817,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3C9C32E3F722","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2020, filed 2021-02-10"}},{"date":"2020-03-31","until":"2020-06-30","published":"2021-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 129,285,000,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_4CCF4B9A6223, https://asof.is/claim/clm_4CCF4B9A6223, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427221000066/0000014272-21-000066-index.htm.","url":"https://asof.is/claim/clm_4CCF4B9A6223","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"129,285,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4CCF4B9A6223","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2020, filed 2021-02-10"}},{"date":"2020-03-31","until":"2020-06-30","published":"2020-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 2,262,689,755 shares\", as of 2020-03-31 (until 2020-06-30). Claim clm_6233ECF4334A, https://asof.is/claim/clm_6233ECF4334A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427220000168/0000014272-20-000168-index.htm.","url":"https://asof.is/claim/clm_6233ECF4334A","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"2,262,689,755 shares","status":"superseded","assertable":true,"id":"clm_6233ECF4334A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2020, filed 2020-05-07"}},{"date":"2020-03-31","until":"2020-06-30","published":"2020-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 10,781,000,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_9C633E980249, https://asof.is/claim/clm_9C633E980249, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427220000168/0000014272-20-000168-index.htm.","url":"https://asof.is/claim/clm_9C633E980249","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"10,781,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9C633E980249","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2020, filed 2020-05-07"}},{"date":"2020-03-31","until":"2020-06-30","published":"2020-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: -775,000,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_A5B3E6D95752, https://asof.is/claim/clm_A5B3E6D95752, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427220000168/0000014272-20-000168-index.htm.","url":"https://asof.is/claim/clm_A5B3E6D95752","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"-775,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A5B3E6D95752","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2020, filed 2020-05-07"}},{"date":"2020-06-30","until":"2020-09-30","published":"2020-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: -85,000,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_0C6130021C29, https://asof.is/claim/clm_0C6130021C29, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427220000229/0000014272-20-000229-index.htm.","url":"https://asof.is/claim/clm_0C6130021C29","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"-85,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0C6130021C29","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2020, filed 2020-08-06"}},{"date":"2020-06-30","until":"2020-09-30","published":"2020-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 10,129,000,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_1480298B3F56, https://asof.is/claim/clm_1480298B3F56, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427220000229/0000014272-20-000229-index.htm.","url":"https://asof.is/claim/clm_1480298B3F56","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"10,129,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1480298B3F56","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2020, filed 2020-08-06"}},{"date":"2020-06-30","until":"2020-09-30","published":"2021-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 128,076,000,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_1DAFE43C35A4, https://asof.is/claim/clm_1DAFE43C35A4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427221000066/0000014272-21-000066-index.htm.","url":"https://asof.is/claim/clm_1DAFE43C35A4","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"128,076,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1DAFE43C35A4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2020, filed 2021-02-10"}},{"date":"2020-06-30","until":"2020-09-30","published":"2020-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 2,253,934,635 shares\", as of 2020-06-30 (until 2020-09-30). Claim clm_2A6910A4AE14, https://asof.is/claim/clm_2A6910A4AE14, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427220000229/0000014272-20-000229-index.htm.","url":"https://asof.is/claim/clm_2A6910A4AE14","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"2,253,934,635 shares","status":"superseded","assertable":true,"id":"clm_2A6910A4AE14","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2020, filed 2020-08-06"}},{"date":"2020-06-30","until":"2020-09-30","published":"2021-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 49,160,000,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_59F5F248270E, https://asof.is/claim/clm_59F5F248270E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427221000066/0000014272-21-000066-index.htm.","url":"https://asof.is/claim/clm_59F5F248270E","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"49,160,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_59F5F248270E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2020, filed 2021-02-10"}},{"date":"2020-06-30","until":"2020-09-30","published":"2021-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 19,934,000,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_A721004E4D01, https://asof.is/claim/clm_A721004E4D01, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427221000066/0000014272-21-000066-index.htm.","url":"https://asof.is/claim/clm_A721004E4D01","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"19,934,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A721004E4D01","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2020, filed 2021-02-10"}},{"date":"2020-06-30","until":"2020-09-30","published":"2020-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 2,522,000,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_CE259F6F0F77, https://asof.is/claim/clm_CE259F6F0F77, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427220000229/0000014272-20-000229-index.htm.","url":"https://asof.is/claim/clm_CE259F6F0F77","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"2,522,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CE259F6F0F77","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2020, filed 2020-08-06"}},{"date":"2020-09-30","until":"2021-02-01","published":"2020-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 2,259,751,518 shares\", as of 2020-09-30 (until 2021-02-01). Claim clm_43AB021CE223, https://asof.is/claim/clm_43AB021CE223, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427220000279/0000014272-20-000279-index.htm.","url":"https://asof.is/claim/clm_43AB021CE223","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"2,259,751,518 shares","status":"superseded","assertable":true,"id":"clm_43AB021CE223","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2020, filed 2020-11-05"}},{"date":"2020-09-30","until":"2020-12-31","published":"2021-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 50,230,000,000 United States dollar\", as of 2020-09-30 (until 2020-12-31). Claim clm_69DE89B77CE2, https://asof.is/claim/clm_69DE89B77CE2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427221000066/0000014272-21-000066-index.htm.","url":"https://asof.is/claim/clm_69DE89B77CE2","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"50,230,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_69DE89B77CE2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2020, filed 2021-02-10"}},{"date":"2020-09-30","until":"2020-12-31","published":"2021-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 19,435,000,000 United States dollar\", as of 2020-09-30 (until 2020-12-31). Claim clm_884B8780B580, https://asof.is/claim/clm_884B8780B580, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427221000066/0000014272-21-000066-index.htm.","url":"https://asof.is/claim/clm_884B8780B580","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"19,435,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_884B8780B580","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2020, filed 2021-02-10"}},{"date":"2020-09-30","until":"2020-12-31","published":"2021-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 125,536,000,000 United States dollar\", as of 2020-09-30 (until 2020-12-31). Claim clm_8AF7E2A90164, https://asof.is/claim/clm_8AF7E2A90164, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427221000066/0000014272-21-000066-index.htm.","url":"https://asof.is/claim/clm_8AF7E2A90164","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"125,536,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8AF7E2A90164","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2020, filed 2021-02-10"}},{"date":"2020-09-30","until":"2021-03-31","published":"2020-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 10,540,000,000 United States dollar\", as of 2020-09-30 (until 2021-03-31). Claim clm_DF8AB3989828, https://asof.is/claim/clm_DF8AB3989828, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427220000279/0000014272-20-000279-index.htm.","url":"https://asof.is/claim/clm_DF8AB3989828","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"10,540,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DF8AB3989828","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2020, filed 2020-11-05"}},{"date":"2020-09-30","until":"2021-03-31","published":"2020-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 2,499,000,000 United States dollar\", as of 2020-09-30 (until 2021-03-31). Claim clm_DFB52240EC1C, https://asof.is/claim/clm_DFB52240EC1C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427220000279/0000014272-20-000279-index.htm.","url":"https://asof.is/claim/clm_DFB52240EC1C","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"2,499,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DFB52240EC1C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2020, filed 2020-11-05"}},{"date":"2020-09-30","until":"2021-03-31","published":"2020-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 1,872,000,000 United States dollar\", as of 2020-09-30 (until 2021-03-31). Claim clm_EAD2E09DD3D8, https://asof.is/claim/clm_EAD2E09DD3D8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427220000279/0000014272-20-000279-index.htm.","url":"https://asof.is/claim/clm_EAD2E09DD3D8","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,872,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EAD2E09DD3D8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2020, filed 2020-11-05"}},{"date":"2020-12-31","until":"2021-03-31","published":"2021-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 14,546,000,000 United States dollar\", as of 2020-12-31 (until 2021-03-31). Claim clm_0B8693A32C26, https://asof.is/claim/clm_0B8693A32C26, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427221000066/0000014272-21-000066-index.htm.","url":"https://asof.is/claim/clm_0B8693A32C26","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"14,546,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0B8693A32C26","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2020, filed 2021-02-10"}},{"date":"2020-12-31","until":"2021-12-31","published":"2021-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb revenue: 42,518,000,000 United States dollar\", as of 2020-12-31 (until 2021-12-31). Claim clm_1987D0BBF44A, https://asof.is/claim/clm_1987D0BBF44A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427221000066/0000014272-21-000066-index.htm.","url":"https://asof.is/claim/clm_1987D0BBF44A","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"42,518,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1987D0BBF44A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2020, filed 2021-02-10"}},{"date":"2020-12-31","until":"2021-12-31","published":"2021-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb net income: -9,015,000,000 United States dollar\", as of 2020-12-31 (until 2021-12-31). Claim clm_57F7E30CC5E5, https://asof.is/claim/clm_57F7E30CC5E5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427221000066/0000014272-21-000066-index.htm.","url":"https://asof.is/claim/clm_57F7E30CC5E5","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"-9,015,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_57F7E30CC5E5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2020, filed 2021-02-10"}},{"date":"2020-12-31","until":"2021-03-31","published":"2021-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 37,822,000,000 United States dollar\", as of 2020-12-31 (until 2021-03-31). Claim clm_65A170B22957, https://asof.is/claim/clm_65A170B22957, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427221000066/0000014272-21-000066-index.htm.","url":"https://asof.is/claim/clm_65A170B22957","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"37,822,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_65A170B22957","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2020, filed 2021-02-10"}},{"date":"2020-12-31","until":"2021-03-31","published":"2021-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 118,481,000,000 United States dollar\", as of 2020-12-31 (until 2021-03-31). Claim clm_A01742400231, https://asof.is/claim/clm_A01742400231, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427221000066/0000014272-21-000066-index.htm.","url":"https://asof.is/claim/clm_A01742400231","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"118,481,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A01742400231","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2020, filed 2021-02-10"}},{"date":"2020-12-31","until":"2021-12-31","published":"2021-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb research and development: 11,143,000,000 United States dollar\", as of 2020-12-31 (until 2021-12-31). Claim clm_F9273E2418F6, https://asof.is/claim/clm_F9273E2418F6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427221000066/0000014272-21-000066-index.htm.","url":"https://asof.is/claim/clm_F9273E2418F6","accessed":"2026-11-09"},"kind":"money","predicate":"research_and_development","value":"11,143,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F9273E2418F6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2020, filed 2021-02-10"}},{"date":"2021-02-01","until":"2021-03-31","published":"2021-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 2,240,475,153 shares\", as of 2021-02-01 (until 2021-03-31). Claim clm_254854D61B35, https://asof.is/claim/clm_254854D61B35, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427221000066/0000014272-21-000066-index.htm.","url":"https://asof.is/claim/clm_254854D61B35","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"2,240,475,153 shares","status":"superseded","assertable":true,"id":"clm_254854D61B35","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2020, filed 2021-02-10"}},{"date":"2021-03-31","until":"2021-06-30","published":"2021-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 10,982,000,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_5027DD4D5A87, https://asof.is/claim/clm_5027DD4D5A87, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427221000126/0000014272-21-000126-index.htm.","url":"https://asof.is/claim/clm_5027DD4D5A87","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"10,982,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5027DD4D5A87","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2021, filed 2021-04-29"}},{"date":"2021-03-31","until":"2021-06-30","published":"2021-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 112,435,000,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_51C303404284, https://asof.is/claim/clm_51C303404284, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427221000126/0000014272-21-000126-index.htm.","url":"https://asof.is/claim/clm_51C303404284","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"112,435,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_51C303404284","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2021, filed 2021-04-29"}},{"date":"2021-03-31","until":"2021-06-30","published":"2021-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 37,605,000,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_8639E1E30F7B, https://asof.is/claim/clm_8639E1E30F7B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427221000126/0000014272-21-000126-index.htm.","url":"https://asof.is/claim/clm_8639E1E30F7B","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"37,605,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8639E1E30F7B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2021, filed 2021-04-29"}},{"date":"2021-03-31","until":"2021-06-30","published":"2021-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 2,021,000,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_866149C707DE, https://asof.is/claim/clm_866149C707DE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427221000126/0000014272-21-000126-index.htm.","url":"https://asof.is/claim/clm_866149C707DE","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"2,021,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_866149C707DE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2021, filed 2021-04-29"}},{"date":"2021-03-31","until":"2021-06-30","published":"2021-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 11,073,000,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_90167993F3AC, https://asof.is/claim/clm_90167993F3AC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427221000126/0000014272-21-000126-index.htm.","url":"https://asof.is/claim/clm_90167993F3AC","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"11,073,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_90167993F3AC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2021, filed 2021-04-29"}},{"date":"2021-03-31","until":"2021-06-30","published":"2021-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 2,225,000,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_A28CB9F163E6, https://asof.is/claim/clm_A28CB9F163E6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427221000126/0000014272-21-000126-index.htm.","url":"https://asof.is/claim/clm_A28CB9F163E6","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"2,225,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A28CB9F163E6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2021, filed 2021-04-29"}},{"date":"2021-03-31","until":"2021-06-30","published":"2021-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 2,232,843,755 shares\", as of 2021-03-31 (until 2021-06-30). Claim clm_D0D1E43C143B, https://asof.is/claim/clm_D0D1E43C143B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427221000126/0000014272-21-000126-index.htm.","url":"https://asof.is/claim/clm_D0D1E43C143B","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"2,232,843,755 shares","status":"superseded","assertable":true,"id":"clm_D0D1E43C143B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2021, filed 2021-04-29"}},{"date":"2021-06-30","until":"2021-09-30","published":"2021-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 1,055,000,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_277248086123, https://asof.is/claim/clm_277248086123, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427221000186/0000014272-21-000186-index.htm.","url":"https://asof.is/claim/clm_277248086123","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,055,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_277248086123","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2021, filed 2021-07-28"}},{"date":"2021-06-30","until":"2021-09-30","published":"2021-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 110,797,000,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_2F273A18E9C9, https://asof.is/claim/clm_2F273A18E9C9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427221000186/0000014272-21-000186-index.htm.","url":"https://asof.is/claim/clm_2F273A18E9C9","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"110,797,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2F273A18E9C9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2021, filed 2021-07-28"}},{"date":"2021-06-30","until":"2021-09-30","published":"2021-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 11,024,000,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_4E5FE51C0655, https://asof.is/claim/clm_4E5FE51C0655, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427221000186/0000014272-21-000186-index.htm.","url":"https://asof.is/claim/clm_4E5FE51C0655","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"11,024,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4E5FE51C0655","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2021, filed 2021-07-28"}},{"date":"2021-06-30","until":"2021-09-30","published":"2021-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 3,271,000,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_5EB4A92B130D, https://asof.is/claim/clm_5EB4A92B130D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427221000186/0000014272-21-000186-index.htm.","url":"https://asof.is/claim/clm_5EB4A92B130D","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"3,271,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5EB4A92B130D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2021, filed 2021-07-28"}},{"date":"2021-06-30","until":"2021-09-30","published":"2021-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 2,222,113,553 shares\", as of 2021-06-30 (until 2021-09-30). Claim clm_6822ABA2EFFD, https://asof.is/claim/clm_6822ABA2EFFD, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427221000186/0000014272-21-000186-index.htm.","url":"https://asof.is/claim/clm_6822ABA2EFFD","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"2,222,113,553 shares","status":"superseded","assertable":true,"id":"clm_6822ABA2EFFD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2021, filed 2021-07-28"}},{"date":"2021-06-30","until":"2021-09-30","published":"2021-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 11,703,000,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_AE7B1C2AA687, https://asof.is/claim/clm_AE7B1C2AA687, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427221000186/0000014272-21-000186-index.htm.","url":"https://asof.is/claim/clm_AE7B1C2AA687","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"11,703,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AE7B1C2AA687","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2021, filed 2021-07-28"}},{"date":"2021-06-30","until":"2021-09-30","published":"2021-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 36,808,000,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_ECFAB0E9DCCB, https://asof.is/claim/clm_ECFAB0E9DCCB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427221000186/0000014272-21-000186-index.htm.","url":"https://asof.is/claim/clm_ECFAB0E9DCCB","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"36,808,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_ECFAB0E9DCCB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2021, filed 2021-07-28"}},{"date":"2021-09-30","until":"2021-12-31","published":"2021-10-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 110,893,000,000 United States dollar\", as of 2021-09-30 (until 2021-12-31). Claim clm_0BB257BBD468, https://asof.is/claim/clm_0BB257BBD468, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427221000224/0000014272-21-000224-index.htm.","url":"https://asof.is/claim/clm_0BB257BBD468","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"110,893,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0BB257BBD468","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2021, filed 2021-10-27"}},{"date":"2021-09-30","until":"2022-03-31","published":"2021-10-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 3,251,000,000 United States dollar\", as of 2021-09-30 (until 2022-03-31). Claim clm_0FC04F2EC1D4, https://asof.is/claim/clm_0FC04F2EC1D4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427221000224/0000014272-21-000224-index.htm.","url":"https://asof.is/claim/clm_0FC04F2EC1D4","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"3,251,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0FC04F2EC1D4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2021, filed 2021-10-27"}},{"date":"2021-09-30","until":"2021-12-31","published":"2021-10-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 37,213,000,000 United States dollar\", as of 2021-09-30 (until 2021-12-31). Claim clm_2C7D852A5EC8, https://asof.is/claim/clm_2C7D852A5EC8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427221000224/0000014272-21-000224-index.htm.","url":"https://asof.is/claim/clm_2C7D852A5EC8","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"37,213,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2C7D852A5EC8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2021, filed 2021-10-27"}},{"date":"2021-09-30","until":"2022-03-31","published":"2021-10-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 11,624,000,000 United States dollar\", as of 2021-09-30 (until 2022-03-31). Claim clm_3ECFD6AA2B23, https://asof.is/claim/clm_3ECFD6AA2B23, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427221000224/0000014272-21-000224-index.htm.","url":"https://asof.is/claim/clm_3ECFD6AA2B23","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"11,624,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3ECFD6AA2B23","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2021, filed 2021-10-27"}},{"date":"2021-09-30","until":"2021-12-31","published":"2021-10-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 13,540,000,000 United States dollar\", as of 2021-09-30 (until 2021-12-31). Claim clm_684FAEE046F2, https://asof.is/claim/clm_684FAEE046F2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427221000224/0000014272-21-000224-index.htm.","url":"https://asof.is/claim/clm_684FAEE046F2","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"13,540,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_684FAEE046F2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2021, filed 2021-10-27"}},{"date":"2021-09-30","until":"2022-03-31","published":"2021-10-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 1,546,000,000 United States dollar\", as of 2021-09-30 (until 2022-03-31). Claim clm_73511A037590, https://asof.is/claim/clm_73511A037590, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427221000224/0000014272-21-000224-index.htm.","url":"https://asof.is/claim/clm_73511A037590","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,546,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_73511A037590","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2021, filed 2021-10-27"}},{"date":"2021-09-30","until":"2022-02-01","published":"2021-10-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 2,219,644,935 shares\", as of 2021-09-30 (until 2022-02-01). Claim clm_CBCD1ADA12BB, https://asof.is/claim/clm_CBCD1ADA12BB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427221000224/0000014272-21-000224-index.htm.","url":"https://asof.is/claim/clm_CBCD1ADA12BB","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"2,219,644,935 shares","status":"superseded","assertable":true,"id":"clm_CBCD1ADA12BB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2021, filed 2021-10-27"}},{"date":"2021-12-31","until":"2022-12-31","published":"2022-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb net income: 6,994,000,000 United States dollar\", as of 2021-12-31 (until 2022-12-31). Claim clm_05937AB12257, https://asof.is/claim/clm_05937AB12257, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427222000051/0000014272-22-000051-index.htm.","url":"https://asof.is/claim/clm_05937AB12257","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"6,994,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_05937AB12257","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2021, filed 2022-02-09"}},{"date":"2021-12-31","until":"2022-03-31","published":"2022-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 109,314,000,000 United States dollar\", as of 2021-12-31 (until 2022-03-31). Claim clm_06C3B1DD4C8B, https://asof.is/claim/clm_06C3B1DD4C8B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427222000051/0000014272-22-000051-index.htm.","url":"https://asof.is/claim/clm_06C3B1DD4C8B","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"109,314,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_06C3B1DD4C8B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2021, filed 2022-02-09"}},{"date":"2021-12-31","until":"2022-12-31","published":"2022-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb research and development: 11,354,000,000 United States dollar\", as of 2021-12-31 (until 2022-12-31). Claim clm_65C9EBE9DAD1, https://asof.is/claim/clm_65C9EBE9DAD1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427222000051/0000014272-22-000051-index.htm.","url":"https://asof.is/claim/clm_65C9EBE9DAD1","accessed":"2026-11-09"},"kind":"money","predicate":"research_and_development","value":"11,354,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_65C9EBE9DAD1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2021, filed 2022-02-09"}},{"date":"2021-12-31","until":"2022-12-31","published":"2022-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb revenue: 46,385,000,000 United States dollar\", as of 2021-12-31 (until 2022-12-31). Claim clm_7C79E3FC9739, https://asof.is/claim/clm_7C79E3FC9739, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427222000051/0000014272-22-000051-index.htm.","url":"https://asof.is/claim/clm_7C79E3FC9739","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"46,385,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7C79E3FC9739","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2021, filed 2022-02-09"}},{"date":"2021-12-31","until":"2022-03-31","published":"2022-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 35,946,000,000 United States dollar\", as of 2021-12-31 (until 2022-03-31). Claim clm_A053AA50D3D6, https://asof.is/claim/clm_A053AA50D3D6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427222000051/0000014272-22-000051-index.htm.","url":"https://asof.is/claim/clm_A053AA50D3D6","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"35,946,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A053AA50D3D6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2021, filed 2022-02-09"}},{"date":"2021-12-31","until":"2022-03-31","published":"2022-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 13,979,000,000 United States dollar\", as of 2021-12-31 (until 2022-03-31). Claim clm_A4D1B1BB0C75, https://asof.is/claim/clm_A4D1B1BB0C75, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427222000051/0000014272-22-000051-index.htm.","url":"https://asof.is/claim/clm_A4D1B1BB0C75","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"13,979,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A4D1B1BB0C75","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2021, filed 2022-02-09"}},{"date":"2022-02-01","until":"2022-03-31","published":"2022-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 2,179,712,820 shares\", as of 2022-02-01 (until 2022-03-31). Claim clm_4C917B021977, https://asof.is/claim/clm_4C917B021977, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427222000051/0000014272-22-000051-index.htm.","url":"https://asof.is/claim/clm_4C917B021977","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"2,179,712,820 shares","status":"superseded","assertable":true,"id":"clm_4C917B021977","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2021, filed 2022-02-09"}},{"date":"2022-03-31","until":"2022-06-30","published":"2022-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 31,580,000,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_1A4A9B63691A, https://asof.is/claim/clm_1A4A9B63691A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427222000114/0000014272-22-000114-index.htm.","url":"https://asof.is/claim/clm_1A4A9B63691A","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"31,580,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1A4A9B63691A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2022, filed 2022-04-29"}},{"date":"2022-03-31","until":"2022-06-30","published":"2022-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 2,260,000,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_2653771A828C, https://asof.is/claim/clm_2653771A828C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427222000114/0000014272-22-000114-index.htm.","url":"https://asof.is/claim/clm_2653771A828C","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"2,260,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2653771A828C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2022, filed 2022-04-29"}},{"date":"2022-03-31","until":"2022-07-15","published":"2022-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 2,129,064,271 shares\", as of 2022-03-31 (until 2022-07-15). Claim clm_5A111C1886F6, https://asof.is/claim/clm_5A111C1886F6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427222000114/0000014272-22-000114-index.htm.","url":"https://asof.is/claim/clm_5A111C1886F6","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"2,129,064,271 shares","status":"superseded","assertable":true,"id":"clm_5A111C1886F6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2022, filed 2022-04-29"}},{"date":"2022-03-31","until":"2022-06-30","published":"2022-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 12,369,000,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_6EEE9A4C63D1, https://asof.is/claim/clm_6EEE9A4C63D1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427222000114/0000014272-22-000114-index.htm.","url":"https://asof.is/claim/clm_6EEE9A4C63D1","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"12,369,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6EEE9A4C63D1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2022, filed 2022-04-29"}},{"date":"2022-03-31","until":"2022-06-30","published":"2022-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 1,278,000,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_78429352030D, https://asof.is/claim/clm_78429352030D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427222000114/0000014272-22-000114-index.htm.","url":"https://asof.is/claim/clm_78429352030D","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,278,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_78429352030D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2022, filed 2022-04-29"}},{"date":"2022-03-31","until":"2022-06-30","published":"2022-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 103,034,000,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_9BF64F4F2EFB, https://asof.is/claim/clm_9BF64F4F2EFB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427222000114/0000014272-22-000114-index.htm.","url":"https://asof.is/claim/clm_9BF64F4F2EFB","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"103,034,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9BF64F4F2EFB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2022, filed 2022-04-29"}},{"date":"2022-03-31","until":"2022-06-30","published":"2022-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 11,648,000,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_D79D783840A8, https://asof.is/claim/clm_D79D783840A8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427222000114/0000014272-22-000114-index.htm.","url":"https://asof.is/claim/clm_D79D783840A8","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"11,648,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D79D783840A8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2022, filed 2022-04-29"}},{"date":"2022-06-30","until":"2022-09-30","published":"2022-07-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 10,750,000,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_4956C44116CA, https://asof.is/claim/clm_4956C44116CA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427222000166/0000014272-22-000166-index.htm.","url":"https://asof.is/claim/clm_4956C44116CA","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"10,750,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4956C44116CA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2022, filed 2022-07-27"}},{"date":"2022-06-30","until":"2022-09-30","published":"2022-07-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 1,421,000,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_5C4983FE28D2, https://asof.is/claim/clm_5C4983FE28D2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427222000166/0000014272-22-000166-index.htm.","url":"https://asof.is/claim/clm_5C4983FE28D2","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,421,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5C4983FE28D2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2022, filed 2022-07-27"}},{"date":"2022-06-30","until":"2022-09-30","published":"2022-07-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 32,600,000,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_7AA355613632, https://asof.is/claim/clm_7AA355613632, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427222000166/0000014272-22-000166-index.htm.","url":"https://asof.is/claim/clm_7AA355613632","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"32,600,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7AA355613632","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2022, filed 2022-07-27"}},{"date":"2022-06-30","until":"2022-09-30","published":"2022-07-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 2,321,000,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_8C160359CC75, https://asof.is/claim/clm_8C160359CC75, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427222000166/0000014272-22-000166-index.htm.","url":"https://asof.is/claim/clm_8C160359CC75","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"2,321,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8C160359CC75","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2022, filed 2022-07-27"}},{"date":"2022-06-30","until":"2022-09-30","published":"2022-07-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 100,357,000,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_B6B6B5AD6907, https://asof.is/claim/clm_B6B6B5AD6907, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427222000166/0000014272-22-000166-index.htm.","url":"https://asof.is/claim/clm_B6B6B5AD6907","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"100,357,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B6B6B5AD6907","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2022, filed 2022-07-27"}},{"date":"2022-06-30","until":"2022-09-30","published":"2022-07-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 11,887,000,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_D5D7ABA783AD, https://asof.is/claim/clm_D5D7ABA783AD, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427222000166/0000014272-22-000166-index.htm.","url":"https://asof.is/claim/clm_D5D7ABA783AD","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"11,887,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D5D7ABA783AD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2022, filed 2022-07-27"}},{"date":"2022-07-15","until":"2022-10-14","published":"2022-07-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 2,135,255,158 shares\", as of 2022-07-15 (until 2022-10-14). Claim clm_12081EE810AD, https://asof.is/claim/clm_12081EE810AD, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427222000166/0000014272-22-000166-index.htm.","url":"https://asof.is/claim/clm_12081EE810AD","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"2,135,255,158 shares","status":"superseded","assertable":true,"id":"clm_12081EE810AD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2022, filed 2022-07-27"}},{"date":"2022-09-30","until":"2023-03-31","published":"2022-10-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 2,418,000,000 United States dollar\", as of 2022-09-30 (until 2023-03-31). Claim clm_0295F3B65E36, https://asof.is/claim/clm_0295F3B65E36, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427222000196/0000014272-22-000196-index.htm.","url":"https://asof.is/claim/clm_0295F3B65E36","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"2,418,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0295F3B65E36","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2022, filed 2022-10-26"}},{"date":"2022-09-30","until":"2022-12-31","published":"2022-10-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 7,734,000,000 United States dollar\", as of 2022-09-30 (until 2022-12-31). Claim clm_75FC4B8D08CA, https://asof.is/claim/clm_75FC4B8D08CA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427222000196/0000014272-22-000196-index.htm.","url":"https://asof.is/claim/clm_75FC4B8D08CA","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"7,734,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_75FC4B8D08CA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2022, filed 2022-10-26"}},{"date":"2022-09-30","until":"2023-03-31","published":"2022-10-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 1,606,000,000 United States dollar\", as of 2022-09-30 (until 2023-03-31). Claim clm_87352964FDF2, https://asof.is/claim/clm_87352964FDF2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427222000196/0000014272-22-000196-index.htm.","url":"https://asof.is/claim/clm_87352964FDF2","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,606,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_87352964FDF2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2022, filed 2022-10-26"}},{"date":"2022-09-30","until":"2023-03-31","published":"2022-10-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 11,218,000,000 United States dollar\", as of 2022-09-30 (until 2023-03-31). Claim clm_9D4962A5216A, https://asof.is/claim/clm_9D4962A5216A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427222000196/0000014272-22-000196-index.htm.","url":"https://asof.is/claim/clm_9D4962A5216A","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"11,218,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9D4962A5216A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2022, filed 2022-10-26"}},{"date":"2022-09-30","until":"2022-12-31","published":"2022-10-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 98,196,000,000 United States dollar\", as of 2022-09-30 (until 2022-12-31). Claim clm_DED849B2AB45, https://asof.is/claim/clm_DED849B2AB45, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427222000196/0000014272-22-000196-index.htm.","url":"https://asof.is/claim/clm_DED849B2AB45","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"98,196,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DED849B2AB45","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2022, filed 2022-10-26"}},{"date":"2022-09-30","until":"2022-12-31","published":"2022-10-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 32,671,000,000 United States dollar\", as of 2022-09-30 (until 2022-12-31). Claim clm_EB64E45B46F0, https://asof.is/claim/clm_EB64E45B46F0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427222000196/0000014272-22-000196-index.htm.","url":"https://asof.is/claim/clm_EB64E45B46F0","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"32,671,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EB64E45B46F0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2022, filed 2022-10-26"}},{"date":"2022-10-14","until":"2023-02-07","published":"2022-10-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 2,126,160,347 shares\", as of 2022-10-14 (until 2023-02-07). Claim clm_FE0F3F8AA345, https://asof.is/claim/clm_FE0F3F8AA345, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427222000196/0000014272-22-000196-index.htm.","url":"https://asof.is/claim/clm_FE0F3F8AA345","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"2,126,160,347 shares","status":"superseded","assertable":true,"id":"clm_FE0F3F8AA345","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2022, filed 2022-10-26"}},{"date":"2022-12-31","until":"2023-03-31","published":"2023-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 31,061,000,000 United States dollar\", as of 2022-12-31 (until 2023-03-31). Claim clm_06609FC4D334, https://asof.is/claim/clm_06609FC4D334, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427223000046/0000014272-23-000046-index.htm.","url":"https://asof.is/claim/clm_06609FC4D334","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"31,061,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_06609FC4D334","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2022, filed 2023-02-14"}},{"date":"2022-12-31","until":"2023-12-31","published":"2023-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb net income: 6,327,000,000 United States dollar\", as of 2022-12-31 (until 2023-12-31). Claim clm_6ACDA9562DBE, https://asof.is/claim/clm_6ACDA9562DBE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427223000046/0000014272-23-000046-index.htm.","url":"https://asof.is/claim/clm_6ACDA9562DBE","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"6,327,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6ACDA9562DBE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2022, filed 2023-02-14"}},{"date":"2022-12-31","until":"2023-12-31","published":"2023-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb research and development: 9,509,000,000 United States dollar\", as of 2022-12-31 (until 2023-12-31). Claim clm_89EE8CD69449, https://asof.is/claim/clm_89EE8CD69449, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427223000046/0000014272-23-000046-index.htm.","url":"https://asof.is/claim/clm_89EE8CD69449","accessed":"2026-11-09"},"kind":"money","predicate":"research_and_development","value":"9,509,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_89EE8CD69449","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2022, filed 2023-02-14"}},{"date":"2022-12-31","until":"2023-12-31","published":"2023-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb revenue: 46,159,000,000 United States dollar\", as of 2022-12-31 (until 2023-12-31). Claim clm_918266837860, https://asof.is/claim/clm_918266837860, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427223000046/0000014272-23-000046-index.htm.","url":"https://asof.is/claim/clm_918266837860","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"46,159,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_918266837860","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2022, filed 2023-02-14"}},{"date":"2022-12-31","until":"2023-03-31","published":"2023-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 96,820,000,000 United States dollar\", as of 2022-12-31 (until 2023-03-31). Claim clm_C58FBFAF2EB4, https://asof.is/claim/clm_C58FBFAF2EB4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427223000046/0000014272-23-000046-index.htm.","url":"https://asof.is/claim/clm_C58FBFAF2EB4","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"96,820,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C58FBFAF2EB4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2022, filed 2023-02-14"}},{"date":"2022-12-31","until":"2023-03-31","published":"2023-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 9,123,000,000 United States dollar\", as of 2022-12-31 (until 2023-03-31). Claim clm_CA5F3EDC2A0A, https://asof.is/claim/clm_CA5F3EDC2A0A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427223000046/0000014272-23-000046-index.htm.","url":"https://asof.is/claim/clm_CA5F3EDC2A0A","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"9,123,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CA5F3EDC2A0A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2022, filed 2023-02-14"}},{"date":"2023-02-07","until":"2023-04-20","published":"2023-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 2,098,775,978 shares\", as of 2023-02-07 (until 2023-04-20). Claim clm_89F8AB78889B, https://asof.is/claim/clm_89F8AB78889B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427223000046/0000014272-23-000046-index.htm.","url":"https://asof.is/claim/clm_89F8AB78889B","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"2,098,775,978 shares","status":"superseded","assertable":true,"id":"clm_89F8AB78889B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2022, filed 2023-02-14"}},{"date":"2023-03-31","until":"2023-06-30","published":"2023-04-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 31,824,000,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_138C33E2F142, https://asof.is/claim/clm_138C33E2F142, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427223000104/0000014272-23-000104-index.htm.","url":"https://asof.is/claim/clm_138C33E2F142","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"31,824,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_138C33E2F142","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2023, filed 2023-04-27"}},{"date":"2023-03-31","until":"2023-06-30","published":"2023-04-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 8,995,000,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_30E73DC7BEE0, https://asof.is/claim/clm_30E73DC7BEE0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427223000104/0000014272-23-000104-index.htm.","url":"https://asof.is/claim/clm_30E73DC7BEE0","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"8,995,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_30E73DC7BEE0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2023, filed 2023-04-27"}},{"date":"2023-03-31","until":"2023-06-30","published":"2023-04-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 2,262,000,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_44CF08290E15, https://asof.is/claim/clm_44CF08290E15, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427223000104/0000014272-23-000104-index.htm.","url":"https://asof.is/claim/clm_44CF08290E15","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"2,262,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_44CF08290E15","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2023, filed 2023-04-27"}},{"date":"2023-03-31","until":"2023-06-30","published":"2023-04-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 94,281,000,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_882076DBB5AA, https://asof.is/claim/clm_882076DBB5AA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427223000104/0000014272-23-000104-index.htm.","url":"https://asof.is/claim/clm_882076DBB5AA","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"94,281,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_882076DBB5AA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2023, filed 2023-04-27"}},{"date":"2023-03-31","until":"2023-06-30","published":"2023-04-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 11,337,000,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_D93AB25093EB, https://asof.is/claim/clm_D93AB25093EB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427223000104/0000014272-23-000104-index.htm.","url":"https://asof.is/claim/clm_D93AB25093EB","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"11,337,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D93AB25093EB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2023, filed 2023-04-27"}},{"date":"2023-03-31","until":"2023-06-30","published":"2023-04-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 2,321,000,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_EAC3E9BA1AAF, https://asof.is/claim/clm_EAC3E9BA1AAF, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427223000104/0000014272-23-000104-index.htm.","url":"https://asof.is/claim/clm_EAC3E9BA1AAF","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"2,321,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EAC3E9BA1AAF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2023, filed 2023-04-27"}},{"date":"2023-04-20","until":"2023-07-20","published":"2023-04-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 2,100,847,138 shares\", as of 2023-04-20 (until 2023-07-20). Claim clm_5DE655C66164, https://asof.is/claim/clm_5DE655C66164, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427223000104/0000014272-23-000104-index.htm.","url":"https://asof.is/claim/clm_5DE655C66164","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"2,100,847,138 shares","status":"superseded","assertable":true,"id":"clm_5DE655C66164","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2023, filed 2023-04-27"}},{"date":"2023-06-30","until":"2023-09-30","published":"2023-07-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 2,258,000,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_3EAB2E029B2D, https://asof.is/claim/clm_3EAB2E029B2D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427223000152/0000014272-23-000152-index.htm.","url":"https://asof.is/claim/clm_3EAB2E029B2D","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"2,258,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3EAB2E029B2D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2023, filed 2023-07-27"}},{"date":"2023-06-30","until":"2023-09-30","published":"2023-07-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 31,973,000,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_6B4C0EC2CB0D, https://asof.is/claim/clm_6B4C0EC2CB0D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427223000152/0000014272-23-000152-index.htm.","url":"https://asof.is/claim/clm_6B4C0EC2CB0D","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"31,973,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6B4C0EC2CB0D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2023, filed 2023-07-27"}},{"date":"2023-06-30","until":"2023-09-30","published":"2023-07-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 11,226,000,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_C21A07FB73A6, https://asof.is/claim/clm_C21A07FB73A6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427223000152/0000014272-23-000152-index.htm.","url":"https://asof.is/claim/clm_C21A07FB73A6","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"11,226,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C21A07FB73A6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2023, filed 2023-07-27"}},{"date":"2023-06-30","until":"2023-09-30","published":"2023-07-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 8,372,000,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_F36D80DAA8A1, https://asof.is/claim/clm_F36D80DAA8A1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427223000152/0000014272-23-000152-index.htm.","url":"https://asof.is/claim/clm_F36D80DAA8A1","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"8,372,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F36D80DAA8A1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2023, filed 2023-07-27"}},{"date":"2023-06-30","until":"2023-09-30","published":"2023-07-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 2,073,000,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_FE7837E61B5C, https://asof.is/claim/clm_FE7837E61B5C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427223000152/0000014272-23-000152-index.htm.","url":"https://asof.is/claim/clm_FE7837E61B5C","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"2,073,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FE7837E61B5C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2023, filed 2023-07-27"}},{"date":"2023-06-30","until":"2023-09-30","published":"2023-07-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 93,489,000,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_FF007609C791, https://asof.is/claim/clm_FF007609C791, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427223000152/0000014272-23-000152-index.htm.","url":"https://asof.is/claim/clm_FF007609C791","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"93,489,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FF007609C791","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2023, filed 2023-07-27"}},{"date":"2023-07-20","until":"2023-10-20","published":"2023-07-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 2,089,102,921 shares\", as of 2023-07-20 (until 2023-10-20). Claim clm_14E3456699D6, https://asof.is/claim/clm_14E3456699D6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427223000152/0000014272-23-000152-index.htm.","url":"https://asof.is/claim/clm_14E3456699D6","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"2,089,102,921 shares","status":"superseded","assertable":true,"id":"clm_14E3456699D6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2023, filed 2023-07-27"}},{"date":"2023-09-30","until":"2024-03-31","published":"2023-10-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 10,966,000,000 United States dollar\", as of 2023-09-30 (until 2024-03-31). Claim clm_2D8B38C2D603, https://asof.is/claim/clm_2D8B38C2D603, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427223000181/0000014272-23-000181-index.htm.","url":"https://asof.is/claim/clm_2D8B38C2D603","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"10,966,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2D8B38C2D603","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2023, filed 2023-10-26"}},{"date":"2023-09-30","until":"2024-03-31","published":"2023-10-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 2,242,000,000 United States dollar\", as of 2023-09-30 (until 2024-03-31). Claim clm_3B07EC588400, https://asof.is/claim/clm_3B07EC588400, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427223000181/0000014272-23-000181-index.htm.","url":"https://asof.is/claim/clm_3B07EC588400","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"2,242,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3B07EC588400","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2023, filed 2023-10-26"}},{"date":"2023-09-30","until":"2023-12-31","published":"2023-10-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 28,998,000,000 United States dollar\", as of 2023-09-30 (until 2023-12-31). Claim clm_5330732B079F, https://asof.is/claim/clm_5330732B079F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427223000181/0000014272-23-000181-index.htm.","url":"https://asof.is/claim/clm_5330732B079F","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"28,998,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5330732B079F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2023, filed 2023-10-26"}},{"date":"2023-09-30","until":"2024-03-31","published":"2023-10-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 1,928,000,000 United States dollar\", as of 2023-09-30 (until 2024-03-31). Claim clm_957BE8C6699C, https://asof.is/claim/clm_957BE8C6699C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427223000181/0000014272-23-000181-index.htm.","url":"https://asof.is/claim/clm_957BE8C6699C","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,928,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_957BE8C6699C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2023, filed 2023-10-26"}},{"date":"2023-09-30","until":"2023-12-31","published":"2023-10-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 91,263,000,000 United States dollar\", as of 2023-09-30 (until 2023-12-31). Claim clm_E52279CD3AD4, https://asof.is/claim/clm_E52279CD3AD4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427223000181/0000014272-23-000181-index.htm.","url":"https://asof.is/claim/clm_E52279CD3AD4","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"91,263,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E52279CD3AD4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2023, filed 2023-10-26"}},{"date":"2023-09-30","until":"2023-12-31","published":"2023-10-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 7,514,000,000 United States dollar\", as of 2023-09-30 (until 2023-12-31). Claim clm_F5D4FDEA17A2, https://asof.is/claim/clm_F5D4FDEA17A2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427223000181/0000014272-23-000181-index.htm.","url":"https://asof.is/claim/clm_F5D4FDEA17A2","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"7,514,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F5D4FDEA17A2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2023, filed 2023-10-26"}},{"date":"2023-10-20","until":"2024-02-06","published":"2023-10-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 2,034,757,742 shares\", as of 2023-10-20 (until 2024-02-06). Claim clm_BA7DB48653DB, https://asof.is/claim/clm_BA7DB48653DB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427223000181/0000014272-23-000181-index.htm.","url":"https://asof.is/claim/clm_BA7DB48653DB","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"2,034,757,742 shares","status":"superseded","assertable":true,"id":"clm_BA7DB48653DB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2023, filed 2023-10-26"}},{"date":"2023-11-01","until":null,"published":"2026-03-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb ceo: Christopher S. Boerner, Ph.D\", as of 2023-11-01. Claim clm_FF61856A3386, https://asof.is/claim/clm_FF61856A3386, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000006/bmy-20260325.htm.","url":"https://asof.is/claim/clm_FF61856A3386","accessed":"2026-11-09"},"kind":"people","predicate":"ceo","value":"Christopher S. Boerner, Ph.D","status":"valid","assertable":true,"id":"clm_FF61856A3386","evidence":{"by":"page-read","on":"2026-11-08","quote":"Christopher S. Boerner, Ph.D. Board Chair & Chief Executive Officer of the Company Director Since: 2023 Age: 55 Board Committees • None Other Public Company Boards • Colgate-Palmolive Company Experience • Bristol Myers Squibb, Chief Executive Officer (November 2023-present)","url":"https://www.sec.gov/Archives/edgar/data/14272/000001427226000006/bmy-20260325.htm"}},{"date":"2023-12-31","until":"2024-12-31","published":"2024-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb revenue: 45,006,000,000 United States dollar\", as of 2023-12-31 (until 2024-12-31). Claim clm_2A5DAEAFCF0E, https://asof.is/claim/clm_2A5DAEAFCF0E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427224000044/0000014272-24-000044-index.htm.","url":"https://asof.is/claim/clm_2A5DAEAFCF0E","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"45,006,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2A5DAEAFCF0E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2023, filed 2024-02-13"}},{"date":"2023-12-31","until":"2024-03-31","published":"2024-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 11,464,000,000 United States dollar\", as of 2023-12-31 (until 2024-03-31). Claim clm_4C220C0862B3, https://asof.is/claim/clm_4C220C0862B3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427224000044/0000014272-24-000044-index.htm.","url":"https://asof.is/claim/clm_4C220C0862B3","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"11,464,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4C220C0862B3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2023, filed 2024-02-13"}},{"date":"2023-12-31","until":"2024-12-31","published":"2024-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb research and development: 9,299,000,000 United States dollar\", as of 2023-12-31 (until 2024-12-31). Claim clm_5D4F25142B06, https://asof.is/claim/clm_5D4F25142B06, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427224000044/0000014272-24-000044-index.htm.","url":"https://asof.is/claim/clm_5D4F25142B06","accessed":"2026-11-09"},"kind":"money","predicate":"research_and_development","value":"9,299,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5D4F25142B06","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2023, filed 2024-02-13"}},{"date":"2023-12-31","until":"2024-03-31","published":"2024-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 29,430,000,000 United States dollar\", as of 2023-12-31 (until 2024-03-31). Claim clm_A14633ABFE56, https://asof.is/claim/clm_A14633ABFE56, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427224000044/0000014272-24-000044-index.htm.","url":"https://asof.is/claim/clm_A14633ABFE56","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"29,430,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A14633ABFE56","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2023, filed 2024-02-13"}},{"date":"2023-12-31","until":"2024-03-31","published":"2024-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 95,159,000,000 United States dollar\", as of 2023-12-31 (until 2024-03-31). Claim clm_B19C8515F7D0, https://asof.is/claim/clm_B19C8515F7D0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427224000044/0000014272-24-000044-index.htm.","url":"https://asof.is/claim/clm_B19C8515F7D0","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"95,159,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B19C8515F7D0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2023, filed 2024-02-13"}},{"date":"2023-12-31","until":"2024-12-31","published":"2024-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb net income: 8,025,000,000 United States dollar\", as of 2023-12-31 (until 2024-12-31). Claim clm_D99EB80D0E65, https://asof.is/claim/clm_D99EB80D0E65, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427224000044/0000014272-24-000044-index.htm.","url":"https://asof.is/claim/clm_D99EB80D0E65","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"8,025,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D99EB80D0E65","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2023, filed 2024-02-13"}},{"date":"2024-02-06","until":"2024-04-18","published":"2024-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 2,022,193,411 shares\", as of 2024-02-06 (until 2024-04-18). Claim clm_961777FB557E, https://asof.is/claim/clm_961777FB557E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427224000044/0000014272-24-000044-index.htm.","url":"https://asof.is/claim/clm_961777FB557E","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"2,022,193,411 shares","status":"superseded","assertable":true,"id":"clm_961777FB557E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2023, filed 2024-02-13"}},{"date":"2024-03-31","until":"2024-06-30","published":"2024-04-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: -11,911,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_051BF490BBD5, https://asof.is/claim/clm_051BF490BBD5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427224000096/0000014272-24-000096-index.htm.","url":"https://asof.is/claim/clm_051BF490BBD5","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"-11,911,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_051BF490BBD5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2024, filed 2024-04-25"}},{"date":"2024-03-31","until":"2024-06-30","published":"2024-04-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 99,031,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_3CB5FFCF4FD6, https://asof.is/claim/clm_3CB5FFCF4FD6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427224000096/0000014272-24-000096-index.htm.","url":"https://asof.is/claim/clm_3CB5FFCF4FD6","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"99,031,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3CB5FFCF4FD6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2024, filed 2024-04-25"}},{"date":"2024-03-31","until":"2024-06-30","published":"2024-04-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 16,490,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_5A393631CB0B, https://asof.is/claim/clm_5A393631CB0B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427224000096/0000014272-24-000096-index.htm.","url":"https://asof.is/claim/clm_5A393631CB0B","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"16,490,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5A393631CB0B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2024, filed 2024-04-25"}},{"date":"2024-03-31","until":"2024-06-30","published":"2024-04-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 11,865,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_8679C4DC1004, https://asof.is/claim/clm_8679C4DC1004, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427224000096/0000014272-24-000096-index.htm.","url":"https://asof.is/claim/clm_8679C4DC1004","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"11,865,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8679C4DC1004","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2024, filed 2024-04-25"}},{"date":"2024-03-31","until":"2024-06-30","published":"2024-04-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 2,695,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_F20B9ABE4C44, https://asof.is/claim/clm_F20B9ABE4C44, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427224000096/0000014272-24-000096-index.htm.","url":"https://asof.is/claim/clm_F20B9ABE4C44","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"2,695,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F20B9ABE4C44","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2024, filed 2024-04-25"}},{"date":"2024-03-31","until":"2024-06-30","published":"2024-04-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 9,330,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_FA0954778351, https://asof.is/claim/clm_FA0954778351, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427224000096/0000014272-24-000096-index.htm.","url":"https://asof.is/claim/clm_FA0954778351","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"9,330,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FA0954778351","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2024, filed 2024-04-25"}},{"date":"2024-04-01","until":null,"published":"2026-03-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb chair: Christopher S. Boerner, Ph.D\", as of 2024-04-01. Claim clm_62358F2F8937, https://asof.is/claim/clm_62358F2F8937, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000006/bmy-20260325.htm.","url":"https://asof.is/claim/clm_62358F2F8937","accessed":"2026-11-09"},"kind":"people","predicate":"chair","value":"Christopher S. Boerner, Ph.D","status":"valid","assertable":true,"id":"clm_62358F2F8937","evidence":{"by":"page-read","on":"2026-11-08","quote":"Christopher S. Boerner, Ph.D. Board Chair & Chief Executive Officer of the Company Director Since: 2023 Age: 55 Board Committees • None Other Public Company Boards • Colgate-Palmolive Company Experience • Bristol Myers Squibb, Chief Executive Officer (November 2023-present) • Board Chair (April 2024","url":"https://www.sec.gov/Archives/edgar/data/14272/000001427226000006/bmy-20260325.htm"}},{"date":"2024-04-18","until":"2024-07-19","published":"2024-04-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 2,027,100,096 shares\", as of 2024-04-18 (until 2024-07-19). Claim clm_70CEDDA7AB48, https://asof.is/claim/clm_70CEDDA7AB48, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427224000096/0000014272-24-000096-index.htm.","url":"https://asof.is/claim/clm_70CEDDA7AB48","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"2,027,100,096 shares","status":"superseded","assertable":true,"id":"clm_70CEDDA7AB48","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2024, filed 2024-04-25"}},{"date":"2024-06-30","until":"2024-09-30","published":"2024-07-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 12,201,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_0C0D23505909, https://asof.is/claim/clm_0C0D23505909, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427224000123/0000014272-24-000123-index.htm.","url":"https://asof.is/claim/clm_0C0D23505909","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"12,201,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0C0D23505909","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2024, filed 2024-07-26"}},{"date":"2024-06-30","until":"2024-09-30","published":"2024-07-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 2,899,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_505BDAA1FD80, https://asof.is/claim/clm_505BDAA1FD80, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427224000123/0000014272-24-000123-index.htm.","url":"https://asof.is/claim/clm_505BDAA1FD80","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"2,899,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_505BDAA1FD80","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2024, filed 2024-07-26"}},{"date":"2024-06-30","until":"2024-09-30","published":"2024-07-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 1,680,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_52FD14B76A9C, https://asof.is/claim/clm_52FD14B76A9C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427224000123/0000014272-24-000123-index.htm.","url":"https://asof.is/claim/clm_52FD14B76A9C","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,680,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_52FD14B76A9C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2024, filed 2024-07-26"}},{"date":"2024-06-30","until":"2024-09-30","published":"2024-07-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 94,646,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_790C721B41A2, https://asof.is/claim/clm_790C721B41A2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427224000123/0000014272-24-000123-index.htm.","url":"https://asof.is/claim/clm_790C721B41A2","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"94,646,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_790C721B41A2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2024, filed 2024-07-26"}},{"date":"2024-06-30","until":"2024-09-30","published":"2024-07-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 6,293,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_A0228A94CF34, https://asof.is/claim/clm_A0228A94CF34, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427224000123/0000014272-24-000123-index.htm.","url":"https://asof.is/claim/clm_A0228A94CF34","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"6,293,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A0228A94CF34","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2024, filed 2024-07-26"}},{"date":"2024-06-30","until":"2024-09-30","published":"2024-07-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 17,015,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_C11E87824631, https://asof.is/claim/clm_C11E87824631, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427224000123/0000014272-24-000123-index.htm.","url":"https://asof.is/claim/clm_C11E87824631","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"17,015,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C11E87824631","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2024, filed 2024-07-26"}},{"date":"2024-07-19","until":"2024-10-24","published":"2024-07-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 2,027,395,178 shares\", as of 2024-07-19 (until 2024-10-24). Claim clm_C54C82499A4C, https://asof.is/claim/clm_C54C82499A4C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427224000123/0000014272-24-000123-index.htm.","url":"https://asof.is/claim/clm_C54C82499A4C","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"2,027,395,178 shares","status":"superseded","assertable":true,"id":"clm_C54C82499A4C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2024, filed 2024-07-26"}},{"date":"2024-09-30","until":"2024-12-31","published":"2024-10-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 93,670,000,000 United States dollar\", as of 2024-09-30 (until 2024-12-31). Claim clm_42EA14C3C2C1, https://asof.is/claim/clm_42EA14C3C2C1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427224000147/0000014272-24-000147-index.htm.","url":"https://asof.is/claim/clm_42EA14C3C2C1","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"93,670,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_42EA14C3C2C1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2024, filed 2024-10-31"}},{"date":"2024-09-30","until":"2024-12-31","published":"2024-10-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 17,142,000,000 United States dollar\", as of 2024-09-30 (until 2024-12-31). Claim clm_7820F77B3C4C, https://asof.is/claim/clm_7820F77B3C4C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427224000147/0000014272-24-000147-index.htm.","url":"https://asof.is/claim/clm_7820F77B3C4C","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"17,142,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7820F77B3C4C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2024, filed 2024-10-31"}},{"date":"2024-09-30","until":"2024-12-31","published":"2024-10-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 7,890,000,000 United States dollar\", as of 2024-09-30 (until 2024-12-31). Claim clm_A709A72CBB2D, https://asof.is/claim/clm_A709A72CBB2D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427224000147/0000014272-24-000147-index.htm.","url":"https://asof.is/claim/clm_A709A72CBB2D","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"7,890,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A709A72CBB2D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2024, filed 2024-10-31"}},{"date":"2024-09-30","until":"2025-03-31","published":"2024-10-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 2,374,000,000 United States dollar\", as of 2024-09-30 (until 2025-03-31). Claim clm_D5943AFEC8DF, https://asof.is/claim/clm_D5943AFEC8DF, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427224000147/0000014272-24-000147-index.htm.","url":"https://asof.is/claim/clm_D5943AFEC8DF","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"2,374,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D5943AFEC8DF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2024, filed 2024-10-31"}},{"date":"2024-09-30","until":"2025-03-31","published":"2024-10-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 11,892,000,000 United States dollar\", as of 2024-09-30 (until 2025-03-31). Claim clm_ED30B6615116, https://asof.is/claim/clm_ED30B6615116, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427224000147/0000014272-24-000147-index.htm.","url":"https://asof.is/claim/clm_ED30B6615116","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"11,892,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_ED30B6615116","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2024, filed 2024-10-31"}},{"date":"2024-09-30","until":"2025-03-31","published":"2024-10-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 1,211,000,000 United States dollar\", as of 2024-09-30 (until 2025-03-31). Claim clm_EEAF18DC3347, https://asof.is/claim/clm_EEAF18DC3347, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427224000147/0000014272-24-000147-index.htm.","url":"https://asof.is/claim/clm_EEAF18DC3347","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,211,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EEAF18DC3347","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2024, filed 2024-10-31"}},{"date":"2024-10-24","until":"2025-02-06","published":"2024-10-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 2,028,176,674 shares\", as of 2024-10-24 (until 2025-02-06). Claim clm_BA7A9DBB64EB, https://asof.is/claim/clm_BA7A9DBB64EB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427224000147/0000014272-24-000147-index.htm.","url":"https://asof.is/claim/clm_BA7A9DBB64EB","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"2,028,176,674 shares","status":"superseded","assertable":true,"id":"clm_BA7A9DBB64EB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2024, filed 2024-10-31"}},{"date":"2024-12-31","until":"2025-03-31","published":"2025-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 10,346,000,000 United States dollar\", as of 2024-12-31 (until 2025-03-31). Claim clm_0EF8BDD4B8BF, https://asof.is/claim/clm_0EF8BDD4B8BF, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427225000039/0000014272-25-000039-index.htm.","url":"https://asof.is/claim/clm_0EF8BDD4B8BF","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"10,346,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0EF8BDD4B8BF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2024, filed 2025-02-12"}},{"date":"2024-12-31","until":"2025-03-31","published":"2025-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 92,603,000,000 United States dollar\", as of 2024-12-31 (until 2025-03-31). Claim clm_28801CE10258, https://asof.is/claim/clm_28801CE10258, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427225000039/0000014272-25-000039-index.htm.","url":"https://asof.is/claim/clm_28801CE10258","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"92,603,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_28801CE10258","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2024, filed 2025-02-12"}},{"date":"2024-12-31","until":"2025-12-31","published":"2025-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb revenue: 48,300,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_78596CC18E60, https://asof.is/claim/clm_78596CC18E60, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427225000039/0000014272-25-000039-index.htm.","url":"https://asof.is/claim/clm_78596CC18E60","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"48,300,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_78596CC18E60","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2024, filed 2025-02-12"}},{"date":"2024-12-31","until":"2025-03-31","published":"2025-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 16,335,000,000 United States dollar\", as of 2024-12-31 (until 2025-03-31). Claim clm_86CA286F16F8, https://asof.is/claim/clm_86CA286F16F8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427225000039/0000014272-25-000039-index.htm.","url":"https://asof.is/claim/clm_86CA286F16F8","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"16,335,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_86CA286F16F8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2024, filed 2025-02-12"}},{"date":"2024-12-31","until":"2025-12-31","published":"2025-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb net income: -8,948,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_93176D9F8458, https://asof.is/claim/clm_93176D9F8458, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427225000039/0000014272-25-000039-index.htm.","url":"https://asof.is/claim/clm_93176D9F8458","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"-8,948,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_93176D9F8458","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2024, filed 2025-02-12"}},{"date":"2024-12-31","until":"2025-12-31","published":"2025-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb research and development: 11,159,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_CC290D20ACB7, https://asof.is/claim/clm_CC290D20ACB7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427225000039/0000014272-25-000039-index.htm.","url":"https://asof.is/claim/clm_CC290D20ACB7","accessed":"2026-11-09"},"kind":"money","predicate":"research_and_development","value":"11,159,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CC290D20ACB7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2024, filed 2025-02-12"}},{"date":"2025-02-06","until":"2025-04-17","published":"2025-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 2,029,312,023 shares\", as of 2025-02-06 (until 2025-04-17). Claim clm_D30764FFE593, https://asof.is/claim/clm_D30764FFE593, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427225000039/0000014272-25-000039-index.htm.","url":"https://asof.is/claim/clm_D30764FFE593","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"2,029,312,023 shares","status":"superseded","assertable":true,"id":"clm_D30764FFE593","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2024, filed 2025-02-12"}},{"date":"2025-03-31","until":"2025-06-30","published":"2025-04-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 2,257,000,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_521ADD71267C, https://asof.is/claim/clm_521ADD71267C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427225000091/0000014272-25-000091-index.htm.","url":"https://asof.is/claim/clm_521ADD71267C","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"2,257,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_521ADD71267C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2025, filed 2025-04-24"}},{"date":"2025-03-31","until":"2025-06-30","published":"2025-04-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 10,875,000,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_544A85081CFD, https://asof.is/claim/clm_544A85081CFD, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427225000091/0000014272-25-000091-index.htm.","url":"https://asof.is/claim/clm_544A85081CFD","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"10,875,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_544A85081CFD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2025, filed 2025-04-24"}},{"date":"2025-03-31","until":"2025-06-30","published":"2025-04-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 17,389,000,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_57623C792BC3, https://asof.is/claim/clm_57623C792BC3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427225000091/0000014272-25-000091-index.htm.","url":"https://asof.is/claim/clm_57623C792BC3","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"17,389,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_57623C792BC3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2025, filed 2025-04-24"}},{"date":"2025-03-31","until":"2025-06-30","published":"2025-04-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 92,427,000,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_750B5DA0FE51, https://asof.is/claim/clm_750B5DA0FE51, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427225000091/0000014272-25-000091-index.htm.","url":"https://asof.is/claim/clm_750B5DA0FE51","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"92,427,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_750B5DA0FE51","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2025, filed 2025-04-24"}},{"date":"2025-03-31","until":"2025-06-30","published":"2025-04-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 2,456,000,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_784E3697A6A8, https://asof.is/claim/clm_784E3697A6A8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427225000091/0000014272-25-000091-index.htm.","url":"https://asof.is/claim/clm_784E3697A6A8","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"2,456,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_784E3697A6A8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2025, filed 2025-04-24"}},{"date":"2025-03-31","until":"2025-06-30","published":"2025-04-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 11,201,000,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_C316438CD5B0, https://asof.is/claim/clm_C316438CD5B0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427225000091/0000014272-25-000091-index.htm.","url":"https://asof.is/claim/clm_C316438CD5B0","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"11,201,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C316438CD5B0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2025, filed 2025-04-24"}},{"date":"2025-04-17","until":"2025-07-24","published":"2025-04-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 2,035,080,810 shares\", as of 2025-04-17 (until 2025-07-24). Claim clm_42F9567D36B6, https://asof.is/claim/clm_42F9567D36B6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427225000091/0000014272-25-000091-index.htm.","url":"https://asof.is/claim/clm_42F9567D36B6","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"2,035,080,810 shares","status":"superseded","assertable":true,"id":"clm_42F9567D36B6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2025, filed 2025-04-24"}},{"date":"2025-06-30","until":"2025-09-30","published":"2025-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 1,310,000,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_08AC6F344E17, https://asof.is/claim/clm_08AC6F344E17, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427225000131/0000014272-25-000131-index.htm.","url":"https://asof.is/claim/clm_08AC6F344E17","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,310,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_08AC6F344E17","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2025, filed 2025-07-31"}},{"date":"2025-06-30","until":"2025-09-30","published":"2025-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 17,435,000,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_35FC8304F747, https://asof.is/claim/clm_35FC8304F747, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427225000131/0000014272-25-000131-index.htm.","url":"https://asof.is/claim/clm_35FC8304F747","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"17,435,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_35FC8304F747","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2025, filed 2025-07-31"}},{"date":"2025-06-30","until":"2025-09-30","published":"2025-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 12,599,000,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_5B41E0056E4E, https://asof.is/claim/clm_5B41E0056E4E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427225000131/0000014272-25-000131-index.htm.","url":"https://asof.is/claim/clm_5B41E0056E4E","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"12,599,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5B41E0056E4E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2025, filed 2025-07-31"}},{"date":"2025-06-30","until":"2025-09-30","published":"2025-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 2,580,000,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_8BF1DFD17C30, https://asof.is/claim/clm_8BF1DFD17C30, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427225000131/0000014272-25-000131-index.htm.","url":"https://asof.is/claim/clm_8BF1DFD17C30","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"2,580,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8BF1DFD17C30","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2025, filed 2025-07-31"}},{"date":"2025-06-30","until":"2025-09-30","published":"2025-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 12,269,000,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_BC0F7635AE7E, https://asof.is/claim/clm_BC0F7635AE7E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427225000131/0000014272-25-000131-index.htm.","url":"https://asof.is/claim/clm_BC0F7635AE7E","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"12,269,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BC0F7635AE7E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2025, filed 2025-07-31"}},{"date":"2025-06-30","until":"2025-09-30","published":"2025-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 94,676,000,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_EBBD764A8BF3, https://asof.is/claim/clm_EBBD764A8BF3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427225000131/0000014272-25-000131-index.htm.","url":"https://asof.is/claim/clm_EBBD764A8BF3","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"94,676,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EBBD764A8BF3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2025, filed 2025-07-31"}},{"date":"2025-07-24","until":"2025-10-23","published":"2025-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 2,035,435,838 shares\", as of 2025-07-24 (until 2025-10-23). Claim clm_92B2391A76BC, https://asof.is/claim/clm_92B2391A76BC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427225000131/0000014272-25-000131-index.htm.","url":"https://asof.is/claim/clm_92B2391A76BC","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"2,035,435,838 shares","status":"superseded","assertable":true,"id":"clm_92B2391A76BC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2025, filed 2025-07-31"}},{"date":"2025-09-30","until":"2025-12-31","published":"2025-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 18,552,000,000 United States dollar\", as of 2025-09-30 (until 2025-12-31). Claim clm_3AA608585C53, https://asof.is/claim/clm_3AA608585C53, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427225000149/0000014272-25-000149-index.htm.","url":"https://asof.is/claim/clm_3AA608585C53","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"18,552,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3AA608585C53","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2025, filed 2025-10-30"}},{"date":"2025-09-30","until":"2025-12-31","published":"2025-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 15,726,000,000 United States dollar\", as of 2025-09-30 (until 2025-12-31). Claim clm_8F913554EE54, https://asof.is/claim/clm_8F913554EE54, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427225000149/0000014272-25-000149-index.htm.","url":"https://asof.is/claim/clm_8F913554EE54","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"15,726,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8F913554EE54","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2025, filed 2025-10-30"}},{"date":"2025-09-30","until":"2025-12-31","published":"2025-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 96,889,000,000 United States dollar\", as of 2025-09-30 (until 2025-12-31). Claim clm_B080F3CCA436, https://asof.is/claim/clm_B080F3CCA436, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427225000149/0000014272-25-000149-index.htm.","url":"https://asof.is/claim/clm_B080F3CCA436","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"96,889,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B080F3CCA436","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2025, filed 2025-10-30"}},{"date":"2025-09-30","until":"2026-03-31","published":"2025-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 2,201,000,000 United States dollar\", as of 2025-09-30 (until 2026-03-31). Claim clm_B6387AF1FB92, https://asof.is/claim/clm_B6387AF1FB92, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427225000149/0000014272-25-000149-index.htm.","url":"https://asof.is/claim/clm_B6387AF1FB92","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"2,201,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B6387AF1FB92","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2025, filed 2025-10-30"}},{"date":"2025-09-30","until":"2026-03-31","published":"2025-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 12,222,000,000 United States dollar\", as of 2025-09-30 (until 2026-03-31). Claim clm_BB784B853512, https://asof.is/claim/clm_BB784B853512, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427225000149/0000014272-25-000149-index.htm.","url":"https://asof.is/claim/clm_BB784B853512","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"12,222,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BB784B853512","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2025, filed 2025-10-30"}},{"date":"2025-09-30","until":"2026-03-31","published":"2025-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 2,528,000,000 United States dollar\", as of 2025-09-30 (until 2026-03-31). Claim clm_F60212FAE72C, https://asof.is/claim/clm_F60212FAE72C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427225000149/0000014272-25-000149-index.htm.","url":"https://asof.is/claim/clm_F60212FAE72C","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"2,528,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F60212FAE72C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2025, filed 2025-10-30"}},{"date":"2025-10-23","until":"2026-02-04","published":"2025-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 2,035,753,027 shares\", as of 2025-10-23 (until 2026-02-04). Claim clm_5DF65CC84443, https://asof.is/claim/clm_5DF65CC84443, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427225000149/0000014272-25-000149-index.htm.","url":"https://asof.is/claim/clm_5DF65CC84443","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"2,035,753,027 shares","status":"superseded","assertable":true,"id":"clm_5DF65CC84443","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2025, filed 2025-10-30"}},{"date":"2025-12-31","until":"2026-03-31","published":"2026-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 90,038,000,000 United States dollar\", as of 2025-12-31 (until 2026-03-31). Claim clm_16735433DCF9, https://asof.is/claim/clm_16735433DCF9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000004/0000014272-26-000004-index.htm.","url":"https://asof.is/claim/clm_16735433DCF9","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"90,038,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_16735433DCF9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2025, filed 2026-02-11"}},{"date":"2025-12-31","until":null,"published":"2026-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb research and development: 9,951,000,000 United States dollar\", as of 2025-12-31. Claim clm_1D1D9926921B, https://asof.is/claim/clm_1D1D9926921B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000004/0000014272-26-000004-index.htm.","url":"https://asof.is/claim/clm_1D1D9926921B","accessed":"2026-11-09"},"kind":"money","predicate":"research_and_development","value":"9,951,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_1D1D9926921B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2025, filed 2026-02-11"}},{"date":"2025-12-31","until":null,"published":"2026-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb net income: 7,054,000,000 United States dollar\", as of 2025-12-31. Claim clm_52D44073C808, https://asof.is/claim/clm_52D44073C808, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000004/0000014272-26-000004-index.htm.","url":"https://asof.is/claim/clm_52D44073C808","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"7,054,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_52D44073C808","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2025, filed 2026-02-11"}},{"date":"2025-12-31","until":"2026-03-31","published":"2026-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 10,209,000,000 United States dollar\", as of 2025-12-31 (until 2026-03-31). Claim clm_71B9DA11CD2A, https://asof.is/claim/clm_71B9DA11CD2A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000004/0000014272-26-000004-index.htm.","url":"https://asof.is/claim/clm_71B9DA11CD2A","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"10,209,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_71B9DA11CD2A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2025, filed 2026-02-11"}},{"date":"2025-12-31","until":null,"published":"2026-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb revenue: 48,194,000,000 United States dollar\", as of 2025-12-31. Claim clm_BB9F55DFC7A5, https://asof.is/claim/clm_BB9F55DFC7A5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000004/0000014272-26-000004-index.htm.","url":"https://asof.is/claim/clm_BB9F55DFC7A5","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"48,194,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_BB9F55DFC7A5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2025, filed 2026-02-11"}},{"date":"2025-12-31","until":"2026-03-31","published":"2026-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 18,473,000,000 United States dollar\", as of 2025-12-31 (until 2026-03-31). Claim clm_D808E9CABB64, https://asof.is/claim/clm_D808E9CABB64, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000004/0000014272-26-000004-index.htm.","url":"https://asof.is/claim/clm_D808E9CABB64","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"18,473,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D808E9CABB64","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2025, filed 2026-02-11"}},{"date":"2026-02-04","until":"2026-04-21","published":"2026-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 2,036,473,705 shares\", as of 2026-02-04 (until 2026-04-21). Claim clm_7BDDFBA6A82F, https://asof.is/claim/clm_7BDDFBA6A82F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000004/0000014272-26-000004-index.htm.","url":"https://asof.is/claim/clm_7BDDFBA6A82F","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"2,036,473,705 shares","status":"superseded","assertable":true,"id":"clm_7BDDFBA6A82F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2025, filed 2026-02-11"}},{"date":"2026-03-31","until":"2026-06-30","published":"2026-04-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 11,489,000,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_3BBDC1786FBC, https://asof.is/claim/clm_3BBDC1786FBC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000010/0000014272-26-000010-index.htm.","url":"https://asof.is/claim/clm_3BBDC1786FBC","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"11,489,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3BBDC1786FBC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2026, filed 2026-04-30"}},{"date":"2026-03-31","until":"2026-06-30","published":"2026-04-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 2,677,000,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_59B16D5CFE58, https://asof.is/claim/clm_59B16D5CFE58, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000010/0000014272-26-000010-index.htm.","url":"https://asof.is/claim/clm_59B16D5CFE58","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"2,677,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_59B16D5CFE58","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2026, filed 2026-04-30"}},{"date":"2026-03-31","until":"2026-06-30","published":"2026-04-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 2,649,000,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_66E70FD09231, https://asof.is/claim/clm_66E70FD09231, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000010/0000014272-26-000010-index.htm.","url":"https://asof.is/claim/clm_66E70FD09231","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"2,649,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_66E70FD09231","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2026, filed 2026-04-30"}},{"date":"2026-03-31","until":"2026-06-30","published":"2026-04-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 20,068,000,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_BD37E595C6F2, https://asof.is/claim/clm_BD37E595C6F2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000010/0000014272-26-000010-index.htm.","url":"https://asof.is/claim/clm_BD37E595C6F2","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"20,068,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BD37E595C6F2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2026, filed 2026-04-30"}},{"date":"2026-03-31","until":"2026-06-30","published":"2026-04-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 9,574,000,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_C1362BDC5761, https://asof.is/claim/clm_C1362BDC5761, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000010/0000014272-26-000010-index.htm.","url":"https://asof.is/claim/clm_C1362BDC5761","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"9,574,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C1362BDC5761","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2026, filed 2026-04-30"}},{"date":"2026-03-31","until":"2026-06-30","published":"2026-04-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 86,476,000,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_EFC619CCF554, https://asof.is/claim/clm_EFC619CCF554, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000010/0000014272-26-000010-index.htm.","url":"https://asof.is/claim/clm_EFC619CCF554","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"86,476,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EFC619CCF554","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2026, filed 2026-04-30"}},{"date":"2026-04-21","until":"2026-07-22","published":"2026-04-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 2,042,071,247 shares\", as of 2026-04-21 (until 2026-07-22). Claim clm_8D842E7F4E9F, https://asof.is/claim/clm_8D842E7F4E9F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000010/0000014272-26-000010-index.htm.","url":"https://asof.is/claim/clm_8D842E7F4E9F","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"2,042,071,247 shares","status":"superseded","assertable":true,"id":"clm_8D842E7F4E9F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2026, filed 2026-04-30"}},{"date":"2026-06-30","until":"2026-09-30","published":"2026-07-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 22,319,000,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_083025B827E0, https://asof.is/claim/clm_083025B827E0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000020/0000014272-26-000020-index.htm.","url":"https://asof.is/claim/clm_083025B827E0","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"22,319,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_083025B827E0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2026, filed 2026-07-30"}},{"date":"2026-06-30","until":"2026-09-30","published":"2026-07-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 3,317,000,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_2F764423414C, https://asof.is/claim/clm_2F764423414C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000020/0000014272-26-000020-index.htm.","url":"https://asof.is/claim/clm_2F764423414C","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"3,317,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2F764423414C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2026, filed 2026-07-30"}},{"date":"2026-06-30","until":"2026-09-30","published":"2026-07-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 2,959,000,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_750726B16C2E, https://asof.is/claim/clm_750726B16C2E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000020/0000014272-26-000020-index.htm.","url":"https://asof.is/claim/clm_750726B16C2E","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"2,959,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_750726B16C2E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2026, filed 2026-07-30"}},{"date":"2026-06-30","until":"2026-09-30","published":"2026-07-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 8,722,000,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_8980CFF36D8A, https://asof.is/claim/clm_8980CFF36D8A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000020/0000014272-26-000020-index.htm.","url":"https://asof.is/claim/clm_8980CFF36D8A","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"8,722,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8980CFF36D8A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2026, filed 2026-07-30"}},{"date":"2026-06-30","until":"2026-09-30","published":"2026-07-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 12,973,000,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_9331256657C6, https://asof.is/claim/clm_9331256657C6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000020/0000014272-26-000020-index.htm.","url":"https://asof.is/claim/clm_9331256657C6","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"12,973,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9331256657C6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2026, filed 2026-07-30"}},{"date":"2026-06-30","until":"2026-09-30","published":"2026-07-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 87,634,000,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_9E417A35E9A3, https://asof.is/claim/clm_9E417A35E9A3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000020/0000014272-26-000020-index.htm.","url":"https://asof.is/claim/clm_9E417A35E9A3","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"87,634,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9E417A35E9A3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2026, filed 2026-07-30"}},{"date":"2026-07-22","until":"2026-10-21","published":"2026-07-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 2,042,714,656 shares\", as of 2026-07-22 (until 2026-10-21). Claim clm_5166F8F7F132, https://asof.is/claim/clm_5166F8F7F132, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000020/0000014272-26-000020-index.htm.","url":"https://asof.is/claim/clm_5166F8F7F132","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"2,042,714,656 shares","status":"superseded","assertable":true,"id":"clm_5166F8F7F132","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2026, filed 2026-07-30"}},{"date":"2026-09-30","until":null,"published":"2026-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 2,162,000,000 United States dollar\", as of 2026-09-30. Claim clm_247D46C4A3C2, https://asof.is/claim/clm_247D46C4A3C2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm.","url":"https://asof.is/claim/clm_247D46C4A3C2","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"2,162,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_247D46C4A3C2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2026, filed 2026-10-29"}},{"date":"2026-09-30","until":null,"published":"2026-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 13,069,000,000 United States dollar\", as of 2026-09-30. Claim clm_41E4C7C8DCE2, https://asof.is/claim/clm_41E4C7C8DCE2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm.","url":"https://asof.is/claim/clm_41E4C7C8DCE2","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"13,069,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_41E4C7C8DCE2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2026, filed 2026-10-29"}},{"date":"2026-09-30","until":null,"published":"2026-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 23,404,000,000 United States dollar\", as of 2026-09-30. Claim clm_724BB1A9B7DC, https://asof.is/claim/clm_724BB1A9B7DC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm.","url":"https://asof.is/claim/clm_724BB1A9B7DC","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"23,404,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_724BB1A9B7DC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2026, filed 2026-10-29"}},{"date":"2026-09-30","until":null,"published":"2026-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 88,772,000,000 United States dollar\", as of 2026-09-30. Claim clm_ABE255E98610, https://asof.is/claim/clm_ABE255E98610, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm.","url":"https://asof.is/claim/clm_ABE255E98610","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"88,772,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_ABE255E98610","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2026, filed 2026-10-29"}},{"date":"2026-09-30","until":null,"published":"2026-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 9,574,000,000 United States dollar\", as of 2026-09-30. Claim clm_D7A2CC833948, https://asof.is/claim/clm_D7A2CC833948, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm.","url":"https://asof.is/claim/clm_D7A2CC833948","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"9,574,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_D7A2CC833948","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2026, filed 2026-10-29"}},{"date":"2026-09-30","until":null,"published":"2026-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 2,365,000,000 United States dollar\", as of 2026-09-30. Claim clm_F9CEFB4CA8DE, https://asof.is/claim/clm_F9CEFB4CA8DE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm.","url":"https://asof.is/claim/clm_F9CEFB4CA8DE","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_research_and_development","value":"2,365,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_F9CEFB4CA8DE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2026, filed 2026-10-29"}},{"date":"2026-10-21","until":null,"published":"2026-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 2,044,085,831 shares\", as of 2026-10-21. Claim clm_434253DF3386, https://asof.is/claim/clm_434253DF3386, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm.","url":"https://asof.is/claim/clm_434253DF3386","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"2,044,085,831 shares","status":"valid","assertable":true,"id":"clm_434253DF3386","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2026, filed 2026-10-29"}}],"complete":true,"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{"low_confidence":"Confidence below 0.5, the line the record asserts at.","unverified":"Unverified: one source that is not primary, or a primary source below confidence 0.7. Asserted once a primary source or a second independent domain confirms it."},"checked_by":{"sec-filing":"parsed from the SEC filing","page-read":"its source page states the value and the date","own-site":"the entity's own site names it (a website whose page names the entity, a handle its website links to)"}}}